The Ergogenic Effects of Oxygen Supplementation on Cycling Performance by Porter, Michael S
  
 
 
 
 
The Ergogenic Effects of Oxygen Supplementation on 
Cycling Performance 
 
Michael Porter 
 
 
A thesis submitted for the degree of Ph.D. in Sports and Exercise Science 
School of Sport, Rehabilitation and Exercise Sciences 
University of Essex 
 
 
August 2020 
  
Page 2 of 254 
 
Quote 
 
“We all have dreams. But in order to make dreams come into reality, it takes an awful lot 
of determination, dedication, self-discipline, and effort.” 
Jesse Owens 
 
 
 
 
 
 
 
Dedication 
 
This thesis is dedicated to all the people that motivated me along the way and especially 
those that had a big impact in my sporting endeavours from a young age till now. Finally, 
I would like to dedicate this thesis to those that were lost through the PhD process. I made 
it!  
Page 3 of 254 
 
Acknowledgements 
 
Dr. Katherine Reed, Lecturer at the University of Essex. 
Firstly, I would like to start with my supervisor Dr. Katharine Reed. Thank you for 
all the guidance and help with setting up the project. It was a challenging task at times but 
worthwhile in the end. Your drive and know how has been so helpful when writing up this 
thesis. Your open-door policy was very helpful throughout the process. Just having 
someone to bounce ideas off and then formulating them into actions to work on. I could 
never thank you enough. Thank you! 
 
Dr. Ben Jones, Lecturer at the University of Essex. 
Secondly, I would like to thank my co-supervisor Ben Jones. It was always so very 
helpful having another pair of eyes to advise me on my work. I’m very thankful for all the 
time you spent helping me improve my writing style and giving me the tools to develop 
myself as an academic.  
 
Patrick Schoenmakers & Robert Southall- Edwards. Postgraduate Research Students.  
Patrick Schoenmakers, where to start. Without constantly using Patricks experience 
to assist me and give me a person to aspire to be was so valuable throughout the whole 
process. Learning from your study’s design and your ability to churn out good papers was 
so important to my own progression. Also, having someone who is going through the 
process a year ahead of me enabled me to have a good idea of a plan and what to do to be 
finished in due time. Plus, the man who converted me to a black coffee drinker, without 
coffee the PhD process would have been very bleak. 
 
Page 4 of 254 
 
Robert Southall-Edwards, AKA lost wallet guy. My very good friend throughout 
this process. We probably kept each other “sane” through each other’s PhD with the coffee 
breaks, banter, and exercise. We certainly pushed each other out of our comfort zones in 
both this country and America. Certainly, have memories that last a lifetime with you. I 
wish you all the best and look forward to working with you on projects in the future. 
 
Claire Colley, Glenn Doel & Jayne Suddaby. Sports Science Laboratory Technicians.  
A special thank you to the laboratory technicians with the sports science department 
here at Essex. We have spent many hours trying to my ambitious ideas into a working plan. 
I am grateful for all the support and technical advice you have provided me along the way. 
Thank You! 
 
Family & Girlfriend. 
To my family, I think it goes without saying but your support and motivation along 
the way really has meant the world. It has been a journey that I will never forget, and you 
facilitated it, for that I will be forever grateful.  
A special thank you to Megan Wilde my girlfriend, without you this would have 
been a distant dream. You have been my sounding board throughout, but most of all you 
have kept me grounded and motivated to keep going.  
 
Research Participants 
A final thanks to all the participants who willingly gave up their time to contribute 
to science but most of all to this PhD journey.   
Page 5 of 254 
 
Chapter Specific Acknowledgements  
Chapter One & Two: 
Thank you to the lecturers within the SRES department who assisted with the 
formulation of my literature review. One of the chapters that has too many ways of writing. 
Also, thank you to the library staff at the University, whom helped me gain access to the 
PGR room at all hours of the day during those crazy writing days at the start of my PhD. 
 
Chapter Three: 
I would like to thank Alina Jantea for all your help with data collection. An extra 
pair of hands has been vital for the completion of everything I needed to do. Also, just to 
have someone to talk to, to make my brain process things differently has been pivotal.  
 
Chapter Four & Five: 
Without the assistance of Jordan Fenton during my large second study, the study 
would have been over before it even started. He was more valuable than just an extra pair 
of hands. The ability to collect data with a friend was something that cannot be overlooked, 
it made the process much more enjoyable. Additionally, having another person to talk to 
and make sure I have not overlooked anything was so important.  
 
Chapter Six: 
I would like to thank the small group of master’s students that helped me collect 
data during my penultimate study. Having the help during the recruitment and data 
collection process was extremely helpful. Without them the whole study would have taken 
a lot longer than it did. Also, working with people whom I would not normally choose to 
work with keeps the process interesting.  
Page 6 of 254 
 
 
Chapter Seven: 
I would like to say thank you to Dr. Siana Jones at University College London, who 
helped with the methodology for measuring muscle VO2 using the NIRS devices. Also, a 
special mention to Jayne one of our lab technicians. Without her I would still be trying to 
work out how to use some of the equipment. Also, her drive to get things done gave me a 
lot of energy to push through myself.   
 
Chapter Eight & Nine:  
Dr. Gavin Sandercock, the stats guru. The man with a bottomless pit of statistical 
know how. Without the repeated stats and writing workshops this whole thesis wouldn’t 
be where it is today. Also, thank you for giving me the confidence to learn and use statistical 
tests that used to make my head hurt. 
  
Page 7 of 254 
 
Thesis Abstract 
Over the past 20 years oxygen supplementation has been proposed as an ergogenic 
aid in a range of sports and endorsed by various governing bodies (including the NFL and 
the NBA). Originally the use of oxygen supplementation in research was related time trial 
and time to exhaustion performances, i.e. predominately aerobic activities. However, more 
recently, oxygen supplementation has also been shown to benefit high intensity short 
duration activity.  
This thesis aimed to further examine how oxygen supplementation may offer performance 
enhancing benefits, particularly during repeated sprint exercise. The first aim, examined in 
study 1, was designed to investigate the effects of oxygen supplementation on repeat sprint 
cycle performance. Studies 2 and 3 followed on with aims to investigate mechanisms that 
underlie these performance enhancements. Next, we aimed to determine how the exact 
timing of oxygen supplementation could potentially influence repeated sprint performance 
(study 4). The final aim, examined in study 5 was to identify whether the observed short-
term performance benefits of oxygen supplementation, would transfer to performance 
improvements as a result of a supplemented training intervention. These aims allowed us 
to investigate some of the gaps in the existing literature, whilst developing a progressive 
narrative within oxygen supplementation research. 
Investigating the mechanisms behind the change in acute and chronic performance 
involved the use of both near infrared spectroscopy (NIRS) and twitch potentiation. The 
use of these devices alongside oxygen supplementation resulted in novel studies. Similarly, 
our training study was conducted on competitive level cyclists, making our results of great 
interest to the cycling community.  
Throughout this thesis, oxygen supplementation was shown to be a beneficial ergogenic 
aid during repeat sprint cycling which can be applied to training on a session by session 
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basis. Further research is needed to evaluate its chronic effectiveness when used during 
high intensity exercise and explore more of the underlying mechanisms.   
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1.1 Introduction  
Oxygen supplementation (O2Supp) is the administration of medical grade oxygen to 
athletes during or between periods of work 1. To date O2Supp has been applied to a variety 
of different training modalities (running, cycling and rowing) at varying degrees of 
concentration (percentage of oxygen consumed) 1–6.  
Many performance and recovery aids are already used by a large proportion of the sporting 
population (such as muscle stimulation, foam rolling, bicarbonate, and stretching), and 
athletes are continuously searching for the more performance enhancers - oxygen 
supplementation (O2Supp) is one of the newer options. 
A common focus within O2Supp research the effect on performance during high intensity 
interval training (HIIT). HIIT is short duration, intense periods of work interspersed with 
periods of active or passive recovery. It is during these periods of recovery where O2Supp 
may be most effective. 
Researchers have already begun to apply O2Supp to a variety of different training 
modalities (rowing, cycling, swimming, running) with varying degrees of effectiveness. As 
the concentration of oxygen varies across studies the findings are not easy to compare. In 
order to reduce the dose response component, the research in this thesis will look at the 
effectiveness of O2Supp during high intensity repeated sprint cycling using only 100% 
medical grade oxygen concentration (fraction of inspired oxygen - FiO2 1.00). The 
experimental chapters within this thesis will incorporate consistent methodology to identify 
the effectiveness of O2Supp as a performance aid. 
 
1.2 Aims of Research  
Several studies 5,7,8 have begun to identify the effectiveness of O2Supp in a variety 
of different sporting modalities, but not specifically repeat sprint cycling.  
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This research aims to assess the effectiveness of O2Supp on repeat sprint cycling and will 
aim to answer the following; 
- During which component of a repeat sprint cycling training session is O2Supp most 
effective at increasing performance? 
- Which physiological components does O2Supp effect to allow for improvements in 
performance capacity? 
- Can a short-term training intervention influence performance or metabolic markers 
of performance? 
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2 – Literature Review: 
The Use of Oxygen Supplementation and its Role Within an Exercise 
Programme  
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2.1 Overview 
This literature review provides an in-depth description of O2Supp, and its purported 
effects on exercise performance with a particular focus on high intensity interval training 
(HIIT).  
HIIT training and its main limiting factor (peripheral fatigue) will be addressed first, 
followed by a description of oxygen supplementation, and how it has been used within 
sports performance research. Published studies exploring both acute and chronic 
supplementation and the resultant effects on both performance and exercise metabolism 
will be examined. 
This review will also explore many of the mechanisms that are believed to underlie the 
effects of O2Supp (such as increased muscle & whole-body oxygenation, reduced blood 
lactate accumulation, enhanced phosphocreatine resynthesis and reduced peripheral muscle 
fatigue,). Within this section, the two of methods used to determine the extent to which 
oxygen supplementation affects physiology are examined in depth – these methods are near 
infrared spectroscopy (NIRS) and twitch interpolation (TI). These methodologies will play 
a vital role in the forthcoming experimental studies.   
The review will finish with a brief outline of gaps in the literature related to 
supplementation and performance, followed by the aims and hypotheses of the current 
thesis. 
 
2.2 HIIT / SIT training 
High-intensity interval training (HIIT) is a common, time efficient training method 
for improving cardiorespiratory and metabolic function and in turn, physical performance 
in athletes 9. HIIT involves recurring bouts of short high-intensity exercise (45 s – 4 min) 
interspersed with short periods of recovery 10. HIIT has been shown to be an optimal 
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stimulus for eliciting maximum cardiovascular and peripheral adaptations in relatively 
short training sessions 11,12. This is achieved by subjecting the athlete to an increased 
amount of time in the ‘red zone’, which is characterised by working at greater than 90% of 
their V̇O2max 10,12. Most HIIT session only last for several minutes with the majority of 
that in the ‘red zone’, eliciting both acute (lactate accumulation, peripheral fatigue) and 
chronic (myocardial enlargement and oxidative muscle adaptation) changes.  
HIIT consists of the variation of  nine variables, including the work interval intensity and 
duration, the recovery interval recovery and duration, exercise modality, number of 
repetitions, number of sets, as well as the between set recovery and duration 13. The 
manipulation of these variables affects the acute physiological responses to HIIT. The most 
common variables to manipulate are the work and recovery durations. HIIT has been split 
into four main areas that incorporates the many different work durations; short intervals, 
long intervals, repeated sprint training (RST) and sprint interval training (SIT) 9,13. Short 
interval HIIT has a work duration of less than 60 s and long interval HIIT has a work 
duration of 60 s or longer. RST and SIT are types of short interval HIIT as they both have 
work durations of less than 60 s. RST commonly has work durations of 3-10 s in length 
and whereas SIT has work periods of 30-45 s in duration 13. 
It is suggested that with a change in work duration, comes a reduction in critical 
maintainable velocity. Taken from Buchheit et al., 2013 13, velocity for SIT ranges from 
85 -100% of maximum sprint speed or 160-200% of velocity of V̇O2max (vV̇O2max),  
whereas, RST can be conducted at a relatively slower intensity of 120 – 160% vV̇O2max. 
The main reason for this drop in maximal velocity is down to the recovery durations 
following the work. RST has short high intensity intervals followed by short (30 s) recovery 
periods; therefore, the velocity must be reduced to maintain multiple repetitions. SIT has 
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slightly longer intervals with long recoveries (2-4 min), allowing for complete recovery 
and increased work velocity. 
It is evident that HIIT training can be applied to an array of different sports (Hockey, 
cycling, running and football 14–17). HIIT training can take many forms, some lending 
themselves to be more effective types of training than others. The most common protocol 
for building peak power is both SIT and RST. SIT allows an individual to work at a very 
high-power output and repeat it until chronic adaptations occur (common in 100 m 
training), whereas RST allows the athlete to test their recovery capabilities when producing 
large power outputs (common in track cycling)18–20. The adaptations that occur during SIT 
and RST are both metabolic and musculoskeletal. The metabolic adaptations that occur are 
the increased efficiency of converting phosphagens and ADP into adenosine triphosphate 
(ATP), restoration of phosphocreatine (PCr), and the anaerobic breakdown of 
carbohydrates, whereas the cardio and musculoskeletal adaptations that occur include 
increase stroke volume, increase microvascular size of the peripheral muscles vessels, and 
muscle fibre recruitment changes 21–23. Short and long duration HIIT work the aerobic 
system that aids endurance performance by increasing V̇O2max and the velocity at which 
it is achieved. These are achieved by increasing the efficiency of muscle glycogen 
utilisation and the cardiopulmonary circuit.  
Performance during both SIT and RST training are limited by several physiological factors; 
resynthesis of anaerobic sources during recovery, muscular fatigue, and the metabolic 
homeostasis within the cells, all of which can improve an individual’s performance 15,16,24. 
 
2.3 Fatigue 
Fatigue comprises many different pathways and symptoms and therefore, researchers 
define fatigue as largely different entities. In this thesis the combination of Edwards 25, and 
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Bigland- Ritchie et al., 26, definitions will be used “The inability to maintain the required 
level of strength or power output, leading to exercise cessation” & “Any exercise induced 
reduction in maximal force or power regardless of whether the task can be sustained or 
not”. These are two definitions that describe what occurs to the physiological performance 
parameters during sport. 
Fatigue is often quantified as either peripheral and central fatigue 27,28. Central fatigue 
represents the decrease in the ability of the recruitment of muscle motor units at the start 
of muscle force generation 29. There are several hypothesises as to why this occurs; 
increased brain serotonin levels, an altered ratio between tryptophan and branch chain 
amino acids 30 and the irritation of nerve endings. Central fatigue is, in essence, those 
chemical imbalances or fluctuations within the brain during daily life and especially during 
exercise. Central fatigue can be measured in many ways; intrusively by taking brain blood 
samples to identify the fluctuations within the biochemistry of the brain, the perception of 
fatigue (ratings of perceived exertion), peripheral twitch interpolation, transcranial 
magnetic stimulation and electromyography.  
Peripheral fatigue on the other hand refers to physiological changes that occur as a result 
of alterations in nerve impulses at a muscular level. Peripheral fatigue thus, is a decrease 
in the contractile strength of the muscle fibres due to changes in the frequency and strength 
of the muscle action potentials 28. Peripheral fatigue can be measured in a plethora of ways, 
such as; a decline in performance, reduced force produced during maximal voluntary 
contraction (MVC) and twitch interpolation (TI) 31–33. TI is the most common way of 
measuring peripheral fatigue and is the measurement of force being produced by a single 
stimulus. The amplitude of the twitch then identifies the contraction intensity and level of 
excitation of the motor neurons 34. A large twitch indicates a larger level of peripheral 
fatigue at a muscular level.  
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2.3.1 Central Fatigue 
Central fatigue is the reduction in the supraspinal recruitment of muscle motor units 
that generate muscle force. Central fatigue governs the supraspinal and spinal changes in 
physiology capable of inducing an excitation in the motor neuron (reduction in 
neurotransmitters and conductive capability at the neuron junction).  
Central fatigue is generated from the cerebellum and the spinal cord that make up the 
central nervous system. These organs are extremely sensitive to alterations in their 
homeostatic regulation, as well as invasive instruments to measure it. Resultantly, due to 
the nature of central fatigue it is problematic to recognise the ‘true’ underpinning 
mechanisms and fatiguing components during exercise. Ethically it would be 
impermissible to attach probes to an individual’s brain to directly monitor the chemical 
composition and oxygenation. Therefore, direct measures are not frequently used. Many 
indirect measures occur as a result; cerebral NIRS, transcranial magnetic stimulation, and 
invasive measures such as cranial cannulas 28,31. 
Central fatigue is one factor that results in performance decline throughout a race. Gandevia 
28 identified that a 25% drop-in force of the motor unit identified using transcranial 
magnetic stimulation was attributed solely to central fatigue. Further, he found that during 
sub maximal low intensity exercise the significant reduction in force was again largely 
(25%) attributed to central fatigue, due to the reduced excitation stimulated by the motor 
cortex. It has also been shown that the amount of central fatigue experienced is directly 
linked to the amount of oxygen available. An inadequate supply of oxygen to the brain and 
low mitochondrial oxygen tension has been shown to influence the function of neurons, 
and thereby their ability to maintain motor activation 35. During hypoxic conditions the 
‘central governor’ reduces the muscle contractile force to deal with the ischaemic 
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conditions the body’s organs are being subjected too. The opposite is hypothesised to 
happen for hyperoxic conditions. The central governor model states that the brain 
dynamically regulates the physical exertion by different inputs to the body, allowing task 
completion in a safe manner 36. The central governor is able to divert greater oxygen supply 
to the working muscles because of an increased availability, supply and volume 37.   
 
2.3.2 Peripheral Fatigue 
Peripheral fatigue occurs when the motor drive within the central nervous system 
is unchanged, but the full electrical excitation produced within the motor units is no longer 
adequate to support maximal voluntary contractions 26. Due to the nature of the 
neuromuscular junction and the mechanism behind muscle contraction many would 
suggest that peripheral fatigue is also multidimensional in nature.  
The neuromuscular junction is where neural signals are transferred from a neuron to its 
target. It comprises a synaptic terminal and a synaptic cleft. The terminal between the 
synaptic terminal, otherwise known as the end of the axon terminal, and the motor end plate 
is regulated by multiple biochemical reactions. Inorganic phosphate (Pi) induces a 
desensitisation in the terminal leading to a reduction in force production 38,39. Subsequently, 
acetylcholine is released and is the primary chemical used to regulate the terminal space to 
ensure full sensitivity and polarisation 40. 
Huxley’s sliding filament theory 41 states that the H bands (myosin) and the I bands (Actin) 
get smaller during a contraction, the zones then overlap and the Z lines move closer together 
(actinin attached with titin). The contraction weakens when the I band disappear, and the 
H bands and the Z line connect. If calcium is not released from the sarcoplasmic reticulum 
efficiently, the muscle fibres cannot contract. The control of calcium production is 
governed by both neural control and build-up of other compounds such as phospholamban.  
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Biochemical changes within the muscles are associated with imbalances within the 
sarcolemma and its electrical potential 42. A change in the electrical signal is a direct result 
of biochemical imbalances, which in turn reduces the force generating capacity of local 
muscles resulting in muscular fatigue 43. A small change in the cellular homeostatic balance 
within the muscle fibres lead to large reductions in the force generating capacity. Factors 
that have the capacity to alter this homeostasis are; the depletion of ATP, depletion of PCr, 
accumulation of inorganic phosphate, and decrease in pH, to name a few.  
ATP availability has been closely correlated to the fatiguability of local muscles. As ATP 
depletion increases fatigue within the skeletal muscles. However it is still up for debate 
whether this phenomenon is coincidental or causative 43. It has been shown that 
intramuscular supply of ATP and PCr are never completely depleted, as a protective 
mechanism with the body, so levels are regulated to maintain integrity within the cells. 
Bergstrom et al., 44 found that ATP and PCr were between 10-70% of their rested values 
during exhaustive exercise. Although, they state that ATP is stored within multiple 
compartments (such as mitochondria and cytoplasm), the local store of ATP maybe 
depleted but the overall cellular level remains intact.  
Lactate and hydrogen ions (H+) play a large role in the materialisation of peripheral fatigue 
during exercise lasting between 15 s and 15 min. During high intensity exercise the build-
up of lactate and H+ is due to the inefficiency of the Cori cycle and production subsequently 
exceeds removal. The effects of lactate in peripheral fatigue are 85% attributed to the 
increase in H+, leading to an exercise induced acidosis 45. Intramuscular acidosis has been 
shown to cause an inhibition of the energy systems (glycolysis), and consequently a 
reduction in power output follows 46.  
Accumulation of inorganic phosphate may also result in peripheral fatigue as it has been 
linked with limiting force generation via inhibiting calcium secretion within the 
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sarcoplasmic reticulum 47. Further,  inorganic phosphate desensitises the cross bridges at 
the neuromuscular junction 38,48. 
 
2.4 Recovering from fatigue 
Fatigue is an outcome that is a consequence of numerous processes that are a result 
of exercise. Physiological fatigue (referred to as performance decline in the following 
chapters) is the result of the acute physiological stress that a single fatiguing training 
session evokes, which is also associated with; minor muscle damage, inflammation, 
nervous system fatigue, and oxidative fatigue 49. To minimise the effects of these stresses, 
multiple recovery strategies have been proposed over the years; adequate nutrition, cool 
down, massage, compression, cold-water immersion and ‘gas therapy’ 49–51. These 
strategies have been proposed to aid recovery post a repeat sprint session. As well as post 
exercise recovery, minimising the amount of fatigue experienced during repeat sprint 
training is also vital for performance. Acute fatigue that is as a result of one sprint is 
associated with increase pH, reduced fuel availability (PCr) and accumulation of lactate. 
Acute fatigue requires different recovery strategies than that of chronic fatigue, these 
strategies may include bicarbonate supplementation, creatine loading and O2Supp 
52. This 
next section of this review will be on the recovery from acute fatigue with the impetus on 
O2Supp.  
 
2.4.1 Recovery Techniques for Acute Fatigue 
Gas therapy, or oxygen therapy, is the use of various gas mixtures to aid in recovery 
depending on type of exercise 53. O2Supp during recovery has been shown to decrease 
lactate production and increase both peak power and mean power 7,54. There are two distinct 
form of O2Supp: normobaric and hyperbaric. 
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Hyperbaric O2Supp is the administration of oxygen at a barometric pressure higher than 
that of the pressure at sea level 53. Hyperbaric O2Supp increases the blood plasma 
concentration of oxygen from 0.3 ml per decilitre to 1.5 ml per decilitre 55, simply by 
increasing the pressure gradient at a cellular level. Due to the large pressures at which   the 
gas must be administered, hyperbaric O2Supp typically occurs in an airtight chamber. This 
enables the correct manipulation of pressures and composition of the air. There are 
important health implications to be considered when using hyperbaric O2Supp. Oxygen is 
needed to sustain life, however too much oxygen is toxic to the central nervous system 56,57. 
Oxygen toxicity is not easily identified until it is in its advanced stages, as it is masked by 
the hyperventilation response that comes from O2Supp. 
 
Potential prolonged use of O2Supp (greater than 6-weeks) may cause health problems as a 
result of cell damage 1. Long term exposure to high concentrations of oxygen (FiO2 > 0.60) 
even at normobaric pressure, may cause oxygen toxicity through the formation of excessive 
reactive oxygen species (ROS) 56,58–60. However, there is no difference in haematological 
and urinary markers of oxidative stress during high intensity prolonged training periods 
with FiO2 of < 0.60 
61. ROS formation within the mitochondria has been reported to 
increase linearly with inhaled oxygen concentration. However, to date no negative effects 
of short term inhalation of oxygen enriched air during exercise at sea level has been 
reported 7,62, although it has been hypothesised that the risk exponentially grows with FiO2 
concentration 1. Therefore, during high intensity exercise it cannot be identified whether it 
is the exercise or the O2Supp toxicity that causes a hyperventilation response. This is one 
of the many reasons, hyperbaric O2Supp is not widely used within the sporting community.  
Normobaric O2Supp is the administration of oxygen at a barometric pressure equivalent to 
pressure at sea level (760 mmHg or 1 Atmosphere [ATM]). Normobaric O2Supp is the 
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most widely used tool for O2Supp because it can be administered using a plethora of 
techniques; Douglas bags, air tight tent, or regulated oxygen cylinder 2. The most crucial 
benefit of normobaric O2Supp above hyperbaria is the pressure of administration is at 
normal air pressure, which is less likely to cause significant adverse effects.  
 
2.5 Near Infrared Spectroscopy 
NIRS is an imaging tool that was designed for clinical and emergency medicine. 
Additional uses have become evident. NIRS is now used in human physiology research to 
quantify and non- invasively measure the oxygenation status of human tissues 63. The 
oxygenation status of a human tissue can be identified by measuring the oxygen saturation 
of haemoglobin molecules, based on the absorbance of near infrared light (Figure 2-1).  
NIRS historically used expensive large spectrometers using fibre optic cables, however 
with the advancements in technology these are now no bigger that a cellular phone. The 
increase in the resolution of near infrared light and the changes in the theoretical models 
(Beer Lambert Law to the Modified Beer Lambert law) has led to NIRS being widely used 
to measure tissue haemodynamics (Figure 2-2).  
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Figure 2-1. Electromagnet Spectrum – Liberated from a Lawrence Berkeley 
Laboratory web page https://www2.lbl.gov/MicroWorlds/ALSTool/EMSpec/EMSpec2.html.  
 
The light absorbing compounds in human tissue within the near infrared range are called 
chromophores 64. The primary chromophores detected by NIRS are oxyhaemoglobin 
(HbO2) and deoxyhaemoglobin (HHb), their concentration varies with time and 
oxygenation status 65.  HHb and HbO2 are responsible for the transport, delivery and 
removal of oxygen and carbon dioxide through-out the human body 63. NIRS works by 
detecting the amount of light absorbed by the tissue and identifying the amount that is 
refracted back and received by the device.  This is used to identify the rate of oxygenation 
and deoxygenation during exercise and, along with measures of cardiac output (heart rate 
and blood flow), helps to identify the central and peripheral components of the exercise. 
This is assessed by detecting the changes in oxygenation and blood flow at both a cerebral 
and peripheral muscle level.  
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Figure 2-2. Visual diagram of infrared light pathway through muscle tissue. 
Liberated from Artinis Medical Systems (https://www.artinis.com/theory-of-nirs). 
 
NIRS has been found to be a useful tool to measure blood flow and volume, which is 
required to determine regional oxygen delivery and uptake 66. Although NIRS is not 
without its downfalls; the proxy of the total NIRS reading (tissue saturation index for 
example) has been shown to comprise 5% skin haemodynamics and the remainder muscle 
67. This is to be considered when looking at desaturation rates. Desaturation and 
resaturation rates of the skeletal muscle cells during exercise have been considered the 
main limiting factor during repeated sprint efforts 68. This was measured using pulse 
oximetry which validates NIRS devices to identify arterial O2 saturation. Muscle oxygen 
desaturation occurs when the working muscle is using more oxygen than is being supplied 
and beginning to work anaerobically. Resaturation is the recovery of the working muscles 
oxygen levels back to a pre exercise state, and this typically occurs during periods of rest.   
NIRS has been shown to be affected by the thickness of adipose tissue. A recent study 
found that thicker adipose tissue the decreased the sensitivity of desaturation and 
overestimation of  actual muscle oxygenation levels 69. Other measures (such as muscle 
biopsies, arterial blood gases) are more accurate for measuring skeletal muscle 
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oxygenation, although all are invasive. NIRS is non-invasive and does not affect concurrent 
human locomotion, so despite its limitations, it is a valuable tool within sport science 
research. 
The development of portable NIRS technology has allowed research into tissue 
oxygenation and localised haemodynamic in an applied exercise environment.  The 
portable nature of NIRS lends itself to research to occur during human locomotion, to 
identify biochemical aspects during exercise performance. The invention of portable NIRS 
devices allows a coach or athlete to monitor their muscle oxygenation directly and alter 
training modality, and training/ recovery duration to elicit the greatest response from 
training they can. A coach using NIRS has the ability to be able to identify when an athlete 
has fully resaturated their peripheral muscles with oxygen. This information can direct 
athletes to start training once they resaturate fully.  
HIIT and SIT based research have employed NIRS extensively 70,71. The rate of muscle 
oxygen resaturation has strong links with the recovery rate of PCr, a metabolite that is a 
vital fuel for high intensity exercise 72. Distinct changes in muscle oxygenation (HbO2 and 
HHb) profiles have been observed, characterised by large desaturation / resaturation 
profiles (Figure 2-3). It has been documented that these profiles (desaturation/ resaturation) 
are strongly correlated (r2 = 0.51) with the rate of resynthesis of PCr 72. The rate of muscle 
oxygen recovery reflects the utilisation of oxygen after exercise to resynthesise PCr. 
Increases in HbO2 between conditions would demonstrate this increase PCr resynthesis. It 
is also suggested that the recovery of HbO2 resaturation could also be used as an index of 
muscle oxidative capacity 72,73. The faster the resaturation of HbO2 in the working muscles 
following exercise, indicates an increase in oxidative capacity of the muscles. A proxy of 
muscle oxidative capacity can be assessed directly using arterial occlusions and NIRS 74,75. 
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This measure looks at the speed at which HbO2 recovers following arterial occlusions and 
the rate at which HHb declines during said occlusions.  
Therefore, the use of these muscle oxygen profiles can provide insight (albeit indirectly) 
into which training programmes and aids are more effective at increasing the resynthesis 
of PCr. PCr resynthesis and muscle oxygenation profile are vital for most exercise, 
particularly HIIT and SIT based sessions. HIIT & SIT are commonly used to enhance 
performance by eliciting improvements in the oxidative capacity of working muscles and 
maximal oxygen uptake 20. Interestingly yet unsurprisingly HIIT/SIT based training 
programs have also demonstrated performance benefits via peripheral adaptations 
(mitochondrial density/ increased microvascular size and amount/ increased enzyme 
activity) 18,70- that lead to enhanced oxidative capacity of working muscles and maximal 
oxygen uptake. 
 It has been found that the consumption of hyperoxic gas causes significant changes in 
NIRS signals. Vanhatalo et al., 76 mentioned that local muscle delivery increased by 29.5% 
during O2Supp, compared to Normoxia. They went on to show that the increased 
availability of oxygen did not change the overall kinetics; as O2 availabilty became higher, 
O2 extraction reduced to maintain equilibrium. The baseline muscle saturation level was at 
an elevated level but recorded similar levels of desaturation as Normoxia. Vanhatalo et al., 
also highlighted that even though there was an increase in muscle oxygen delivery, muscle 
fractional O2 extraction was reduced by 36% -estimated using HHb. HHb can be used to 
assess the relationship between muscle resaturation and muscle desaturation. 
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Figure 2-3. Example of NIRS muscle hemodynamic responses during a swim test. 
Taken from Jones et al., 2018 77. 
Legend: ΔO2Hb+O2Mb, change in Oxyhaemoglobin and oxymyoglobin levels; 
ΔHHb+HMb, change in deoxyhaemoglobin and deoxy myoglobin levels; ΔtHb change in 
total haemoglobin oxygenation. 
 
Supplementing high intensity exercise with hyperoxia has been shown to enhance the 
clearing of BLa and prevent the rate of muscle desaturation 54,78. It has also been noted that 
the prevention of less than 10% drop in arterial O2 saturation, significantly lessens the 
amount of exercised induced force reduction of the quadriceps muscles, following cycling 
tasks 79. Although, not directly measured using NIRS, changes in arterial saturation will 
affect the periphery further down the oxygen cascade where NIRS measures are taken 
(peripheral muscle oxygen levels) 80.  Preventing a decrease in arterial oxygenation will aid 
the maintenance of the homeostasis in the periphery. It has been shown that a decrease in 
arterial oxygen saturation significantly effects peripheral muscle fatiguability 81,82. A 
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reduction in the muscle oxygen level aligns with local muscle fatigue at a peripheral level, 
and this is visibly evident by large reductions in muscle resaturation.  
The recovery of muscle oxygen (resaturation rate) strongly correlates with the resynthesis 
of PCr during recovery periods 72. Resynthesis of PCr is a key component which affects 
performance during repeated sprint efforts. Additionally, Balsom et al., 83 found that post 
exercise multiple subcutaneous injections of erythropoietin (EPO) during hypoxia and 
O2Supp, enhanced anaerobic metabolism, and an increased O2 availabilty (due to 10% 
increase in haemoglobin concentration) which led to a significant increase in PCr 
resynthesis during 15 x 6 s cycling sprints. Similar increases in PCr resynthesis are 
proposed to occur during O2Supp due to the increased oxygen availability, comparable to 
EPO injections.   
 
 
2.6 Oxygen Supplementation 
Hyperoxia occurs when cells, tissues and organs are exposed to an excess supply of 
oxygen or higher than normal partial pressure of oxygen 84. O2Supp causes a hyperoxic 
response within the body. High oxygen availability is used to treat patients with chronic 
obstructive pulmonary diseases (COPD). Oxygen can be used to supplement their air 
supply, so they have sufficient oxygen delivery to their cells in light of their disease. 
Comparable to this, altitude training has similar physiological restraints as COPD 85.  
One point of note is the correct use of the term hyperoxia. Hyperoxia occurs when cells, 
tissues and organs are exposed to an excess supply of oxygen or higher than normal partial 
pressure of oxygen 59. Hyperoxia is the internal change due to the consumption of high 
oxygen content gas, not the physical gas that is being administered.  
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2.6.1 Normal Respiratory Physiology 
During breathing, normal atmospheric air (~21% oxygen, 0.04% carbon dioxide, 
78% nitrogen and ~1% other gases) travels down the pulmonary ventilation system into the 
lungs where it diffuses into the capillaries at a speed of up to 3 L·min-1 of oxygen (during 
exercise). The average oxygen pressure gradient between alveoli (100 mmHg) and 
capillaries (40 mmHg) is 60 mmHg. A healthy lung at rest will reach an equilibrium in 
pressure (atmospheric pressure and alveoli pressure difference) within 0.25 s which is about 
⅓ of the bloods transit time around the lung. During vigorous exercise blood transit time is 
increased by as much as 3-fold, and this increase in velocity does not usually restrict the 
loading of oxygen in the blood 86,87. This increase in velocity of the blood coincides with 
an increase in the ventilatory equivalent (ratio of the volume of gas expired per minute to 
the volume of oxygen consumed per minute), enabling the maintenance of oxygen loading 
to the blood.   
Once oxygen has passed into the blood it combines with the metallic compound 
haemoglobin (iron containing globular protein). There are over 280 million haemoglobin 
molecules per red blood cell (and 25 trillion RBCs in the body). The nature of RBCs means 
that greater than 70 times more oxygen is combined within haemoglobin than dissolved in 
the plasma There is on average 15 g of haemoglobin per 100 ml of blood with an oxygen 
carrying capacity of 1.34 ml O2·g
-1. Therefore, per 100 ml of blood around 20 ml of oxygen 
is carried at any one time.  
The saturation of haemoglobin with oxygen is altered by internal fluctuations in oxygen 
pressure, core temperature, cellular pH and carbon dioxide, as indicated by an 
oxyhaemoglobin dissociation curve. 88. 
Myoglobin, the iron globular protein that is found in muscle microvascular, on the other 
hand is less affected by these internal changes. Oxygen is transported from the alveoli to 
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the muscles by haemoglobin and is then passed onto myoglobin to be used at muscular 
level. Additionally, myoglobin facilitates the transfer of oxygen to the mitochondria at the 
beginning of exercise and during intense exercise in an attempt  to attenuate a large drops 
in cellular partial pressure of oxygen 89. Unlike haemoglobin, myoglobin retains a large 
percentage (95%) of its bound oxygen even when pressures are very low (5 mmHg).  
Mole et al., 90 indicated that myoglobin may provide a source of readily available O2 at the 
onset of exercise and increase the PO2 gradient from capillary to muscle cell even at low 
levels of activity, suggesting that myoglobin has a role that is intermediate between two 
other functions, O2 storage and facilitated O2 diffusion 
91.   
Once oxygen has been transported from atmosphere to mitochondria it can be used during 
cellular respiration 92. Cellular respiration is the combination of processes and reactions 
where biochemical energy from nutrition is ‘converted’ into ATP. Cellular respiration can 
be split into two distinct categories: aerobic and anaerobic. Aerobic respiration brings about 
the biggest energy yield, using oxygen to resynthesise ATP. Oxidative respiration occurs 
during the citric acid cycle and oxidative phosphorylation 92 and more than 90% of the total 
ATP synthesis is achieved during these processes. Oxygen is during these processes to bind 
with hydrogen to form water and remove the acidity from the mitochondria and buffer it 
elsewhere. 
PCr resynthesis during HIIT and SIT with a recovery duration of 45 s is insufficient in 
duration to fully replenish PCr stores (only ~75% of resynthesis occurs in this time). 
Therefore, after several repeated sprints (~5 x 15 s sprints), PCr resynthesis would be 
diminished, with most PCr stores depleted. Significant performance reductions would be 
evident with such a reduction in PCr resynthesis capacity. A continued depletion of ATP-
PC stores and an inadequate resynthesis of PCr will lead to a reduction in performance until 
other energy systems are able to produce larger amounts ATP and aid in the resynthesis 
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process. Mendez- Villanueva et al., 93 found that an 8% increase in PCr resynthesis during 
30 s recovery bouts from 10 x 6 s cycling sprints significantly enhanced peak and mean 
power. Similarly Glaister, 52 identified that an increase in peak and mean power has been 
attributed to an enhanced PCr resynthesis during repeated high intensity exercise. 
There is a small (< 10%) aerobic contribution to energy production during a short (up to 
30 s duration) maximal effort sprint and is suggested that this contribution increases as 
sprints are repeated, perhaps due to the alterations in oxygen kinetics 94–96. This is part due 
to increased oxygen demand post sprints in order to re-establish the saturation of myoglobin 
with oxygen and PCr. This may result in subsequent sprints starting at progressively higher 
V̇O2. Additionally, Bogdanis et al.,97  found that aerobic metabolism during the second 
sprint (30 s) provided ~49% of the energy yield. These values were estimated due to an 
increase in oxygen uptake by ~0.5 L·min-1 (increase of 20%). These findings can be 
explained by Wagner 98 who concluded that an increased FiO2 raises the partial pressure of 
oxygen in the blood and resultantly increases V̇O2max (sparing anaerobic energy at higher 
workloads). Importantly, oxygen is also used for the resynthesis of PCr, the resynthesis of 
PCr occurs using products from both the Krebs cycle and aerobic glycolysis, which have 
been shown to be enhanced following the use of O2Supp 
99. 
 
2.6.2 Hyperoxia 
O2Supp principally works on the basis of increasing the availability of oxygen, thus 
more is ready to be utilised by the body. O2Supp can be administered two ways; hyperbaric 
and normobaric.  
Hyperbaric hyperoxia is when additional oxygen is pressurised greater than 1 ATM (760 
mmHg) and administered to an individual, whereas normobaric O2Supp is administered at 
1 ATM or lower. Hyperbaric O2Supp is provided to patients in hospital either through nasal 
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cannulas or hyperbaric chambers. This additional pressure overcomes the physiological 
restraints the patients experience due to the increased pressure gradient at an alveoli/ 
capillary level.   
Hyperbaric O2Supp works on the premise that oxygen is pressured into the body cells thus 
increasing delivery. Increasing the intrapulmonary pressure within the lungs due to 
pressurised air (3 ATM) increases the pressure gradient between alveolus walls and the 
capillary wall by 10-fold 100. Such a dramatic increase in pressure results in additional 
oxygen ‘leaking’ and dissolving into the blood plasma. The increase in dissolved oxygen 
within the plasma is sufficient to meet resting cellular requirements without any 
contribution from haemoglobin. Additionally, this dissolved oxygen can be provided to the 
areas into which red blood cells are unable to pass, such as the interstitial fluid 101,102. 
O2Supp has also been shown to cause vasoconstriction within the microvascular, thus 
reducing heart rate and blood flow, which is compensated by the increased plasma oxygen 
content 103,104. This is typically used to treat crush injuries or burns but it is speculated that 
it can be applied to a variety of sporting population, shooting, archery and biathlon. This is 
due to vasoconstriction having a calming effect on the body and reduces heart rate, 
preventing the shakes during precision sports. 
 
Normobaric O2Supp refers to additional oxygen greater than a FiO2 of 0.21 at 1 ATM of 
pressure, so supplementing the cells with additional oxygen, rather than higher pressurise. 
Normobaric O2Supp does not differ from hyperbaric oxygen in terms of its effect on 
oxygen delivery and consumption, other than the difference in pressure that it is 
administered. Normobaric O2Supp is believed to be safer than hyperbaric O2Supp as the 
increase in pressure may cause oxygen toxicity through the formation of excessive reactive 
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oxygen species (ROS) 56,58–60. The formation of ROS is still possible during normobaric 
O2Supp but much less likely than when the oxygen is pressurised before administration.  
 
2.6.3 Cellular Response to Oxygen Supplementation 
O2Supp causes large changes within the cellular equilibrium of the body. Firstly, it 
increases the partial pressure of oxygen (PaO2) within the alveoli, and consequently the 
entire oxygen cascade. Increasing the FiO2 to 1.00 (O2Supp), leads to a subsequent six fold 
increase within the arterial PaO2, to approximately 600 mmHg 
105. Hypothetically this 
gradient could increase further with hyperbaric hyperoxia, even though the determining 
factor for oxygen diffusion is the gradient between plasma and cells.  
 
The body has various mechanisms to deal with the change in equilibrium that occurs during 
the administration of O2Supp to prevent an accumulation of ROS. Most of the mechanisms 
associated with O2Supp have a direct influence on cardiac output; changes within rate of 
blood flow, and heart rate, impacting cardiac output. One of the most pronounced responses 
to O2Supp  is the change in the microvascular blood flow 
78,106 as the immediate response 
to O2Supp is vasoconstriction. Chemoreceptors detect the change in PaO2, which is relayed 
to the brain and triggers the medulla oblongata to respond with peripheral vasoconstriction 
of the blood vessels, reducing the diameter of the vessels restricting the amount of blood 
that can pass through them. Thus, less blood is flowing through the microvascular, lowing 
the oxygen concentration of the tissue 78,107,108.  
 
Another response to O2Supp is a reduction in heart rate. Again, changes in PaO2 are detected 
and the medulla oblongata to responds via the parasympathetic nervous system, reducing 
heart rate at any given workload 78,109,110. The final response is the change  in energy 
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pathway, when more oxygen is available at a cellular level there is an increased efficiency 
within the mitochondria and an elevated rate of cellular respiration 111. Additionally, an 
attenuation of metabolic by-products resulting from a reduced need for glycogenolysis, 
glycolysis and pyruvate production is evident during O2Supp 
112–114. Reducing the need for 
these processing spares fuel and the attenuates the accumulation of by-products till later in 
exercise. Current research also suggests that O2Supp during exercise would be enough of 
a stimuli to counteract the decline in the saturation of arterial haemoglobin (SaO2) during 
exhaustive exercise 115,116. 
 
These responses are likely to be at least partially responsible for the effects sporting 
performances. Research in the field has increased over the last 6-8 years, with the ban of 
inhalation of oxygen enriched air being lifted by WADA in 2005. This has opened a door 
for many researchers to explore the effects of O2Supp on recovery, as a training aid, and 
its use longitudinally. Currently due to the size of the equipment needed for safe  
administration, it is not widely accessible nor practical, although beneficial effects during 
exercise by decreasing lactate accumulation and increasing cycling power output are 
evident and worth the challenges O2Supp poses at this moment in time 
1. Training with 
concurrent supplementary oxygen in an environmental chamber allows the user to be free 
from masks and tubing, which is more natural for the user. Environments (hyperbaric) 
chambers allow the user to change the oxygen content of the air safely and quickly.  
 
2.6.4 Mechanisms 
During exercise BLa levels increase with increasing demand on the metabolic 
systems.  Lactic acid is a by-product of anaerobic glycolysis, and quickly converted to 
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lactate and hydrogen ions. Lactate is produced within the cytoplasm and distributed within 
the blood and is cleared by active muscles, liver and kidneys.  
Blood lactate has been shown to increase in an exponential manner when accumulation 
exceeds removal, this is known as the as the lactate threshold (LT). LT is typically 
numerically referred to as 4 mmol·L-1. LT is exceeded very early on in a repeat sprint 
protocol. The response of the BLa during repeated sprints gives practitioners an idea that 
the participant is responding to the training correctly. For example, during 10 repetitions 
of an intense cycling activity, lactate increases until it reaches a physiological ceiling and 
then plateaus. Ergogenic aids are any aid that leads to a direct increase in performance 
capacity, some aids have been shown to increase this ceiling or reduce the BLa 
concentration for any given workload 117. 
The performance improvements with O2Supp are shown as increased physical work and 
changes in metabolism too. O2Supp effects the accumulation of BLa by increasing the 
efficiency of the aerobic metabolic processes 113. Increasing the efficiency of these 
pathways results in the sparing of fuel and attenuates accumulation of by-products. BLa 
accumulation and increase of hydrogen ions (H+) leads to the desensitisation of the cross 
bridges which subsequently causes peripheral fatigue and the termination of exercise (See 
section 2.3.2 Peripheral Fatigue). Acutely, decreased lactate accumulation has been 
credited in part to an increase in performance 7.  Additionally, decreased lactate 
accumulation has also been shown to attenuate the build-up of peripheral fatigue 46.  
 
However, BLa is not always attenuated by O2Supp, as some studies have shown BLa to be 
similar during Normoxia. This has been proposed to be due to the individual participants 
reaching the ‘ceiling’ for the amount of O2 being utilised by the working muscles 113,118. 
Participants are unable to utilise the additional oxygen available, so it is simply exhaled.    
Page 50 of 254 
 
 
The increase in full body oxygenation associated with O2Supp 
3 has been shown to improve 
the efficient of multiple metabolic pathways, leading to an increase in performance. SaO2 
increases a result of O2Supp, and  some researchers have hypothesised that a small increase 
(1-3%) in SaO2 is enough to improve performance by as much as 3% 
108,119,120. Contrary to 
this, others speculate that due to the already high SaO2 at rest (99%), it would be pointless 
to give O2 during recovery bouts of less than 1 min because it will have no effect on SaO2, 
which  will naturally restore during this bout 121. 
 
One noteworthy reason for O2Supp being an effective recovery tool between bouts of 
exercise is its ability to increase the rate of PCr resynthesis. PCr resynthesis during HIIT 
and SIT with a recovery duration of 45 s is insufficient in duration to fully replenish PCr 
stores (only ~75% of resynthesis occurs in this time). Therefore, after several repeated 
sprints (~5 x 15 s sprints), PCr resynthesis would be diminished, with most PCr stores 
depleted. Significant performance reductions would be evident with such a reduction in 
PCr resynthesis capacity. A continued depletion of ATP-PC stores and an inadequate 
resynthesis of PCr will lead to a reduction in performance until other energy systems are 
able to produce larger amounts ATP and aid in the resynthesis process. Mendez- Villanueva 
et al., 93 found that an 8% increase in PCr resynthesis during 30 s recovery bouts from 10 
x 6 s cycling sprints significantly enhanced peak and mean power. Similarly Glaister, 52 
identified that an increase in peak and mean power has been attributed to an enhanced PCr 
resynthesis during repeated high intensity exercise. 
 
As shown, there are important acute effects of O2Supp which subsequently aid performance 
though the sustained improvements in performance through chronic use is unknown. 
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Whether the acute responses to O2Supp are an adequate stimulus to lead to long term 
physiological adaptation is yet to be established, and it is likely that multiple sessions with 
O2Supp are needed to lead to chronic adaptations. 
 
2.7 Effects of Oxygen Supplementation 
O2Supp has many potential applications in the sporting world (e.g. increased power 
output & decreased BLa) as well as in the pharmaceutical world – (temporarily reversing 
the effects of COPD). Much is known about the therapeutic use of O2Supp and its effects, 
though little is known about the effects of O2Supp following repeated intersession use on 
performance. The acute use (lasting seconds to hours but less than one day) have been 
shown to improve performance. Little is known about the effects of long term (chronic - 
days) use of O2Supp and whether it is detrimental to health and performance 
122. This 
section will explore the effects of acute and chronic use of O2Supp on sports performance. 
 
2.7.1 Effects of Acute Oxygen Supplementation 
The consumption of O2 has been shown to improve a variety of physiological and 
performance parameters within the short term (effects diminish within 30 min of removal 
from O2Supp). The acute performance effects of O2Supp are what most research has been 
focused on. The parameters O2Supp has been shown to improve are; increase time to 
exhaustion (TTE), decreased accumulation of lactate, increase power output and increase 
SaO2. 
O2Supp can be applied to any part of a session, the pre-loading phase before exercise, 
during the exercise bout, during the recovery between repetitions (inter sprint recovery) 
and during recovery between sets of exercise (inter exercise recovery).  
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Due to the natural high oxygen saturation of the blood at rest, research has moved away 
from administering O2Supp prior to exercise, in turn giving it as a recovery aid between 
bouts of exercise 121. Sperlich et al., 121 found that pre-loading an athlete with 25 breaths of 
O2Supp (FiO2 0.6) before 15 s maximal cycling sprint was not sufficient at eliciting a 
response in mean power output (MPO), peak power output (PPO), BLa, pH or H+. 
 
O2Supp during either of the two recovery periods, has two distinct main effects; its effect 
on high intensity exercise and its effect on endurance performance following inter exercise 
recovery bouts. O2Supp during high intensity exercise has been shown to increase power 
and SaO2, with minimal changes in BLa and pH 
1,6,123. The effects of O2Supp on subsequent 
endurance performance is yet to be documented conclusively, although some include 
improvements in V̇O2peak, V̇O2max, and oxygen kinetics 6,124.  
 
2.7.2 Acute Supplementation during Exercise 
O2Supp has been shown to be effective during the recovery periods for maintaining/ 
increasing power output during sprint-based exercise, and it has also been shown to be 
beneficial for improving longer duration efforts. This could be due to endurance 
performance being largely limited by oxygen uptake.   
 
The work by Bonetti et al., 125 found that participants who received O2 (FiO2 0.6) during 
‘work’ periods experienced positive effects on oxygen efficiency (lower oxygen demand 
for same work output) and V̇O2peak. Participants consumed less oxygen for any given 
workload during O2Supp. Furthermore, work by Ulrich et al., 
6 examined the effects of a 
medium O2Supp dosage (FiO2 0.5) on endurance performance, and found that maximal 
workload (progressive exercise) and endurance time (constant load) increased 
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meaningfully during O2Supp. Most importantly they found significant systemic increases 
in O2 delivery (measured by NIRS), SpO2 and V̇O2. They also found significant increases 
in tissue oxygenation in both cerebral and local muscle tissue. Bartholomew et al., 126 also 
found that the higher the concentration of O2, given during a test, the greater the 
improvements in Wingate cycling performance compared to Normoxia. O2Supp has also 
been shown to be beneficial in increasing TTE, by up to a 131% 81,112,114,127–130. Similarly, 
Amann et al., 81 found that PPO and MPO were higher during a 5 km time trial with 
increased oxygen content (FiO2 1.00).   
 
Opposing these findings, Church et al., 131 Robbins et al., 132 and Snell et al., 133 all found 
that O2Supp of FiO2 0.55-1.00 is insufficient to effect performance or oxygen kinetics when 
used during performance or as a recovery tool. Given that O2Supp increases the delivery 
of O2 therefore, it is likely that the methodology (long submaximal durations) of these 
studies was not sufficient to elicit the responses others found during O2Supp.  
 
2.7.3 Acute Supplementation during Recovery Periods 
O2Supp has also been shown to be a useful tool when given during acute exercise 
as well as when given in the recovery periods between successive exercise bouts. Findings 
from research by both Holmberg et al., 7 and Kay et al., 126 has found that the delivery of 
FiO2 0.6-1.00 during recovery of 4-6 min in duration following repetitions of 30 s – 1 min 
was sufficient to significantly improve both PPO in swimmers and cyclists alike.  Maeda 
et al., 54 also replicated these findings. Maeda et al., found that during exercise at 70% of 
V̇O2max for 5 x 5 min with O2Supp during 6 min recovery periods was enough to elicit 
significant reductions in BLa. They also found that recovery was significantly faster during 
the higher concentration (FiO2 0.8) than the four lower concentrations. 
Page 54 of 254 
 
 
O2Supp as a useful recovery tool has also been demonstrated by Hamalainen et al., 
134 who 
found that O2Supp attenuates the decrease in SaO2 during subsequent exercise. Similarly, 
Andersson et al., 135 also found a similar increase in SaO2 following a hyperoxic response 
when used during the recovery periods between (2 min) a 6 x 3 min repeated sprint 
protocol. Neither studies were able to find any significant decrease in pH level or BLa 
because of O2Supp. 
 
The success of O2 as a performance enhancing tool is equivocal. Sperlich et al., 
3 found 
that a duration of O2Supp (FiO2 1.00) for 6 min during recovery periods between 30 s 
sprints was not sufficient to elicit any change in PPO, MPO or even BLa, despite each 
athlete having a lower rating of perceived exertion. Additionally, Hauser et al., 136 found 
that O2Supp (FiO2 1.00) during recovery from repeated sprint skiing was not a significant 
stimuli to increase MPO, even though there was a large positive difference in endurance 
performance variables. It is speculated that O2Supp may in fact cause reductions in 
performance if the duration is to short and delivery is intermittent due to rapid changes in 
internal oxygen equilibrium.  
 
Additional, details of these studies can be seen in Table 2-2 and Table 2-3. The tables also 
highlight many of the limitations of using O2Supp during exercise or subsequent recovery 
periods. There is currently a lack of consistency in the FiO2 used, with it varying from 0.4 
to 1.00. A consistent use of one concentration should be proposed so a consistent narrative 
can be formed. Additionally, a consistent FiO2 will enable direct comparisons between 
studies - something that is currently lacking in O2Supp research. Another inconsistency 
regarding when to use O2Supp - the most effective ‘time’ to administer O2Supp needs to 
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be established before training modalities are manipulated effectively. Future research 
should therefore focus on answering these research questions: 1) When exactly is O2Supp 
most effective during a training session? 2) what is the common consensus in O2Supp 
research when using a consistent FiO2 of 1.00? 
 
2.7.4 Effects of Chronic Supplementation  
Few studies have examined the long-term use of O2Supp so little is known about 
the chronic physiological adaptations that O2Supp may stimulate. Those that have tried to 
identify the long-term benefits of O2Supp have reported mixed results (Table 2-4). Most of 
the O2Supp research applies a HIIT protocol to a multi week training intervention. One 
commonly referenced study in HIIT is that of Burgomaster et al., 70, who found that similar 
adaptations are established during HIIT as those experienced through endurance training 
(without additional aids). The major benefit of HIIT is it is significantly less training 
duration to elicit the same adaptations.  
Perry et al., 137, Morris et al., 138, and Murray et al., 8 found that 3-5 hyperoxic sessions per 
week for 3-6 weeks was enough to stimulate an improvement in time to exhaustion, PPO 
and power at lactate threshold and power at maximum lactate steady state during cycling 
(FiO2 0.6, 0.26, 1.00 respectively). Morris et al., 
138 found that a combination of low 
O2Supp and high O2Supp in a ‘Live High, Train Low’ approach resulted in significant 
performance improvements for junior elite cyclists. Each participant lived at altitude and 
then completed training with high oxygen availability, effectively living high and training 
low. Every participant was able to train at higher intensities and significantly improve their 
cycling time trial performance to 120 KJ of work and their maximum steady state power 
by as much as 20 W. However, the stimulus from living at altitude may be the main driving 
point for adaptation rather than the O2Supp training sessions.  
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However, there is also evidence to suggest long term use of O2Supp in recovery or training 
has no effect on performance measures. Perry et al., 109, Ploulz-Snyder et al., 139 and 
Kilding et al., 125 found no improvements in either V̇O2max, PPO, maximum heart rate, 
maximum lactate accumulation and no increase in muscle fibre recruitment or size in 
response to training with supplementary oxygen. The duration of these studies ranged from  
4-6 weeks, with HIIT as the main training stimulus, and used O2Supp concentrations 
between 0.6-0.7.   
In a later study, Perry et al., 137 did find that after a 6-week O2Supp interval training plan, 
PPO improved by 8% whilst at 90% of maximum heart rate. However, peripheral factors 
such as metabolic overload were attributed to this improvement rather than the O2Supp 
itself. Despite similar methodologies and oxygen content of the inhaled air (FiO2 0.60) in 
their two studies, Perry et al., 109  found these conflicting results. In their second study they 
found that enzyme activity in skeletal muscle was the same as the Normoxia condition, and 
that O2Supp was not a significant extra stimulus above Normoxia at evoking pronounced 
skeletal and whole-body oxygen uptake (measured using V̇O2max and muscle biopsies). 
However, they did attribute the findings of their second study to an untrained population. 
They suggested that the increase in stimulus from the training alone led to large changes, 
but which were not different between conditions.    
 
Recently, research is starting to assess the mechanisms underlying potential effects of 
O2Supp on chronic adaptations. Cardinale et al., 
140 are at the forefront of this. They have 
recently assessed the oxidative capacity of the peripheral muscle following O2Supp 
training, using a muscle biopsy and high resolution respirometry. They found that a 3-
session a week, 6-week O2Supp training programme was not sufficient at eliciting 
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additional stimulus for chronic adaptation, compared with training in Normoxia. Although, 
Cardinale et al., found little difference between conditions in oxidative capacity, Ploulz et 
al., found that O2Supp did improve the efficiency of the working muscles using oxygen 
consumption (VO2) and mitochondrial enzymes (creatine kinase, 3-hydroxyacyl CoA 
dehydrogenase and cytochrome c-oxidase).  
 
The research into the chronic effects of O2Supp is scarce with varied results; from O2Supp 
providing an additional positive training stimulus, to it having no effect on training at all. 
The research therefore highlights the need to establish answers to pressing questions: 1) 
Does O2Supp provide an additional positive stimulus during training interventions with 
chronic exposure? 2) What are the mechanisms underlying the potential effects of O2Supp 
during chronic use? 3) What training modality (HIIT or endurance) is most effective at 
eliciting positive adaptations following chronic use of O2Supp?  
 
2.8 Summary  
Many new potential ‘ergogenic aids’, are available to the consumer, such as Boost 
Oxygen®, Oxy Sport and OXY 99™. However, there is currently insufficient evidence to 
support the long-term use of these products. The research conducted on the effects of 
O2Supp is still equivocal. Studies have attempted to identify the effect of O2Supp on 
performance using a range of concentrations from 0.30 to 1.00 with varying degrees of 
success. Studies have also used O2Supp during different parts of a training session (before 
exercise, inter repetition recovery and inter exercise recovery) making it difficult to 
establish any strong consensus regarding results.  
As shown by Table 2-5 and Table 2-6 there is a variety of concentrations that have been 
administered during O2Supp, all with varying degrees of results. Therefore, this research 
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will apply maximum dosage (FiO2 of 1.00) to each of the experimental chapters to build a 
narrative within the literature. Future research can look at lowering this once a clear theme 
has been established. Additionally, the administration procedures need standardising to 
minimise inter study differences. The research conducted in this thesis will apply a 
standardised methodology to each of the experimental chapters, as mentioned in chapter 3 
- Methodology Chapter. 
The research on chronic applications of O2Supp is sparse, and the few existing studies using 
a variety of modalities (eg. cycling, swimming, hockey 7,8,141) and concentrations (0.60 to 
1.00) similar to acute supplementation research. It is also evident that researchers are to 
fully understand the mechanisms underlying the effects of supplementary oxygen.  
It is evident that a minimum dose of FiO2 value has yet to be identified, as this may be one 
of the reasons there are large discrepancies between results of studies with broadly similar 
methodologies. Future research should use an FiO2 of 1.00 and identify its effects during 
different tasks, before reducing it to identify a dose response relationship.  
It is now prudent to provide research to fill the gaps within the literature to maximise the 
potential benefits of O2Supp on sporting performance. If O2Supp is going to be used as an 
impactful ergogenic aid many of these areas need to be explored and answered - when is 
O2Supp most effective during a training session? and Can a short-term training intervention 
influence performance or metabolic markers of performance? 
 
2.9 Aims and Hypotheses of the Thesis  
This thesis set out to investigate three main research questions.  
- During which component of a repeat sprint cycling training session is O2Supp most 
effective at increasing performance? 
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- Which physiological mechanisms does O2Supp effect to allow for improvements in 
performance capacity? 
- Can a short-term training intervention influence performance or metabolic markers 
of performance? 
As there is yet to be a specific oxygen supplementation dosage recommended, this research 
will use an FiO2 of 1.00 and maintain it throughout the experimental chapters, minimising 
the effect of dosage. There are a series of 5 experimental studies that aimed to add empirical 
information to the  O2Supp research field, specifically those areas identified in this section 
(Table 2-1). 
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Table 2-1 Identified gaps in the literature leading to experimental chapters’ aims.   
Chapter Gap in the literature Chapter Aims 
1 - Lack of research within the area of short high 
intensity repeat sprint cycling during O2Supp. 
- To explore the effects of O2Supp, both during recovery and during cycling, on sprint cycle 
performance. 
- To confirm the methodologies used throughout the latter thesis chapters. 
2 - Lack of consistent understanding of the importance 
of timing of supplementation, 
- To determine whether O2Supp is more effective during or between repeat sprint intervals. 
3 - Lack of research identifying the mechanisms 
underlying potential effects on performance. 
- To develop the understanding of the effects of O2Supp on repeat sprint cycling fatigue, 
using twitch interpolation technique. 
4 - Lack of research identifying the mechanisms 
underlying potential effects on performance 
- To further develop the understanding the effects of O2Supp on repeat sprint cycling during 
using near infrared spectroscopy. 
5 - Limited number of training programmes using 
O2Supp within SIT. 
- Additional mechanisms underlying chronic O2Supp 
adaptation. 
- To explore the feasibility of using NIRS, arterial occlusions and repeated cycling sprints 
during a multi session training study with periods of supervised and unsupervised training. 
- To identify whether the proposed methodologies (NIRS) are sensitive enough to detect 
changes in muscle oxidative capacity using arterial occlusions. 
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Supplementary Tables 
Table 2-2 Acute effects of Oxygen Supplementation. 
Study  
Participant Characteristics 
Measure Protocol Result Sample size, Gender, 
Age 
Populations 
Kyro et al., (1999) 
n = 6, Male (1), Female 
(5), 25 ± 4 years 
Endurance trained 
runners 
Arterial O2 Sats, RPE, 
BLa 
3 visits. 4 x 4 min treadmill running at 
50,60,70,80% of max. 3 different conditions 0.15, 
0.21, 0.29. 
BLa is lowest during O2Supp. O2 sats are 
independent of FiO2. O2 sats decreased in 
hyperoxia. 
Bonetti et al., (2012) 
n = 16, Male, 24.8 ± 
9.1years 
Well trained competitive 
individuals.  
MPO, PPO, HR, OXH sat 
2 groups, O2Supp (0.60) and NORM (0.21). 
Baseline + fam. 12 x 2min with 2min recovery 
then 5 x 5min with 3min recovery.  
MPO sig better in O2Supp. SPO2 was higher 
in O2Supp. Small change in BLa and 
V̇O2peak. 
Croft et al., (2013) n = 10, Male, 22 ± 2 years 
Endurance trained 
athletes 
OXH sat, BLa, HR, PPO, 
MPO 
3 visits. Baseline + fam. 10 x 3min at 85% Vmax 
with 90 s recovery. O2Supp 1.00 or NORM 0.21 
during recovery and 15mins post.   
No Sig results. O2Supp only helped improve 
OXH sats. 
Andersson et al., (2011) 
n = 7, Male (5), Female 
(2), N/A  
National level Kayak 
athletes 
BLa, PPO, MPO, OXH 
sat, RPE 
2 visits. 6 x 3min with 2min recovery. O2Supp 
0.99 or NORM 0.21 during recovery.  
Only sig result – OXH sat improved. No sign 
result in PPO or BLa or RPE. 
Legend: FiO2- Fraction of inspired oxygen, min- Minutes, n – Sample size, BLa – Blood lactate, AT- Anaerobic threshold, PPO- Peak power, MPO- mean power, BV- Blood 
volume, RPE- Ratings of perceived exertion, Sats – Saturation, Haem – Hemoglobin, NMF- neuromuscular fatigue, RPM- Revolutions per minute, HR- Heart rate, OXH – 
Oxyhaemoglobin, HYPO- Hypoxia, O2Supp – Oxygen supplementation, NORM- Normoxia, TT- Time Trial, TTE- time to exhaustion, Q- Cardiac Output, VMax- velocity at 
V̇O2max.  
Page 62 of 254 
 
Table 2-3 Continued. Acute Effects of Oxygen Supplementation 
Study  
Participant Characteristics 
Measure Protocol Result Sample size, 
Gender, Age 
Populations 
Holmberg et al., (2011) 
n = 12, Male, 21 ± 3 
years 
Elite level swimmers 
PPO, MPO, fatigue 
index, LT, NMF, RPE 
3 visits. 1 Max measure + Fam. Visit 2-3 5 x 40 
butterfly strokes with 6min recovery at 1.00 or 
0.21.  
PPO and MPO sig diff in 1.00. Fatigue index No 
change. Enhanced PO2 and haem sats with no 
change in BLa or PH. 
Maeda et al., (1997) 
n = 14, Male, 21 ± 0.8 
years 
Healthy Individuals  BLa, AT 
V̇O2max + AT prior to experiment. 5 x 5min at 
70% V̇O2max at 60rpm with 6min recovery at 
0.21, 0.30, 0.40, 0.60, 0.80 O2 during recovery.  
BLa sig lower during O2Supp. O2Supp improved 
recovery at high AT.  
Amman et al., (2006) 
n = 8, Male, 22.5 ± 1.7 
years 
Healthy trained cyclists. MPO, EMG, BLa, PPO  
Baseline + fam. 4 sessions, 5km cycling TT at 
0.21, 0.15, 0.24-0.30, 1.00 O2. 
Performance increased per O2 content. PPO+ 
MPO increased with O2 increases. MPO and time 
increased by over 20% in 1.00.  
Peltonen et al., (2001) 
n = 6, Male, 24 ± 5 
years  
Endurance trained 
cyclists 
TTE, FiO2, Q, PPO, 
MPO, BLa 
3 visits, Incremental test 100 W every 5min until 
exhaustion after 400 W up in 50 W increments at 
either HYPO 0.15, NORM ~0.21 and O2Supp 0.31. 
FiO2 had a sig effect on PPO was 12.8% smaller 
in HYPO and 5.5% greater in O2Supp then 
NORM. V̇O2max 13.6% greater in O2Supp than 
NORM.  
Legend: FiO2- Fraction of inspired oxygen, min- Minutes, n – Sample size, BLa – Blood lactate, AT- Anaerobic threshold, PP- Peak power, MP- mean power, BV- Blood volume, RPE- Ratings 
of perceived exertion, Sats – Saturation, Haem – Haemoglobin, NMF- neuromuscular fatigue, rpm- Revolutions per minute, HR- Heart rate, OXH – Oxyhaemoglobin, HYPO- Hypoxia, O2Supp 
– Oxygen supplementation, NORM- Normoxia, TT- Time Trial, TTE- time to exhaustion, Q- Cardiac Output, Vmax- velocity at V̇O2max.  
Page 63 of 254 
 
Table 2-4. Chronic Effects of Oxygen Supplementation. 
Study  
Participant Characteristics 
Measure Protocol Result Sample size, Gender, 
Age 
Populations 
Cardinale et al., 
(2019) 
n = 32, Male (24), female 
(7) 34 ± 7 years 
Ultra-endurance 
cyclists 
V̇O2max, MITO, BV, 
6-week training intervention. 15 sessions 
supervised and 10 non supervised at 0.21 or 0.30. 
Small increase in O2Supp cycling performance. no 
change in V̇O2max, MITO, BV and Haem. 
Murray et al., (2016)  
n = 15, Female, 28 ± 4 
years 
International hockey 
players 
MAS, distance run, 
RPE, BLa HR. 
6-week training program. 3 groups O2Supp 1.00, 
NORM pressurized 0.21, Control 0.21. 
MAS increased in O2Supp, no change in RPE, BLa, 
or distance run. Lower HR in O2Supp. 
Perry et al., (2005) 
n = 11, Male (8), Female 
(3), 26 years (no SD 
given) 
Active untrained 
participants 
V̇̇O2max, MPO, Vmax. 
6-weeks in each condition (0.60 or 0.21) with 12-
week detraining in middle.  
No change in Vmax or V̇O2max. 8% increase in MPO 
with O2Supp. 
Morris et al., (2000) n = 15, Male, 17 ± 1 years Highly training cyclists  PPO, V̇̇O2max, BLa 
3-week training. 3 sessions supervised and 3 non 
supervised Norm and O2Supp equivalent to 0.26. 
No Sig changes in PPO, positive changes in BLa and 
power at Vmax.  
Ploutz-Snyder et al., 
(1996) 
n = 19, Male, 23 ± 2 years Untrained cyclists 
HR, BLa, muscle 
biopsies, Q. 
5-week training intervention. 5 days a week 
(0.21 or 0.70) 
Q, BLa and VO2 significantly decreased for same 
workload in O2Supp. Both groups showed significant 
increase in type II muscle fibers. 
Burgomaster et al., 
(2005) 
n = 16, Male (14) female 
(2), 25 ± 2 years 
Healthy untrained 
cyclists 
V̇O2max, muscle 
biopsies, PPO, 
endurance capacity 
6 Sprint interval sessions over two weeks 
Endurance capacity doubled with no change in 
V̇O2max, or PPO during O2Supp. Increase muscle 
oxidative capacity (muscle biopsy) with O2Supp. 
Legend: FiO2- Fraction of inspired oxygen, min- Minutes, n – Sample size, BLa – Blood lactate, AT- Anaerobic threshold, PPO- Peak power, MPO- mean power, BV- Blood 
volume, RPE- Ratings of perceived exertion, Sats – Saturation, Haem – Haemoglobin, NMF- neuromuscular fatigue, RPM- Revolutions per minute, HR- Heart rate, OXH – 
Oxyhaemoglobin, HYPO- Hypoxia, O2Supp – Oxygen Supplementation, NORM- Normoxia, TT- Time Trial, TTE- time to exhaustion, Q- Cardiac Output, VMax- velocity at 
V̇O2max, MITO – Mitochondria oxidative capacity, MAS- Maximal aerobic speed, SD- Standard deviation.  
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Table 2-5. Methodological Variations Within Oxygen Supplementation Studies. 
Study  
Participant Characteristics Oxygen Percentage and 
Mixture 
Administration Technique Result 
Sample size, Gender, Age Populations 
Kyro et al., (1999) 
n = 6, Male (1), Female (5), 25 
± 4 years 
Endurance trained 
runners 
FiO2 0.15, 0.21 & 0.29 
Medical grade air  
Gas cylinder to 100 L Meteorological balloons. 
Maintained at ambient pressure and humidified 
before use. 
BLa is lowest during O2Supp. 
Little change in performance.  
Bonetti et al., (2012) n = 16, Male, 24.8 ± 9.1years 
Well trained 
competitive 
individuals.  
FiO2 0.21 & 0.60 
Medical grade air mixed with 
nitrogen 
Gas cylinder to 250 L Douglas bags. Humidified 
before use. 
MPO sig better in O2Supp. SPO2 
was higher in O2Supp. Small 
change in BLa and V̇O2peak. 
Croft et al., (2013) n = 10, Male, 22 ± 2 years 
Endurance trained 
athletes 
FiO2 0.21 & 1.00 
Medical grade oxygen 
Connected directly to medical oxygen cylinder, flow 
rate of 10 L per minute. 
No Sig results. O2Supp only 
helped improve OXH sats. 
Andersson et al., (2011) 
n = 7, Male (5), Female (2), 
N/A  
National level Kayak 
athletes 
FiO2 0.21 & 0.99 
Medical grade oxygen 
No data on procedure. 
No sign result in PPO or BLa or 
RPE. 
Holmberg et al., (2011) n = 12, Male, 21 ± 3 years Elite level swimmers 
FiO2 0.21 & 1.00 
Medical grade oxygen 
Gas cylinder to 250 L Douglas bags.  
PPO and MPO sig diff in 1.00. 
Enhanced PO2 and haem sats  
Maeda et al., (1997) n = 14, Male, 21 ± 0.8 years Healthy Individuals  
FiO2 0.21 0.30, 0.40, 0.60 & 
0.80 
Micro blended gases 
Blended gasses (Bird 3800, microbrender), into 250 
L Douglas bags. Humidified to 50% before use.  
BLa sig lower during O2Supp. 
O2Supp improved recovery at 
high AT.  
Legend: FiO2- Fraction of inspired oxygen, n – Sample size, L- Litre, Peak power, MPO- mean power, RPE- Ratings of perceived exertion, Sats – Saturation, OXH – 
Oxyhaemoglobin, HYPO- Hypoxia, O2Supp – Oxygen Supplementation, BLa – Blood lactate, AT- Anaerobic threshold. 
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Table 2-6. Continued Methodological Variations Within Oxygen Supplementation Studies. 
Study  
Participant Characteristics 
Oxygen Percentage and 
Mixture 
Administration Technique Result Sample size, Gender, 
Age 
Populations 
Amman et al., (2006) n = 8, Male, 22.5 ± 1.7 years 
Healthy trained 
cyclists. 
FiO2 0.15, 0.21, 0.24-0.30 & 
1.00 
Medical grade air 
No data on procedure. 
PPO+ MPO increased with O2 increases. 
MPO and time increased by over 20% in 
1.00.  
Peltonen et al., (2001) n = 6, Male, 24 ± 5 years  
Endurance trained 
cyclists 
FiO2 0.21 & 0.31 
Medical grade air. 
Gas cylinder to 250 L Douglas bags. Humidified 
before use. And a taro oxygen concentrator to a 200 
L Douglas bag.  
FiO2 had a sig effect on PPO 5.5% greater 
in O2Supp. V̇O2max 13.6% greater in 
O2Supp. 
Cardinale et al., (2019) 
n = 32, Male (24), female (7) 
34 ± 7 years 
Ultra-endurance 
cyclists 
FiO2 0.21 & 0.30 Medical 
grade oxygen 
Dosing unit used to send gas bolus into a face mask 
per breath using a gas cylinder.  
Small increase in O2Supp cycling 
performance. no change in V̇O2max, 
MITO, BV and Haem. 
Murray et al., (2016)  n = 15, Female, 28 ± 4 years 
International hockey 
players 
FiO2 0.21, pressurized 0.21 
& 1.00 
Medical grade oxygen 
Breathing directly from cylinder at 8 L per minute.  
MAS increased in O2Supp, no change in 
RPE, BLa, or distance run. Lower HR in 
O2Supp. 
Perry et al., (2005) 
n = 11, Male (8), Female (3), 
26 years (no SD given) 
Active untrained 
participants 
FiO2 0.21 & 0.60 
Medical grade oxygen  
Gas cylinder to 300 L reservoir bags. Humidified 
before use. 
No change in Vmax or V̇O2max. 8% 
increase in MPO with O2Supp. 
Morris et al., (2000) n = 15, Male, 17 ± 1 years Highly training cyclists  
FiO2 0.21 & 0.26 
Medical grade oxygen 
Gas cylinder to 120 L reservoir bags. Humidified 
before use. 
No Sig changes in PPO, positive changes 
in BLa and power at Vmax.  
Ploutz-Snyder et al., 
(1996) 
n = 19, Male, 23 ± 2 years Untrained cyclists 
FiO2 0.21 & 0.70 
Medical grade oxygen 
Gas cylinder to a mixing chamber, then hydrated 
and humidified, then connected to 5000 L 
meteorological balloon. 
Q, BLa and VO2 significantly decreased 
for same workload in O2Supp. 
Legend: FiO2- Fraction of inspired oxygen, n – Sample size, L- Litre, Peak power, MPO- mean power, RPE- Ratings of perceived exertion, Sats – Saturation, OXH – 
Oxyhaemoglobin, HYPO- Hypoxia, O2Supp – Oxygen Supplementation, BLa – Blood lactate, AT- Anaerobic threshold.  
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3 - Methodology Chapter 
The Main Methodologies Used Throughout the Experimental Chapters 
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3.1 Introduction 
 The research in this thesis was conducted in accordance with the Declaration of 
Helsinki. In all cases, ethical consideration, and comprehensive risk assessment documents 
were provided to and approved by the University of Essex Ethics Committee, prior to 
conducting experimental analysis. All participants provided written informed consent 
detailing that they were informed and happy to partake in every aspect of each study. 
The experimental data collected throughout the experimental chapters (chapters 4-9) is 
numerical quantitative data in nature. Physiological data collected were used to represent 
primary physical outcomes (Power (W), NIRS and fatigue).  
A large amount of experimental measures were replicated across each of the experimental 
chapters. The reoccurrence of these measures are outlined within this chapter. Other 
experimental measures are introduced within the experimental chapters during which they 
are used.  
 
3.2 Reoccurring Methods  
Several different methodologies were used to identify the effectiveness of O2Supp 
within a sporting population. Various combinations of methodologies (NIRS, Rate of 
Perceived Exertion (RPE), and Iso kinetic dynamometer with twitch interpolation) were 
selected throughout the experimental chapters in order to give a comprehensive overview 
of O2Supp on repeat sprint cycling.  
Table 3-1 shows the measures included during each experimental chapter. The reoccurring 
measures (measures that appear in two or more experimental chapters) are discussed in 
more detail in the paragraphs that follow.  
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Table 3-1 Measures conducted in each experimental chapter 
Measure 
Experimental Chapter 
 
1 2 3 4 5 
Sprint Cycling      
Blood Lactate      
Rating of Perceived 
Levels of Exertion  
     
Near Infrared 
Spectroscopy 
     
 
 
3.2.1 Sprint Cycling 
 During the experimental chapters 1 through 5 the physical work was conducted on 
a Wattbike Pro model – B cycle ergometer (Wattbike, Nottingham, UK). Wattbike are 
cycle ergometers with varying degrees of resistance and functionality (exercise modes). 
Wattbike pro has various mechanisms for applying resistance to the cyclist. There are two 
main ways; air resistance flywheel and a magnetic resisted flywheel. The air resistance 
flywheel works by regulating the flow of air entering the flywheel by increase the size of 
the hole in which air flows into the flywheel (bigger the hole the more air flows through 
it). The air resistance flywheel is there to replicate the ‘gears’ on a road bike whilst cycling 
on flat road. Setting 1 (low) simulates the easiest gear, increasing until 10 (high) the hardest 
gear on the bike. The magnetic resisted flywheel on the other hand, is designed to replicate 
the ‘gradient’ of the road. Similar, to the air resistance, 1 (low) simulates a flat road and 7 
(high) a steep gradient.  
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Wattbike Pro’s strain gauge measures the force applied to the chain through each pedal 
revolution at 100 Hz. Due to the functionality of the Wattbike, over 40 variables (including 
peak power, mean power, cadence, work, and speed) can be collected at 100 Hz per pedal 
revolution. The accuracy of the Wattbike is a reliable power measure for trained athletes 
and has been shown to be accurate to within 2% across the full range of Watts (0-3760 W) 
with a high reproducibility (CV = 2.6%, 95% CI = 1.18-5.1%) 142,143. During the 
experimental chapters, variables such as, mean power output (W), peak power output (W), 
relative mean power output and relative peak power output were used for statistical 
analysis. The conversion of peak and mean power output to relative power output was 
conducted to consider each participants body mass. The power output of the participant 
(peak and mean) was divided by their body mass to give a power output relative to their 
body mass. This allowed for classification of performance status (power to weight) and the 
ability to directly compare each participant with one another.  
Mean power output was used to determine the extent of performance decline throughout 
the 10 repeated sprints. Performance decline was calculated taking the first sprint (highest) 
and then their sprint with the lowest power output and calculating the percentage decline. 
Percentage decline = [(highest– lowest) / highest] *100. The higher the number the greater 
the decline in performance. 
 
During each experiment participants were required to complete a pre-set protocol 
programmed into the Wattbike display unit. Programme consists of three distinct sections: 
warm up, recovery, and sprints. Warm up consists of 5 min at an air brake of 4 and a 
cadence of 70-80 rpm.  The recovery section was a 5 min static recovery seated on the bike. 
The sprint protocol consisted of 10 x 15 s sprints with 45 s of static recovery. 
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3.2.2 Oxygen Administration  
 The main independent variable of the thesis was the manipulation of the content of 
air the participants were required to inspire. Each study used the same underlying 
methodology and equipment during various time frames. Hyperoxic gas was used to fill up 
a rig of 4 x 200 L Douglas bags (Hans Rudolph, Shawnee, KS, USA) (see Figure 3-2). 
Each rig consisted of 4 x 200 L Douglas bags connected via four 34" long breathing tubes 
EVA with a diameter of 35 mm. 
Oxygen supplementation was created using medical grade oxygen (British Oxygen 
Company, Surrey, UK) and stored in a size G cylinder prior to administration. The gas was 
administered to the participants via a face mask (Hands Rudolph 7400 Series Silicone 
Vmask™ Oro-Nasal Mask) which was attached to a T-shaped two-way non-rebreathing 
valve, via a 72" long breathing tubes EVA with a diameter of 35 mm. The 72" breathing 
tube had a dead space of 1.76 L. Therefore, it would take approximately 3 breaths to clear 
the air in the tubes. Administration of either mixtures was started and stopped 5 s prior to 
the start and end of the specific administration periods (sprint, inter sprint recovery), to 
ensure timings of the gas administration were accurate throughout.  During the Normoxia 
sessions participants were administered normal atmospheric air, via the same rig set up in 
order to minimise placebo effect. Douglas bags were filled with atmospheric air was via an 
electric air pump (Bosch GmbH, Stuttgart, Germany). During pre-experimental pilot 
testing the medical oxygen was pumped into four Douglas bags, and left for 45 minutes to 
test the seals of the bags and three-way valves. The bag was monitored and tested for 
oxygen percentage every 5 minutes for 45 minutes. After 45 minutes the content of the bag 
was still 99.8% oxygen with less than 0.3 L of gas escaping in the 45minutes. This 
established an appropriate storage and administration strategy for medical grade oxygen. 
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Figure 3-2. Douglas bag rig set up 
 
3.2.3 Blood Lactate 
 During exercise by-products are excreted due to the metabolic function of 
biological tissues. Lactate within the blood is a by-product that is widely measured within 
sport due to its relative ease to measure. Lactate is found within the blood and can be used 
as a measure of metabolic function. Capillary samples are typically taken from the ear 
lobule or the index finger. BLa has been shown to be consistently higher in the finger than 
the ear lobule. During this thesis the right ear lobule was used for EVERY sample.  
Figure 3-1. Hans Rudolph Mask and Two-Way Non-
Rebreathing Valve 
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During each specimen a 20 µl capillary BLa sample was taken from the right ear lobe. Each 
sample was mixed with haemolysing solution within a 0.5 ml haemolysing solution cup 
(1:50 ratio). The haemolysing solutions prevents haemolysis (rupturing of red blood cells) 
during the sampling process. Once collected each specimen was analysed using a Biosen 
C- Line Clinic lactate analyser (EKF diagnostics, Cardiff, UK). The Biosen lactate analyser 
measures each sample by a process called enzymatic-amperometry using chip sensor 
technology. Biosen C- Line Clinic has been shown to accurate and reliable to a CV < 1.5%. 
Following the sampling all specimens were analysed and destroyed within 24 h of 
withdrawal from the participant.   
 
3.2.4 Rate of Perceived Exertion  
Rating of perceived exertion is the use of an ordinal scale where individuals can 
describe the physiological effect at which they perceive they are working at, at any given 
moment. The most widely recognised way of reporting this is through the use of the ‘Rate 
of Perceived Exertion’ (RPE) scale 144. The scale consists of a fifteen-point vertical list of 
numbers which are supplemented by a descriptor every other point, from ‘6- No Exertion’ 
to ‘20 – Maximal Exertion’. RPE has been shown to be strongly correlated with both heart 
rate and BLa, regardless of gender, age, testing modality and ability 145,146.  
In order to investigate the relationship RPE has with exercise during O2Supp it was 
included in chapters 1-5. RPE was included as a secondary focus of the research.  
 
3.2.5 Near Infrared Spectroscopy 
NIRS is a non-invasive method of measuring the presence of oxygen within 
biological tissue, especially muscle. NIRS technology works on the premise of transmitting 
infrared light into biological tissue and calculating how much is absorbed. NIRS 
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technology is based on two main principles; firstly, that biological tissue has been shown 
absorb light in the near infrared region (700-900 nm) and secondly that biological tissues 
are oxygen dependent on absorbing infrared light.  
NIRS assesses the changes in oxygen concentration (oxygenated [O2Hb]/ deoxygenated 
[HHb]) haemoglobin (Hb), myoglobin (Mb) and cytochromes. The changes in 
concentration of oxygen (thus light absorption) vary over time, which provide evidence on 
the status of tissue oxygenation. The current understanding is that NIRS signals cannot 
distinguish between the oxygenation status of Hb and Mb individually. Therefore, the 
NIRS output should be inclusive of Hb and Mb together (O2Hb + O2Mb) whenever a 
oxygenation value is mentioned, thus throughout this thesis for ease it will be referred to 
as only O2Hb. The same occurs for the deoxygenation values as they are also inclusive of 
HHb + HMb and will therefore be referred to as HHb alone. 
NIRS works by emitting an infrared light into a biological tissue, which penetrates the 
tissue, the light is absorbed in different quantities and the amount that is refracted back and 
detected by a light detector once leaving the tissue. The Beer Lambert Law is then used to 
identify the change in the light absorbed and measure changes in O2Hb and HHb. The Beer-
Lambert Law describes the absorption of light in a non-scattering medium. Human tissue 
on the other hand is a scattered medium, therefore a modified Beer Lambert law is used. 
The modified law takes into account the amount of light lost due to scattering and includes 
a differential pathlengths factor (DPF). DPF is different for different muscle groups. The 
DPF for the quadriceps is 4 as used by Ruiter et al., 147. Therefore, during this thesis a DPF 
of 4 was used throughout.   
Spatially resolved spectroscopy (SRS) utilises several light sources at varying distances 
from the light detector. Light intensity from infrared is detected leaving the tissue and is 
measured at different distances from the source then it is possible to derive the absorption 
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and scattering coefficients of the tissue. Using this method ratios of oxygenated 
haemoglobin can be derived and scaled to identify absolute haemoglobin concentration 148. 
 
 
Figure 3-3. Diagram of spatially resolved spectroscopy (SRS) 149,150 
 
Participants wore the portable NIRS device on the belly of the right vastus lateralis 
(PortaMon, Artinis Medical Systems B.V., Elst, The Netherland). Any bodily hair was 
removed within the device placement area and cleaned with an alcohol wipe to remove any 
moisturiser or shaving cream residue.  
The device was placed 3 cm anterior to the midpoint between the top of the greater 
trochanter and the lateral epicondyle of the right knee 151. The device was subsequently 
taped with an adhesive wrapping and secondly wrapped with a blacked-out sports strapping 
to eliminate the chance of ambient light being detected.  
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The device was attached to the leg by the same researcher on every occasion, ensuring an 
external pressure of less than 20 mmHg on the device 152. The external pressure was 
achieved during pilot testing using a MicroLab, PicoPress bladder placed beneath the NIRS 
device. Indelible ink was used to draw around the device to guarantee accurate NIRS 
placement during the subsequent visits. Throughout the experimental protocol the NIRS 
device was connected to a personal computer via the Bluetooth™ system for data 
acquisition (10 Hz), and conversion from analogue to digital data. 
Throughout this thesis NIRS data was processed in line with the methodology suggested 
in Rodriguez et al., 153 research. A one second moving average was applied to the data to 
attenuate the “noise” in the signal, whilst maintaining the integrity of the original data. This 
has been shown to be one of the most effective ways of smoothing the data ready for 
statistical analysis. 
NIRS signals O2Hb + O2Mb, make up the oxygenation trace that is used to examine the 
rate of reoxygenation of the muscle following a desaturation period. Reoxygenation rate is 
the speed at which the body can recovery peripheral muscle oxygen levels. Additionally, 
HHb + HMb make up the deoxygenation portion of the NIRS trace, used to examine the 
extent of deoxygenation during periods of work. 
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Figure 3-4. Diagram of Near Infrared Device Placement 
 
3.3 Statistical Analyses 
IBM SPSS version 21-25 software was used for all statistical analyses (IBM Corp. 
Released 2013. IBM SPSS Statistics for Windows). Experimental chapters use the newest 
version of the IBM SPSS available at the time. The algorithms used to run the statistical 
tests do vary slightly from version 23 to 25, although themes of data are the same. Small 
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variations in the physical number for significance may be different across each 
experimental study and is taking into consideration during thesis discussion 154–157.  
Sample size was calculated for all experimental chapters and was established that samples 
sizes between 8 -12 were sufficient to determine a difference in the primary outcome 
measure (mean power output). A priori power analysis revealed that 8 participants would 
provide significant power to detect differences at an α-level of 0.05 for experimental 
chapter one (G∗POWER 3.1 Software, Düsseldorf, Germany). Means and standard 
deviations from the literature were used alongside meaningful differences (change in 30 
W) to determine sample size for experimental chapter one. The subsequent chapters used 
the group means and standard deviations of chapter one due to the large effect size and 
power. The data was then deemed acceptable for further power analyses for subsequent 
experimental chapters.   
Repeated measures ANOVAs were conducted in each experimental chapter. Where 
repeated measures ANOVA was used, sphericity was assessed using the Mauchley’s test 
of sphericity. During One-Way ANOVA’s and t-tests, heterogeneity of the data was 
assessed using Levene’s test for equality of variance. ANOVAs were primarily used to 
answer each of the hypotheses during the experimental chapters 
Pearson’s correlations were conducted to test the relationships between two continuous 
variables. For example, - Experimental Chapter: Pearson’s correlations were used between 
tissue oxygenation and power output between the two experimental conditions. A 
correlation coefficient between 0.1-0.3 was classified as a small correlation, 0.3-0.5 was 
classified as a medium correlation and 0.5-1.0 was classified as a large correlation. This is 
the same for both positive and negative coefficients. Correlations define the fit of the data, 
identifies the variation in the data and the relationships in the data (linear or nonlinear).  
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Paired samples t-tests were conducted during each experimental chapter for post hoc 
analysis of both primary and secondary measures. t-tests were used to identify mean 
differences in conditions for each variable (mean power, peak power, BLa) during sprints 
at an individual level. 
 
3.3.1 Imputation of Missing Values 
Data was imputed using ‘Expectation Maximisation Imputation’ following a 
missing value procedure to assess whether data was missing at random or not.  Expectation 
maximisation is an iterative method to compute maximum likelihood estimates from 
incomplete data series 158. Little’s MCAR test was initially conducted on each data set to 
assess whether data was missing at random or whether there were patterns to the missing 
data (i.e. all the start or end values missing). The null hypothesis for Little’s MCAR test is 
that the data is missing completely at random. If the results from the Little’s MCAR are 
non-significant, estimation maximisation imputation can be run to complete the incomplete 
data series 159.  
An α-level of 0.05 was set to signify statically significance across all experimental chapters. 
As well as the use of p values, Cohens d effect size and confidence interval statistics were 
used when appropriate to identify the magnitude of effects. Additional statistical analysis 
that is specific to that chapter alone is presented in the relevant section.  
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4 - Experimental Chapter: 
When Is Oxygen Supplementation Most Effective for Sprint Cycling 
Performance?  
 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
A version of this chapter has been submitted for review as a research article. – 
European Journal of Sports Science. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
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4.1 Abstract  
4.1.1 Objectives  
Concurrent supplementation with oxygen enhances performance but this type of 
delivery is not feasible in performance situations due to the size of equipment and expertise 
needed. This study aimed to determine exactly when hyperoxic gas elicits the greatest 
effect on cycling performance. We aimed to determine whether O2Supp given after a 
fatiguing task but prior to repeated sprints had a similar effect to when O2Supp was given 
during the sprints alone. 
 
4.1.2 Design and Methods  
Eight trained male amateur level cyclists underwent four visits to the laboratory. 
Each session comprised a pre-fatiguing task (15 km cycling time-trial), 15 min recovery 
(100% oxygen (H) or Normal (N) air), followed by 10 x 15 s repeated sprints (during which 
time H or N was given). The 4 conditions were NN, HN, HH & NH. Repeated measures 
ANOVA’s (p < 0.05) were used to examine difference between conditions in power output 
(peak and mean W). 
 
4.1.3 Results  
Peak and mean power output were significantly increased during full hyperoxic 
(HH, 4% and 3% respectively) compared to normoxic (NN) condition (p < 0.05). 
 
4.1.4 Conclusion  
O2Supp (FiO2 1.00) during exercise and recovery appears to elicit the greatest 
improvements in peak and mean power, without increasing lactate accumulation. This 
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shows that use of supplementary oxygen is beneficial during a maximal activity, and 
between set exercise recovery periods. 
 
Keywords: Supplementary oxygen, maximal effort, sprinting, power
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4.2 Background 
Following the literature review (Chapter 1) several areas of research were apparent, 
one being the need to narrow down the specific timing of administration within O2Supp 
research. Additionally, tables 2-5, and 2-6 highlight the need to standardise both the FiO2 
as well as the procedure used to administer O2Supp within the research. Experimental 
chapter one has been designed to begin to answer when the most effective time to 
administer O2Supp is and to standardise the methodologies used to achieve this.  
 
4.3 Introduction  
Supplementary oxygen was removed from the ‘World Anti-Doping Agency’ 
(WADA) 160 banned lists (2010), and has since gained significant attention from sport 
scientists 1,122 as both a performance and recovery enhancing tool.  
O2Supp has been administered at many different performance time points; before exercise, 
during and between exercise bouts 1, yet the exact timing of supplementary oxygen in 
relation to the greatest acute or chronic performance enhancement is not yet clear. At rest 
arterial haemoglobin is almost 100% saturated with oxygen, and the consumption of 
O2Supp has little to no effect on subsequent performance 
121. As a result, the temporal focus 
of O2Supp has moved away from before exercise, to during the performance and during 
recovery bouts between intervals. 
Ergogenic aids are any aid that leads to a direct increase in performance capacity, some 
aids have been shown to increase this ceiling or reduce the BLa concentration for any given 
workload 117. The performance improvements with O2Supp are shown as increased 
physical work and changes in metabolism too. O2Supp effects the accumulation of BLa by 
increasing the efficiency of the aerobic metabolic processes 113. Increasing the efficiency 
of these pathways results in the sparing of fuel and attenuates accumulation of by-products. 
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BLa accumulation and increase of hydrogen ions (H+) leads to the desensitisation of the 
cross bridges which subsequently causes peripheral fatigue and the termination of exercise. 
 
Under the WADA guidelines administration of O2Supp during competition is illegal, and 
not surprisingly several researchers have shown this is where the greatest performance 
benefits can be achieved 1,161. Amman et al., 81 found that the consumption of varied levels 
of O2Supp (FiO2 0.24-1.00) during 5 km cycling time trials resulted in significant increases 
in both peak and mean power (W), and faster times by up to 20%. O2Supp has also been 
shown to improve dynamic knee extensor exercise during varied FiO2 (0.21 or 1.0). In this 
case, O2Supp induced a 10 W increase in power output during the final minute of dynamic 
leg extensions 111.   
 
Several studies provide supplementary oxygen during the recovery periods between intense 
exercise bouts and this has been shown to be effective at both improving and maintaining 
performance during both long (> 3 min) and short (< 45 s) duration recoveries 3,7,126. 
Research by both Sperlich et al., 7 and Kay et al., 126 found that the delivery of FiO2 of 0.6-
1.00 during 4-6 min recovery following repetitions of 30-60 s was sufficient to significantly 
improve peak power (4-6%) output in swimmers and cyclists alike. Similarly, pilot data 
conducted in our lab found that when O2Supp was administered to cyclists during the 
recovery period between sprints (10 x 15 s sprints, 45 s recovery), they were able to elicit 
significant improvements in mean power output (4%).  
However not all researchers have found O2Supp during recovery intervals to be beneficial 
on subsequent performance. Sperlich et al.,3 found that O2Supp  (FiO2 1.00) given during 
6 min recovery periods between 30 s sprints was not sufficient to evoke a change in peak 
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power, mean power or even BLa, despite athletes reporting a reduced rating of perceived 
exertion.  
The available data directly comparing the influence of O2Supp are sparse, both due to the 
lack of studies, the large variation in the FiO2 given to participants and similar exercise 
modalities. It appears that the most effective time to use O2Supp during short term high 
intensity exercise in order to improve performance, remains equivocal. Therefore, the aim 
of this study was to evaluate the effects of inhaling hyperoxic gas (FiO2 1.00) during 
recovery periods and/or exercise on cycling performance. Previous work has researched 
the effects of O2Supp during recovery or during exercise but not combined. This will be 
the first study to combine O2Supp during both recovery and or sprints. This study will allow 
practitioners to identify the most effective time to administer O2Supp in a training 
programme. Identifying the most effect time to administer O2Supp will aid many sporting 
events that involve repeated high intensity intervals within training and competition.  
 
It was hypothesised that the greatest increase in cycling performance would occur during 
the full hyperoxic condition compared with both partial O2Supp or a control (Normoxia 
condition). Second, it was hypothesised that during the full O2Supp condition, BLa would 
be compared with the other conditions. 
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4.4 Methods  
4.4.1 Study Design 
In order to identify the effects of O2Supp on repeated cycling performance, four 
different conditions were identified. A combination of gases was administered in a recovery 
period following 15 km pre fatiguing cycle, and during a set of repeated sprints. The 
protocol replicates similar training undertaken by track points race cyclists, as they 
complete high intensity sprints after several laps around the track.   
Eight male cyclists completed four sessions each in a randomised cross-over design 
whereby two participants conducted each study order. Each testing session occurred at the 
same time of day (± 2 h) for each participant. Performance variables (peak and mean power) 
were measured throughout each exercise task. BLa was measured at consistent intervals 
throughout the whole study.  
 
Eight healthy male amateur level cyclists from University of Essex participated (26.5 ± 5.2 
years; 85.1 ± 11.7 kg; 1.82 ± 0.01 m). To ensure homogeneity of ability, participants were 
required to evidence that they were able to complete a 10-mile cycling time trial (TT) 
between 26- 28 min prior to taking part in the study. 
Participants were requested to refrain from alcohol and caffeine prior to participating, 24 h 
and 4 h respectively. Participants were informed of the procedure, completed written 
consent and a pre-exercise readiness health questionnaire. Ethical approval for the study 
was granted by the University of Essex ethics committee.  
 
4.4.2 Experimental Protocol 
Prior to completing the repeated sprints, participant completed 15 km TT as a pre-
fatiguing task. This cycle was followed by 15 min ‘post TT recovery’ period where the 
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middle 5 minutes was active recovery to allow for warm up prior to intense repeated sprints. 
Finally, participants completed 10 x 15 s sprints, interspersed with 45 s recovery. Each 
participant completed 4 visits in a randomised counterbalanced order; Normoxia in the 15 
min post TT recovery and during the 10 x 15 s sprints (NN), O2Supp in both post TT 
recovery and sprints (HH), O2Supp in the post TT recovery and Normoxia in sprints (HN) 
and Normoxia in post TT recovery and O2Supp during sprints (NH) (Figure 4-1).  
 
The four visits to the laboratory were separated by a minimum of 48 h and completed over 
a 3-week duration. Hyperoxic (O2Supp - FiO2 1.00) and normoxic (FiO2 0.21) gas mixtures 
during recovery and/or sprints, were administered via a rig of 4 x 200 L Douglas bags, 
connected to a mask and head net (Hans Rudolph, Shawnee, KS, USA). O2Supp was 
created using medical grade oxygen (British Oxygen Company, Surrey, UK) prior to 
administration. The washout period for medical oxygen is unknown, although the internal 
environmental changes take 15 s to detect changes in oxygen concentration, similar to 
hypoxia 162. Therefore, training stimulus (fatigue) is purported to be the only reason for 48 
h recovery period following each session.  
 
Prior to the start of any physical activity, a pre-exercise 20 µl capillary BLa sample was 
taken from the right ear lobe. Each sample was mixed with haemolysing solution within a 
0.5 ml haemolysing solution cup. Subsequent lactate samples were taken every 2 min 
during recovery post TT. Further samples were taken during recovery from each sprint 
repetition. All samples were analysed within 1 h of withdrawal during which they were 
kept cool and stored in a secure biohazard fridge. 
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The 10 x 15 s maximal cycling sprints with 45 s of recovery (1:3 Work rest ratio) 52 were 
undertaken on a stationary cycle (WattBike, Nottingham, UK). Mean sprinting power for 
each of the 10 sprints was determined per individual. A ‘group mean’ sprinting power for 
each individual sprint, in each condition was also calculated using the average of each 
participant’s sprint 1 to sprint 10. The same process was used to calculate individual and 
group peak sprinting power. Mean power output was used to determine the extent of 
performance decline throughout the 10 repeated sprints. Performance decline was 
calculated taking the first sprint (best) and then their sprint with the lowest power output 
and calculating the percentage decline. Percentage decline = [(best – worst) / best] *100. 
The higher the number the bigger the decline in performance.
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Figure 4-1. A schematic representation of the experimental methodology during experimental Chapter 1. 
25-28 min Sprints 10 x 15 s, 45 s recovery 
Blood lactate 
measure 
15 min Recovery Period 
15 km Time 
Trial 
Full Duration ~ 60 min 
Session: 
- 15 sprint (seated) 
- 45 s recovery (passive) 
- 10 sprints  
- Maximal air brake and 1 magnetic brake  
Passive 
Recovery 
Oxygen supplementation or normoxia 
Recovery: 
- 15 min total recovery 
- 5 min passive recovery 
- 5 min active recovery 
- 5 min passive recovery 
Passive 
Recovery 
Active 
Recovery 
5 min 5 min 5 min 
15 km Time Trial: 
- Blood lactate every 2 min 
- Rating of Perceived Exertion 
- Mean Power and Cadence 
Oxygen supplementation or normoxia 
AND/ OR 
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4.4.3 Statistical Analysis 
All statistical analysis was performed using the statistical package, SPSS statistics 
version 21 for windows (SPSS, Inc, Chicago, IL, USA). Statistical analysis was performed 
using two-way within group ANOVA, to analyse the effect of condition on mean power 
(W), peak power (W), and BLa (mmol·L-1) and the effect of time across the 10 sprints. 
Partial eta squared values were calculated to determine overall effect sizes. In the case of 
large effect size, post hoc tests were used to look between conditions. Post hoc analysis 
was conducted using paired samples t-tests with Bonferroni correction on sprints at an 
individual level. α-level was set to p = 0.05 for all data analysis. 
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4.5 Results  
Time Trial. There was no significant difference between the work (J) conducted in 
the TT prior to the sprints in any of the four conditions, F (3,21) = 2.98, p = 0.06. HN = 
1471.78 ± 13.57 J, NH = 1586.69 ± 17.32 J, HH = 1482.68 ± 14.65 J, NN = 1462.01 ± 
11.86 J.  
Mean Power. There was a significant main effect of time across the 10 Sprints F 
(9,45) = 11.24, p < 0.01, ƞp2 = 0.69, but no significant main effect of  condition F (3,15) = 
3.05, p = 0.06, ƞp2 = 0.48 (Figure 4-2). No interaction effect was evident. The post hoc 
analysis showed that HH induced an average power 4.2% higher than HN (p < 0.05), which 
is (HH) also 3.2% higher than that of NN (p = 0.02) (Figure 4-2). No significance was 
shown following post hoc analysis at an individual sprint level p > 0.05.  
  
Figure 4-2. Mean cycling power output over 10 sprints in four conditions (n = 8). 
Legend: O2Supp -Normoxia; HN, Normoxia – O2Supp; NH, O2Supp- O2Supp; HH, 
Normoxia – Normoxia; NN, Watts; W.  
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Peak Power. There was a significant main effect of time across 10 sprints F (9,45) 
= 7.30, p < 0.01, ƞp2 = 0.59. There was no main effect of condition in peak power F (3,15) 
= 0.83, p = 0.50, ƞp2 = 0.14. However, given the large effect size, further analysis was 
carried out and it was found that HH induced a peak power of 841.5 ± 60.7 W, which was 
3.5% higher than the NN condition (810.3 ± 61.0 W, p > 0.05). There was also a non-
significant difference (3.7%) peak power in the HN condition (840.1 ± 82.4 W) compared 
with NN (810.3 ± 61.0 W, p > 0.05). NH was not significantly different to any of the other 
three conditions (842.8 ± 61.0 W, p > 0.05). No interaction effect between condition and 
time was evident (Figure 4-3).  
 
Figure 4-3. Peak cycling power output four conditions -M ± SD (n = 8). 
Legend: O2Supp-Normoxia; HN, Normoxia -O2Supp; NH, O2Supp - O2Supp; HH, 
Normoxia – Normoxia; NN, 
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Lactate Accumulation. There was no difference in lactate accumulation during the 
recovery prior to the repeated efforts across the four conditions, F (3,15) = 0.23, p = 0.87, 
ƞp2 = 0.04, nor in the lactate accumulation during sprints across the four conditions, F (3,12) 
= 0.73, p = 0.55, ƞp2 = 0.15 (Figure 4-4).  
 
 
Figure 4-4. Mean lactate accumulation over 10 sprints in four conditions (n = 8). 
Legend: O2Supp-Normoxia; HN, Normoxia -O2Supp; NH, O2Supp - O2Supp; HH, 
Normoxia – Normoxia; NN,   
 
Performance Decline. There was no significant difference between the performance 
decline throughout the sprints in any of the four conditions, F (3,18) = 0.98, p = 0.43. HN 
= 30.59 ± 4.61%, NH = 22.54 ± 4.67%, HH = 26.04 ± 3.54%, NN = 31.14 ± 5.29%.  
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Figure 4-5. Percentage decline in cycling mean power output across the four 
conditions – M ± SD (n = 8). 
Legend: O2Supp-Normoxia; HN, Normoxia -O2Supp; NH, O2Supp – O2Supp; HH, 
Normoxia – Normoxia; NN 
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4.6 Discussion 
The aim of this research was to determine the effect of O2Supp on sprint cycling 
performance, dependent on the timing of supplementation. The current study found that 
O2Supp during recovery periods and exercise was most effective in eliciting increases in 
mean power output, HH was 4.2% higher than control condition NN.  O2Supp during 
exercise bouts alone (NH) was the second most beneficial administration time, with HH 
mean power output only being 1% higher than NH. Sprint cycling performance when 
O2Supp was given during the pre-sprint recovery period was 3.2% higher than the mean 
power in NH condition.  
 
The increase in mean sprint cycling performance seen during the HH and NH conditions 
can be credited to a number of different factors; the rate of PCr resynthesis, the efficiency 
of clearing metabolic by products, and an increased potential to use aerobic ATP 
regeneration. Although, PCr resynthesis was not directly measured within this study, the 
maintenance of BLa levels with increased power output, it can be speculated that this is as 
a direct result of increased PCr resynthesis 1,7.  
 
Administering O2Supp throughout the session likely influences the resynthesis of PCr. The 
effects of O2Supp prior to exercise dissipate quickly due to the rapid diffusion of dissolved 
oxygen into/ out of the blood, and due to arterial haemoglobin (SaO2) being near fully 
saturated at rest 121. However, during exercise there may be a drop in SaO2 of up to 15%, 
and concurrent O2Supp has been shown to increase full body oxygenation, increasing SaO2 
by as much as 7% 163. This has been demonstrated when O2Supp at an FiO2 of 0.4 was used 
during and after 9 x 300 m running sprints 134. 
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The combination ATP and PCr provides the energy needed during high intensity exercise 
lasting between 10-15 s. Consequently, repeated sprint exercise continuously depletes PCr 
stores. A 45 s rest after 10 s of high intensity exercise only replenishes ~75% of total PCr 
stores 164. Consequently, after the 5th successive sprint in a series, PCr stores will become 
significantly diminished resulting in a reduced sprinting ability. Even though, the PCr 
energy system is anaerobic in nature, its resynthesis requires oxygen. The resynthesis of 
PCr occurs using products from both the Krebs cycle and aerobic glycolysis, which have 
been shown to be enhanced following the use of O2Supp 
99. Enhanced PCr resynthesis due 
to the consumption of hyperoxic gas 99,165 will allow performance to be maintained for 
longer – as seen in the current study.  
 
There is a small (< 10%) aerobic contribution to energy production during a short (up to 
30 s duration) maximal effort sprint and is suggested that this contribution increases as 
sprints are repeated, perhaps due to the alterations in oxygen kinetics 94–96. This is part due 
to increased oxygen demand post sprints in order to re-establish the saturation of myoglobin 
with oxygen and PCr. This may result in subsequent sprints starting at progressively higher 
V̇O2. Additionally, Bogdanis et al.,97  found that aerobic metabolism during the second 
sprint (30 s) provided ~49% of the energy yield. These values were estimated due to an 
increase in oxygen uptake by ~0.5 L·min-1 (increase of 20%). These findings can be 
explained by Wagner 98 who concluded that an increased FiO2 raises the partial pressure of 
oxygen in the blood and resultantly increases V̇O2max (sparing anaerobic energy at higher 
workloads).  
 
Accordingly, an increase in peak and mean power during repeated high intensity exercise 
can be attributed to an enhanced PCr resynthesis during O2Supp, 
52,93 and an increased 
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ability to respire aerobically. Glaister 52, suggests that repeated sprint exercise performance 
is determined by high energy yields from PCr resynthesis during exercise, but during 
recovery periods the processes are exclusively aerobic. The current study shows that 
O2Supp is most effective at increasing peak and mean power output when used both after 
a fatiguing cycle AND during (15 s) and between (45 s) bouts of exercise, thus supporting 
the study hypothesis.  
 
The effect of O2Supp during exercise has been credited, in part, to the reduction in the 
accumulation of lactate in the blood 7. O2Supp during recovery has also been shown to aid 
enhanced metabolic clearing 2,54. The reduced accumulation of lactate during exercise is 
strongly correlated with the cost of the anaerobic contribution during exercise. The present 
study measured BLa as a proxy of the anaerobic contribution of exercise. BLa was found 
to be similar across conditions, even with an increased power output in the O2Supp 
conditions (HH and HN). It is suggested that the metabolic cost of producing more power 
was negated by the consumption of O2Supp, confirming the hypothesises of this study. 
Therefore, it is to be assumed that the consumption of O2Supp  during both recovery and 
exercise is most effective in reducing the anaerobic cost and by products of repeated sprint 
training 166. This work has shown that O2Supp benefits acute performance outcomes, but 
the longer-term effects of O2Supp on the training response need to be examined.
 
 
4.6.1 Limitations  
Several limitations of this study, participants underwent a 15km time trial as a pre fatiguing 
exercise bout. This could have been standardised by controlling the amount of ‘work’ 
undertaken rather than a time or distance limit. This would have allowed each visit to be 
identical in nature, rather than the small differences in work between visits. Additionally, 
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no direct measure of fitness (V̇O2 max) was conducted to characterise the study population. 
Level of fitness is a potential mediator of response to O2Supp. 
 
4.6.2 Practical Implications 
This research was set up with the aim of improving sporting performance and 
maximising the effectiveness of O2Supp. Coaches and athletes can apply this relatively 
inexpensive training aid to provide short term increases in sprinting performance. Athletes 
will be able to produce more power for the same training stimuli resulting in greater 
potential for adaptation and acclimatisation.  
 This ergogenic aid can only be applied to training as it is banned in competition. Caution 
still needs to be applied when using O2Supp as a training tool, particularly in relation to the 
longer-term effects.  
 
4.7 Conclusion  
In conclusion, the present study demonstrates that the most effective time to 
administer hyperoxic air is during recovery and exercise. Enhancements in performance 
with no meaningful influence of BLa concentration were apparent. As a result, O2Supp 
should be considered as a meaningful tool for coaches to implement in training programmes 
(during intervals) enabling athletes to work harder during training without becoming more 
fatigued. 
 
4.8 What Next?  
Following the findings of this experimental chapter it is proposed that future research 
should look at trying to identify when during a training session is the most effective time 
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to administer O2Supp. With that information coupled with the results of this study a strong 
practical application for O2Supp in cycling will be evident.   
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5 - Experimental Chapter: 
 The Effect of Manipulating the Timing of Oxygen 
Supplementation on Repeat Sprint Cycling Performance  
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A version of this chapter has been published as a research article. Citation as seen 
below.  
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5.1 Abstract  
5.1.1 Objectives:  
The aim of this study was to determine the optimal time to administer oxygen 
during a repeat sprint protocol on cycling performance, when the oxygen delivery was 
changed rapidly during session. 
 
5.1.2 Design and Method:  
Ten male amateur trained cyclists took part. Testing comprised four visits to the 
laboratory in a counterbalanced design. Each session entailed; 5 min cycling warm up 
(~200 W), 5 min passive recovery, followed by 10 x 15 s repeated sprints interspersed with 
45 s passive recovery, during which the air inspired was manipulated using a FiO2 of 1.00 
or 0.21 (normal air). The content inspired during the 15 s sprints and/or the 45 s recovery 
periods, comprised the four visits: NH, HN, HH, NN. It was hypothesised that the HH 
condition would evoke the largest performance improvements.  
Outcome measures included mean power (W), BLa and performance decline. Repeated 
measures ANOVA were used to examine the difference between conditions in outcome 
measures.  
 
5.1.3 Results:  
There was no significant effect of oxygen supplementation on mean power (W), 
BLa (mmol·L-1) or performance decline (%) (p > 0.05). However, a common trend in HH 
condition (continuous) was evident, with lowest levels of lactate accumulation and the 
shallowest decline in performance across the 10 sprints. Performance was not enhanced 
when the oxygen supplementation was discontinuous. 
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5.1.4 Conclusion:  
Oxygen supplementation during repeat sprint cycling has a net detrimental effect on 
performance when administered in short (15-45 s) discontinuous periods throughout a 
session and is not as effective at maximising performance compared with training with 
oxygen throughout.  
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5.2 Background 
The findings of chapter 4 begin to identify the most effective administration time of 
O2Supp. Chapter 4 found that O2Supp was most effective during large duration 
administration. However, it has yet been established whether O2Supp is effective during 
single components of a training session, such as the sprints and not the inter sprint recovery 
periods. This additional knowledge will highlight the practical application of O2Supp; 
therefore, the forthcoming study will look to shed light on this.  
 
5.3 Introduction 
Hyperoxia occurs when cells, tissues and organs are exposed to an excess supply of 
oxygen or higher than normal partial pressure of oxygen 59. Normoxia on the other hand is 
the natural body conditions that occur at sea level in absence of disease. To create hyperoxic 
conditions within the body one must breathe an oxygen enriched gas mixture (O2Supp). 
Previously, O2Supp was banned by the WADA due to its potential performance enhancing 
effect 161. Recent evidence 114,136,163,167 has led to the reinstatement of O2Supp within 
training for a competitive sport, resulting in its increasing application in exercise training 
160. 
O2Supp is increasingly becoming a popular ergogenic aid within a range of sporting 
populations. Research has been conducted on runners, cyclists, swimmers and hockey 
players 7,8,134,168, most of which use the supplement during a continuous period of 30-240 
s. These durations may elicit the biggest performance improvements, but they are not so 
easy to administer in a real-world setting (i.e. outside of the lab).  
Companies such as Boost Oxygen© and Oxygen Plus© offer handheld oxygen canisters 
that contain between 25 to 220 breaths of pure 100% oxygen. These offer enough oxygen 
to complete short duration exercise or sporadic use during recovery periods between 
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exercise bouts. Oxygen has been administered at many different performance time points; 
before exercise, during and between exercise bouts 1, yet the exact timing of supplementary 
oxygen in relation to the greatest acute performance enhancement is not yet clear. However, 
chapter 4 has shed some light on this, showing that O2Supp seems to be most effective 
during both sprints and recovery but is yet to be confirmed.  
With the correct timing, supplementary oxygen given  during a repeated sprint training 
session will be effective at increasing the resynthesis rate of PCr and subsequently 
performance 76,114. It appears that the most effective time to use O2Supp during short term 
high intensity exercise in order to improve performance, remains equivocal.  
 
The aim of this research was to evaluate the effects of altering the timing of supplementary 
oxygen (FiO2 1.00) (during recovery periods and/or exercise) during a single repeat sprint 
cycling session.  It was hypothesised that the greatest increase in mean sprint cycling power 
output (W) would occur during the full O2Supp condition (HH) compared with both partial 
O2Supp (HN and NH) and a control (Normoxia condition, NN). Additionally, it was 
hypothesised that the HH condition would result in similar BLa concentration during each 
sprint, compared with the other conditions. 
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5.4 Methods  
5.4.1 Study Design 
Ten healthy university students were recruited to take part in the study. Participants 
(1.79 ± 0.05 m, 74.7 ± 10.5 kg, 22.8 ± 4.5 years) were amateur cyclists who all had previous 
experience using a cycle ergometer and repeated sprint protocols.  
Participants were informed of the procedure and provided written informed consent prior 
to study commencement. Ethical approval for the study was granted by the University 
ethics committee in accordance with the Helsinki declaration.  
This study was a single-blind, within-participant design comprising four counterbalanced 
assessments of repeat sprint performance using O2Supp (FiO2 1.00) or normal air (FiO2 ~ 
0.21).   
Laboratory tests were completed at the same time of the day (± 2 h). Participants were 
asked to maintain normal activity and sleep pattern between testing sessions. Participants 
were asked to refrain from strenuous physical activity 24 h prior to participating. 
 
5.4.2 Experimental Protocol 
Participants undertook the same procedure on all 4 visits: 5 min warm up at a 
workload of ~200 W, 5 min passive recovery, and 10 x 15 s cycle sprints with 45 s recovery.  
Details of oxygen supplementation are detailed in chapter 3. In brief, O2Supp and normoxic 
gas mixtures were administered via a rig of 4 x 200 L Hans Rudolph Douglas bags 
connected to a Hans Rudolph mask and head net (Hans Rudolph, Shawnee, KS, USA). The 
O2Supp (FiO2 1.00) condition used medical grade oxygen cylinder (BOC, Surrey, UK). In 
each condition, participants wore the mask and breathed from the Douglas bag during the 
repeated sprints and the recovery periods. Gas was administered to the participants through 
the Douglas bags after saturating and warming the compressed gas.  
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Gas administration was manipulated during the sprint and recovery to make up four 
conditions; O2Supp in the 10 sprints and Normoxia in the 10 inter sprint recoveries (HN), 
Normoxia in sprints and O2Supp in recoveries (NH), O2Supp in both sprints and recoveries 
(HH), and finally Normoxia in both sprints and recoveries (NN) (Figure 5-1). 
 
A pre-exercise 20 µl capillary sample was taken from the right ear lobe as a baseline 
measure. Each sample was mixed with haemolysing solution within a 0.5 ml haemolysing 
solution cup. Subsequent samples were taken during the recovery period of each sprint 
repetition. All samples were analysed for BLa within ~1 h of withdrawal using a Biosen 
(EKF diagnostics, Cardiff, UK). 
Following the warmup each participant undertook ten repetitions of 15 s cycling sprint 
followed by 45 s static recovery. Participants were instructed to stay seated to isolate leg 
power.  
During the sprints the Wattbike (Watt Bike Ltd, Nottingham, UK) with the magnetic setting 
set to 1 and air brake set to 10. This protocol was set in accordance with pilot testing 
conducted prior to this study as it was determined this resistance allowed participants to 
generate their peak power whilst not exceeding their peak cadence. Performance data used 
for analysis were peak sprinting power (the highest Watts achieved in each cycle) and mean 
sprint power (the average Watts produced during each 15 s cycle)
Page 106 of 254 
 
 
 
Figure 5-1. A schematic representation of the experimental methodology during experimental Chapter 2. 
5 min Sprints 10 x 15 s, 45 s recovery 
Blood 
Lactate 
Measure 
Recovery 
Full Duration ~ 25 min 
Session: 
- 15 sprint (seated) 
- 45 s recovery (passive) 
- 10 sprints  
- Maximal air brake and 1 magnetic brake  
Oxygen supplementation or normoxia 
Recovery: 
- 5 min passive recovery 
Warm Up: 
- 5 min active warm up 
- ~200 W Power Output 
5 min 
Warm Up 
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5.4.3 Statistical Analysis 
All statistical analysis was performed using the statistical package, SPSS statistics 
version 25 for windows (SPSS Inc, Chicago, IL, USA). An a priori power analysis revealed 
that ten participants would provide significant power to detect differences in mean power 
by 3-4% at an α-level of 0.05 (G∗POWER 3.1 Software, Düsseldorf, Germany). Power 
analysis detected using data from previously published work with large differences in 
cycling power output 169. 
Repeated measures analysis of variance (ANOVA) were conducted to look for differences 
according to condition (O2Supp / Normoxia) for; peak power (W), mean power (W), and 
BLa (mmol·L-1) for each sprint.   
α-level set p = 0.05 for all data analysis. Effect size for individual measures were calculated 
and reported as Cohen’s d and interpreted using bounds as 0.2, 0.5, > 0.8, where they are 
small, medium and large respectively 170. 
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5.5 Results 
Mean Power (Table 5-1). There was a significant main effect of time on sprint 
performance across the 10 Sprints F (9,27) = 35.73, p < 0.01, d = 2.61. There was no 
significant main effect for sprint performance according to condition F (3,12) = 0.21, p = 
0.99, d = 0.35. No interaction effect was evident.  
Peak Power. There was a significant main effect of time for peak sprinting power 
across 10 sprints F (9,27) = 16.78, p < 0.01, d = 1.77. There was no main effect of condition 
in peak power F (3,12) = 0.37, p = 0.99, d = 0.46. No interaction effect was evident.  
Percentage decline in performance (Figure 5-2). There was a significant main effect of 
time on sprint performance across the 10 Sprints F (8,72) = 24.42, p < 0.01, d = 7.22. No 
significant main effect for sprint performance according to condition was found, F (3,23) 
= 1.19, p = 0.33, d = 0.72. No interaction effect was evident.  
Lactate accumulation during sprint (Figure 5-3). There was no difference in lactate 
accumulation across the four different gas mixtures, F (3,12) = 1.22, p = 0.21, d = 0.87 
(Figure 5-3). However, HH (7.15 ± 0.77 mmol·L-1) had a lower lactate level than HN (9.45 
± 0.71 mmol·L-1, d = 3.11) whilst HH was also meaningfully lower (change greater than 
10%) than both NH (mean differences (MD) = -2.13 mmol·L-1) and NN conditions (MD = 
-2.13 mmol·L-1). (Figure 5-3). 
On questioning, 70% of participants were able to correctly deduce the NN condition 
once they had completed all four visits, whereas only 40% of the participants were able to 
correctly deduce the HH condition. In the two other conditions were 50% and 60% 
respectively, participants correctly guessed the conditions. 
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Table 5-1 Mean cycling power over ten sprints in four conditions (M ± SD) (n = 10). 
 Sprint 1 (W) Sprint 2 
(W) 
Sprint 3 
(W) 
Sprint 4 
(W) 
Sprint 5 
(W) 
Sprint 6 
(W) 
Sprint 7 
(W) 
Sprint 8 
(W) 
Sprint 9 
(W)  
Sprint 10 
(W) 
HH 677.8 ± 128.0 615.4 ± 105.0 581.0 ± 111.6 550.3 ± 121.9 526.5 ± 122.9 500.3 ± 120.7 498.9 ± 117.0 504.2 ± 121.2  489.3 ± 93.5 510.7 ± 108.1 
HN 735.8 ± 138.6 657.5 ± 118.1 584.8 ± 103.7 535.2 ± 94.4 514.5 ± 95.4 492.1 ± 102.5 462.9 ± 116.4 467.9 ± 129.7 463.5 ± 109.7 470.6 ± 122.4 
NH 709.6 ± 125.0 616.4 ± 68.3 578.1 ± 96.5 540.0 ± 93.2 529.1 ± 100.9 502.5 ± 97.9 478.5 ± 106.8 475.1 ± 116.2 444.5 ± 98.4 456.8 ± 121.7 
NN 709.9 ± 138.3 620.5 ± 106.8 567.6 ± 111.9 541.2 ± 91.4 517.2 ± 89.8 504.8 ± 82.2 474.1 ± 83.8 471.3 ± 95.6 490.9 ± 91.5  502.6 ± 99.8 
Legend: O2Supp -Normoxia; HN, Normoxia -O2Supp; NH, O2Supp – O2Supp; HH, Normoxia – Normoxia; NN, Number; No, Watts; W.  
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Figure 5-2. Percentage change in sprint performance from sprint one across nine subsequent sprints in four conditions (n = 10). 
Legend: O2Supp -Normoxia; HN, Normoxia -O2Supp; NH, O2Supp – O2Supp; HH, Normoxia – Normoxia; NN, Number; No, 
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Figure 5-3. Mean lactate at rest and over ten sprints in four conditions (n = 10). 
Legend: O2Supp -Normoxia; HN, Normoxia -O2Supp; NH, O2Supp – O2Supp; HH, Normoxia – Normoxia; NN, Number; No, Millimole per Litre; 
mmol·L-1.  
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5.6 Discussion  
The aim of this research was to determine the effect of O2Supp on sprint cycling 
performance, with a specific focus on the timing of administration. The current study found 
that administering O2Supp to a sprint cycling athlete has no statistically significant benefits 
for mean and peak power output (W), but a meaningful reduction in BLa concentration 
were evident in HH condition compared to the other conditions. 
Primary findings revealed that mean sprint power output (15 W- 2.5%, d = 0.35) increased 
non significantly in the presence of extra oxygen (FiO2 1.00). This change was replicated 
by the performance decline data that showed a shallower slope across each sprint in the HH 
condition. 
Due to the relative early years of O2Supp research many of the assumptions are developed 
to diametrically oppose the themes (reduced O2 availability and utilisation) within hypoxia 
research (low O2Supp). O2Supp research, largely hypothesises that the opposites (to 
hypoxia) occur with little evidence to suggest why. 
 
During the conception of the study we speculated that the two conditions that have 
discontinuous oxygen supplementation (NH, HN), would result in reduced performance 
capacity due to the continued alterations of the gas concentrations, this is evident within 
the current data. Participants performance deteriorated as their internal equilibrium is 
unable to effectively utilise rapid changes in oxygen concentration. 
Changes that occur with additional oxygen include decreased blood flow 124, 
vasoconstriction 106,107, and increased arterial oxygen content 171. During repeated changes 
in the oxygen consumption, and the continuous changes in the homeostatic responses, the 
individual cannot react effectively fast enough, thus performance capabilities are reduced 
as a result.  The reasons why both the NH and HN conditions showed decreases in 
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performance compared to HH and NN conditions could be attributed fluctuating nature of 
the O2Supp. NH and HN has changes in gas content every 15 s and 45 s respectively. In 
hypoxia research the detection of the internal change in oxygen occurs 15 s after its 
administration 162. The timing of the response could be purported to be similar in O2Supp. 
Resultantly the continuous manipulation in oxygen levels leave the medulla oblongata 
continuously trying to respond to fluctuations in the blood oxygen levels, by decreasing 
peripheral blood flow 124, and peripheral vasoconstriction 106,107. Supplementary oxygen is 
appearing to be more effective when administered during longer periods of work/rest to 
allow for changes in internal equilibrium to occur and probably why we see large 
improvements in HH condition compared to the other three conditions (NH, HN, NN). 
 
Performance changes (mean and peak power output) in the HH and NN conditions were as 
expected, whereby the full oxygen condition results in greater performance (albeit non-
significant) than the Normoxia condition (NN) 140,166,169. Performance decline followed a 
similar trend across each condition until sprint 6- this is where HH condition plateaus. This 
change in the slope of  performance  has also been suggested in previous studies 52,169. 
Similarly, pilot work in our lab found that supplementary oxygen has significant 
performance benefits in particular following the first 5 sprints of a 10-sprint programme.  
 
The performance enhancing effects of O2Supp have been credited, in part, to the reduction 
in the accumulation of lactate in the blood 7. Despite this study only resulting in small 
changes in performance during the HH condition, lactate was also lowest in this full oxygen 
condition. It could be suggested that the metabolic cost of producing more power was 
attenuated by the consumption of oxygen 166. Hogan et al., 113 suggest lactate accumulation 
can explain the differences in performance during varied oxygen conditions. O2Supp can 
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also lead to an increased ‘lactate threshold’ or an increased ability to attenuate the 
accumulation of lactate, resulting in potential positive performance outcomes 2,54,113. 
 
It is evident that O2Supp is effective at improving performance during cycling, when 
administered over an extended duration. The duration appears to be an important variable 
in O2Supp research. O2Supp should therefore be applied to training and or recovery periods 
that last over 1 min in duration, with more investigation needed to identify the exact 
minimum time to elicit improvements in performance. This said the current marketed 
cannisters that only last for between 20-220 breaths may not be effective for use in a single 
training session, as each cannister may only last 200 s or less during periods of exercise or 
recovery.  
 
The novel findings of this study open further avenues for investigation. The effects that 
occur during interrupted administration of O2Supp, may lead us to understanding why we 
get performance improvements and what specific internal environments change. It would 
appear reasonable for further studies to identify the specific microvascular and chemical 
changes experienced by simultaneously exercising whilst manipulating the oxygen content 
for very short durations as was the case in this study. 
 
5.6.1 Limitations 
We acknowledge several limitations to this study. Participants pre study fitness 
level was not accounted for (V̇O2max) which could potentially mediate the response to 
O2Supp. Additionally, the physical dead space in the breathing tubes, this meant two 
breaths were needed to attain the mixture in the reservoir bags even though oxygen would 
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have started to saturate (via diffusion) the space immediately. This may have stunted the 
response during the mixed conditions (NH, HN). 
 
5.6.2 Practical Implications 
O2Supp has shown its ability to be applied to training programmes that can cater for 
continuous supplementation of oxygen, or programmes that have extended (> 1 min) 
periods of recovery. Both have sufficient administration duration to see internal changes 
and resultantly performance improvements. Over the counter O2Supp cannisters should be 
used with caution and forethought within an exercise programme as they may not allow 
enough exposure before, they run out. 
 
5.7 Conclusion 
In conclusion, the present study demonstrates that when O2Supp is used during 
longer duration (recovery and sprints) bouts it can be effective, though more conclusive 
evidence is needed. O2Supp during short discontinuous periods is not effective at increasing 
cycling performance, if any it has a net detrimental effect on performance.  
Similar performance characteristics are evident during HH and NN, whilst there is evidence 
of meaningful reductions in BLa concentration.  
 
5.8 What Next? 
The combination of the last two chapters confirm when the most effective time for 
administration of O2Supp is. Additionally, chapters 4 & 5 have both shown positive 
performance enhancing effects as a direct result of O2Supp, although the research has 
little understanding behind the mechanisms for why these are so evident. Future research 
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should look at what mechanisms cause such changes in performance. Is it a reduction of 
fatigue or is it a case of enhanced oxygen delivery to the working muscles?  
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6 - Experimental Chapter: 
 The Effects of Oxygen Supplementation on Repeated Sprint 
Cycling Performance and Muscle Fatigue 
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6.1 Abstract  
6.1.1 Objectives:  
O2 Supp (> 21% oxygen) can evoke performance improvements in aerobic and 
anaerobic exercise. The aims of the current study were to determine the effects of breathing 
hyperoxic gas (FiO2 1.00) on repeated cycle performance, and to assess the nature and 
extent of fatigue after intermittent sprinting. 
 
6.1.2 Design and Methods:  
Testing (n = 14 males) comprised two visits to the laboratory. Each session involved 
10 x 15 s repeated cycle sprints breathing FiO2 1.00 (O2Supp) or FiO2 0.21 (Normoxia). 
Muscle fatigue was measured pre and post sprints using maximal voluntary contraction 
(MVC), voluntary activation (VA) and potentiated doublet twitch (PTF). BLa was taken 
between sprints. 
Paired samples t-tests were used to examine difference between conditions in power output 
(peak and mean W) and BLa. Two-way ANOVA was used to examine fatigue variables 
pre and post sprints according to condition.  
 
6.1.3 Results:  
Mean power output was 4% greater in O2Supp (p < 0.01), with no difference in 
peak power (p > 0.05). There was a significant increase in BLa in O2Supp compared with 
Normoxia (p < 0.01) in sprints 4 and 8, as well as meaningful difference in sprints 4-10. 
There was no significant difference in fatigue factors (MVC, VA and PTF) (p > 0.05) in 
response to the cycling, although a large drop in PTF occurred in both conditions. 
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6.1.4 Conclusion:  
O2Supp can elicit improvements in mean cycling power, with no significant change 
in post exercise muscle fatigue. O2Supp as a training aid may provide performance 
enhancing effects during repeated sprint cycling by reducing concurrent muscle fatigue, 
primarily via peripheral factors.  
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6.2 Background  
The previous two chapters (chapters 4 & 5) highlighted the most effective time to 
administer O2Supp during a repeated sprint protocol. The findings of these studies will be 
applied to the methodology of this and the coming studies. Additionally, chapter 1 
highlighted that the research has yet to establish any mechanisms for why specific such 
large changes (4%) in cycling performance are evident. This coming study will begin to 
establish the fatiguing component within O2Supp research, whilst standardising the 
administration procedure to mirror the previous studies.   
 
6.3 Introduction 
O2Supp is the inhalation of air with an FiO2 greater than that of sea level (~0.21). 
Supplementing high intensity exercise with FiO2 > 0.21 allows the maintenance of 
performance when fatigue would usually become apparent, both during aerobic and sprint 
exercise 114,126. The mechanism behind this attenuation of performance decline are 
multifactorial and include  reduced production of BLa 114, enhanced clearance of BLa, 
prevention of muscle oxygen desaturation 54,78 the maintenance of blood pH  and enhanced 
resynthesis of creatine phosphate 134. These factors are associated with peripheral fatigue, 
i.e. the exercise induced decrease in muscle force production.  
A reduction in neural drive from the motor cortex to muscle appears as a decrease in 
voluntary muscle activation (VA) during exercise 28. This ‘central fatigue’, may also be 
influenced by the FiO2. Indeed, research has shown that a reduced cerebral O2 delivery 
resulting from hypoxia (FiO2 0.18) results in curtailment of exercise performance due to 
fatigue 37. Thus, whether O2Supp can alleviate central fatigue in a sport situation is 
unknown.  
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Performance decline is likely a combination of both central and peripheral factors and the 
relative contribution of each depends upon the nature of the task 172. Peripheral fatigue is 
likely the limiting factor in short, high intensity exercise, with central fatigue playing a 
greater role as the exercise bout continues. For example, a single 4 km TT lasting around 
5 min was shown to be limited by peripheral fatigue, whilst a 20 km TT (lasting around 32 
min) was primarily limited by central fatigue 172.  
Repeated sprint efforts represent a short term high intensity exercise, which are likely to be 
limited primarily by peripheral fatigue 173. However, the extent to which central fatigue 
contributes to performance decline in repeated sprint performance is equivocal. Racinais et 
al., 174 determined that the ability to repeat short duration sprints was associated with both 
central and peripheral factors. The twitch interpolation technique is widely used and is 
considered a reliable method to estimate the origin of neuromuscular fatigue. Peripheral 
fatigue is measured by comparing the force responses to electrical stimulation pre and post 
fatiguing exercise. To determine the contribution of central factors the twitch interpolation 
technique is used, superimposing single or double twitches on MVC then comparing the 
superimposed response to the potentiated response obtained from the relaxed muscle 
Thus, the aims of the current study were to determine the effects of O2Supp on repeated 
cycle performance, and to assess the nature and extent of fatigue after sprinting. 
It was hypothesised that repeated sprint cycle performance would decrease to a larger 
degree in the Normoxia condition compared with the O2Supp condition.  Second, it was 
hypothesised that both central and peripheral components of fatigue would be reduced to a 
greater extent in the O2Supp condition.   
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6.4 Methods  
6.4.1 Study Design 
Fourteen male amateur level cyclists were recruited to take part in the study. 
Participants (1.81 ± 0.04 m, 77.6 ± 11.0 kg, 25.9 ± 7.3 years) were amateur cyclists who 
had all previously used a cycle ergometer. Participants were accustomed to cycling on a 
weekly basis, but none had ever competed at any cycling events. One participant had 
previous experience with O2Supp. 
Participants were informed of the procedure and provided informed consent. Ethical 
approval for the study was granted by the University ethics committee.  
This study was a within subject’s design with two visits to the laboratory in a counter 
balanced order, in a single blind fashion. Participants completed a series of sprints under 
two different conditions: O2Supp (FiO2 ~ 1.00) or Normoxia (FiO2 ~ 0.21). Visits were 
separated by at least 48 h. 
 
6.4.2 Experimental Protocol 
Laboratory tests were completed at the same time of the day (± 2 h). Participants 
were asked to maintain normal activity and sleep patterns between testing sessions. 
Participants were requested to refrain from any caffeinated products or eating 3 h prior to 
participation. Participants were asked to refrain from strenuous physical activity 24 h prior 
to participating. 
Participants undertook the same procedure on both visits; 3 x 5 s Maximal Voluntary 
Contractions (MVC) then 15 min relative intensity warm up at 52% of heart rate reserve 
using the rearranged Karvonen formula 175,176. This was followed by 10 min passive 
recovery, 3 x 5 s MVCs (pre-sprint baseline) and 10 x 15 s cycle sprints with 45 s of 
recovery. Finally, a further set of 3 x 5 s MVCs (post-sprint). Gas administration occurred 
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at the commencement of the first sprint and continued throughout the sprints and the post 
sprint MVC’s (Figure 6-1). 
Hyperoxic and normoxic gas mixtures were administered via a rig of 4 x 200 L Douglas 
bags connected to a mask and head net (Hans Rudolph, Shawnee, KS, USA). The O2Supp 
condition used medical grade oxygen (BOC, Surrey, UK). In each condition, participants 
wore the mask and breathed from the Douglas bag during the repeated sprints and the last 
set of MVC’s.  
Prior to starting the protocol, a pre-exercise 20 µl capillary sample was taken from the right 
ear lobe. Each sample was mixed with haemolysing solution within a 0.5 ml haemolysing 
solution cup. Further samples were taken during the recovery period of each sprint 
repetition. All samples were analysed for BLa within 24 h of withdrawal using a Biosen 
(EKF diagnostics, Cardiff, UK). 
Muscle fatigue was assessed prior to and after the repeated sprints using electrical 
stimulation of the right femoral nerve. The right leg was used regardless of dominance due 
to measurement restraints. The variables obtained to assess muscle performance were; 
maximal voluntary contraction (MVC), voluntary activation (VA) and potentiated doublet 
twitch force (PTF).  Muscle fatigue was measured within 1 min of exercise cessation before 
the decline in force dissipates 177. 
Knee extensor force (N) during voluntary and stimulated contractions was measured using 
a calibrated load cell dynamometer (Kin-Com, Chattanooga Group Inc., USA), attached to 
a custom-built chair. The participant’s ankle was strapped to a load cell immediately 
superior to the right malleoli. Participants were instructed to maximally extend their leg 
against a static load cell at 90° for 5 s. Femoral nerve stimulation was delivered during the 
middle of each contraction and additionally ~5 s after contraction, to determine potentiated 
quadriceps twitch force and peripheral voluntary activation. PTF was measured as the 
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highest force produced during the three repetitions evoked by a paired pulse stimulus, 
administered to the resting muscle via the nerve at rest, 5 s post the MVC 178. VA was 
determined using the interpolated doublet twitch technique and is estimated by the changes 
in the interpolated doublet twitch relative to the PTF (equation 1.). The force evoked by 
the imposed electrical stimulus on top of the MVC is the interpolated doublet twitch (IT). 
 
Equation 1. Determining voluntary activation 179. 
𝑉𝐴(%) = (1 −
𝐼𝑇
𝑃𝑇𝐹
) ∙ 100 
 
Doublet- twitch electrical stimuli of 200 µs pulse width were delivered to the right femoral 
nerve via surface electrodes (Axelgaard ValuTrode) and a constant current stimulator 
(DS7AH; Digitimer Ltd., Welwyn Garden City, UK). A signal converter was used to 
convert the digital signals of the computer to analogue signals of the digitimer with a 
sampling rate of 2000 Hz (PowerLab/4st – ML760, AD Instruments, UK). The cathode 
was positioned on the femoral triangle. The anode was positioned 3 cm proximal to the 
base of the patella, whilst the knee was fully flexed 79. Prior to application of the pads, the 
area was shaven. The electrode placement was marked with semi-permanent ink to ensure 
consistent placement between trials.  
 
Prior to the MVCs, participants completed resting twitch stimuli in order to determine the 
maximal twitch amplitude and M-wave of the muscle at rest (the resting immediate 
response to an electrical stimulation). Doublet twitch stimuli were delivered starting at 100 
mA and increasing to 150 mA then increasing in stepwise increments of 25 mA, until a 
plateau occurred in twitch amplitude. To ensure a full and optimal stimulus the last twitch 
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was increased by a further 30%.  Offline analysis was enabled with the use of LabChart 7.0 
software (AD Instruments, UK).   
 
Following the warmup and two sets of MVCs each participant undertook 10 repetitions of 
15 s cycling sprint (Watt Bike, Nottingham, UK) followed by 45 s static recovery. 
Participants were instructed to stay seated to isolate leg power. The air brake was set to 10 
and magnetic brake set to 1 to allow sufficient resistance to generate peak force, whilst not 
exceeding peak cadence. During each sprint and recovery period the participants breathed 
either normoxic or hyperoxic air via the Douglas bag system. Data used for analysis were 
peak sprinting power (the highest W achieved in each cycle) and mean sprint power (the 
average W produced during each 15 s cycle). An overall peak and an overall mean were 
also calculated for each participant.
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Figure 6-1. A schematic representation of the experimental methodology during experimental Chapter 3. 
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6.4.3 Statistical Analysis 
All statistical analysis was performed using the statistical package, SPSS statistics 
version 25 for windows (SPSS Inc, Chicago, IL, USA). 
Paired samples t-tests (Bonferroni corrected) were conducted to examine differences 
according to condition (O2Supp / Normoxia) for; peak power (W), mean power (W) across 
each 15 s sprint, and BLa (mmol·L-1) for each sprint. Two-way analysis of variance 
(ANOVA) were conducted to test the differences between MVC, VA, PT before and after 
the repeated sprints, according to condition. α-level was set at p = 0.05 for all data analysis. 
Effect size for individual measures were calculated and reported as Cohen’s d and 
interpreted using bounds as 0.2, 0.5, > 0.8, where they are small, medium and large 
respectively 170. 
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6.5 Results 
There was no difference in peak sprinting power between the O2Supp (753.3 ± 87.8 
W) and Normoxia (761.0 ± 97.4 W) conditions across the 10 sprint repetitions: t (9) = 1.09, 
p =0.30, d = -0.08. However, average power was significantly higher (around 25 W) in the 
O2Supp condition (654.6 ± 86.9 W) compared with the Normoxia condition (629.2 ± 96.2 
W) across the 10 sprint repetitions; t (9) = -4.65, p < 0.01, d = 0.28 (Figure 6-2). 
Mean BLa was higher in the O2Supp condition (9.81 mmol·L
-1), although only by a 
small margin (0.43 mmol·L-1) t (9) = 3.36, p < 0.01, ES = -0.13. When comparing sprints 
directly between conditions, it was only after sprints 4 and 8 that this difference reached 
significance (Figure 6-3). 
MVC : As expected there was a main effect of time on muscle force, (F (1,12) = 
34.47, p < 0.01, d = 4.14) with a decrease in MVC post the sprints (pre 774.4 ± 46.3 N vs 
post 587.9 ± 43.7 N) Despite a somewhat larger decline in MVC in the O2Supp trial, there 
was no statistical difference between conditions (p = 0.66, d = 0.25) (Table 6-1). There was 
no interaction effect for condition x time (p = 0.08)  
PTF: Again a main effect was found for time (F (1,12) = 53.03, p < 0.01, d = 8.66) 
with a smaller potentiated doublet twitch production post sprints compared to pre-sprint 
(pre 459.2 ± 22.2 N vs post 290.4 ± 16.5 N), but not for condition  (p = 0.86, d = -0.03). 
There was no interaction effect reported for condition x time (p = 0.31) for PTF. 
VA: A main effect was found for condition (F (1,12) = 8.23, p = 0.01, d = 2.23) with 
a higher voluntary activation in O2Supp compared with Normoxia (O2Supp 79.1 ± 2.2% vs 
Normoxia 74.3 ± 2.1%),  but no effect of time (p = 0.14). Importantly there was no 
interaction effect reported for condition x time (p = 0.79) for VA.
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Table 6-1: Neuromuscular function of the knee extensors; Maximal Voluntary contraction (MVC), potentiated doublet twitch (PTF) and 
voluntary activation (VA) (n = 14). 
 Normoxia Oxygen Supplementation 
 Pre-Sprint Post Sprints % Difference Pre-Sprint Post Sprints % Difference 
MVC (N) 762.6 ± 169.1 611.3 ± 150.6 19.8 786.1 ± 187.0 564.4 ± 204.6 28.2 
PTF (N) 452.1 ± 86.0 295.4 ± 64.0 34.6 466.2 ± 95.5 285.4 ± 67.4 38.8 
VA (%) 75.8 ± 10.0 72.8 ± 9.7 3.9 81.2 ± 10.3 77.1 ± 9.6 5.0 
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Figure 6-2. Mean sprinting power across 10 sprints (n = 14). * significant difference between conditions (O2Supp & Normoxia) (p < 0.05). 
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Figure 6-3. Mean blood lactate concentration (mmol·L-1) over 10 sprints (n = 14). * significant difference between condition (O2Supp and 
Normoxia) (p < 0.05). 
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6.6 Discussion  
The aim of this study was to identify the effects of O2Supp on repeated sprint ability and 
begin to examine its effects on muscle fatigue using interpolated twitch. Though peak cycling 
power was not different between conditions, average power was higher in the O2Supp trials, 
by around 4%, indicating that a higher work output could be maintained in the presence of 
extra oxygen. This higher mean power was associated with a higher BLa level. There was no 
significant effect of condition on changes in muscle fatigue measures (assessed by MVC and 
electrical stimulation). 
 
The current study found that breathing hyperoxic air during 15 s repeated sprint efforts led to 
a higher mean power output, (around 25 W), with no significant influence on peak power. 
Hauser et al.,136 found that mean power was not different between the two conditions in their 
study (FiO2 1.00 and FiO2 0.21). However, their methodology of 3 x 3 min sprints meant their 
participants were potentially predominately using a different energy system to that used in a 15 
s sprint. The lactic acid system and the aerobic system are the predominate sources of ATP 
production during maximal 3 min efforts, whereas the during 15 s sprints the majority of ATP 
is supplied by the ATP-PC system. Second, Hauser’s participants experienced O2Supp between 
efforts only. Timing of O2Supp is potentially key. For example, Sperlich et al., 
3 also report no 
difference in mean or peak power across 2 sets of 5 x 30 s cycle sprints. Although nature of the 
exercise was more similar to the current study, in contrast, their participants only had 
supplementary oxygen in the 6 min recovery period between sets of cycle sprints.  
 
O2Supp has been shown to attenuate the onset of fatigue at a peripheral level whilst also 
maintaining cerebral oxygenation 127. In the current study, MVC, a global measure of fatigue, 
dropped by around 20% in the Normoxia condition, and by around 28% in the O2Supp 
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condition. This shows that there was greater (albeit non-significant) muscle fatigue as a result 
of the higher mean power output in the O2Supp condition. The change in PTF and %VA were 
broadly similar across conditions. The drop in voluntary activation (%) was small and less than 
1.5% different between conditions. The drop in PTF however was large, although again similar 
between conditions (34 and 38%, Table 6-1). These results support the findings of Thomas et 
al., 172, who report performance in shorter efforts is predominately curtailed by peripheral 
measures.  
 
The ability to maintain power throughout repeated efforts has been attributed to several factors 
including the ability to maintain BLa, regulate pH, to maintain neural input180 and importantly, 
to replenish PCr stores. According to Linossier et al., 114 sprint capacity is not reduced to the 
same extent in O2Supp due to the increased rate of cellular metabolic resynthesis of PCr, and 
ATP. PCr resynthesis during 45 s of recovery only replenishes ~75% of the stores 52. Therefore, 
after sprint 5 in a series such as this one would expect to see a significant performance 
reduction. A continued depletion of ATP-PC stores and an inadequate resynthesis leads to a 
reduction in performance until additional energy systems aid in the resynthesis process (lactic 
acid system). An increase in peak and mean power has been attributed to an enhanced PCr 
resynthesis during repeated high intensity exercise by both Mendez- Villanueva et al.,93 , and 
Glaister,52. Mendez- Villanueva 93 analysed PCr recovery rate during 10 x 6 s sprints with 30 s 
recovery and found that subsequent sprinting performance (peak power) during a final single 
sprint was increased corresponding with an 8% higher PCr resynthesis.  
 
Increasing the percentage of inspired oxygen to 100% increases the rate of PCr replenishment 
from a half-life of 25 s to 20 s 163,181. Haseler et al., 163 used a plantar flexion exercise protocol 
with increasing workload till exhaustion. They found that an increased rate of PCr resynthesis 
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aided subsequent performance, and that O2Supp maintained mean plantar flexion power further 
into the ramp test protocol (1 W increase every 2 min by pulley system). This is replicated in 
in the findings of the current study as it is shown that mean sprinting power during O2Supp is 
similar to that during Normoxia until sprint 4 and beyond where the difference becomes 
statistically significant. Additionally, sprint 6 is where peak power in the normoxic group 
appears to decline at a greater rate than the hypoxia condition. Sprint 6 in a typical series is 
where it has been documented the reliance on aerobic metabolism increases 52.  
 
Interestingly, the increase in sprint performance as a result of O2Supp is similar to that seen 
with creatine supplementation, likely through the same mechanisms of PCr resynthesis 52. 
Additional to this enhanced rate of resynthesis, O2Supp has been shown to attenuate the build-
up of metabolic by products of lactate, and inorganic phosphate (Pi) 167. Pi in particular is 
detrimental to performance via inhibition of muscle afferents. Type III and IV muscle afferents 
relay exercise induced metabolic changes in the muscles to the central nervous system. The 
accumulation of metabolic by-products reduces the effectiveness of these afferents, 
subsequently leading to peripheral fatigue. However, both afferents are positively influenced 
by O2Supp, by allowing the electrical feedback to be transmitted efficiently for longer 
167, so 
attenuating fatigue. 
 
O2Supp elicits reductions in BLa at many workloads 
114,122 and although O2Supp given during 
recovery periods attenuates lactate accumulation, the effects are more variable 54. Maeda et al., 
54 gave varying percentages of O2Supp (FiO2 0.30 to 1.00) in the recovery between sprints, and 
found that whilst overall increasing the FiO2 resulted in reduced BLa after standardised 
exercise, the response was dependent on the subjects’ fitness. In the current study, higher power 
outputs seen in the O2Supp condition were associated with slightly increased lactate levels. 
Page 135 of 254 
 
 
Knight et al., 182 suggest that the increase in oxygen kinetics during O2Supp is enough to 
attenuate the accumulation of lactate due to the increased diffusion of oxygen into the 
mitochondria. However, they add that that this attenuation can only last so long, and after a 
critical point lactate levels will increase exponentially. This could explain the increases in 
lactate that have been seen in the current study. 
 
Therefore, it is suggested that O2Supp results in a combination of increased PCr resynthesis 
and a slightly attenuated build-up of BLa, leading to a ‘maintained’ performance compared to 
the Normoxia condition seen in the current study. Acute exposure to additional oxygen appears 
to enhance repeated sprint performance, however, determining whether chronic physiological 
adaptation is blunted is crucial before its widespread use as a training tool can be advised. 
 
6.6.1 Limitations 
Several limitations of this study, participants were required to avoid strenuous exercise 
24 h prior to testing but it is noted that the effects of training may be evident for 48/72 h. To 
minimise the effects of this, participants were requested to mimic the training three days prior 
to testing before both visits. Further, no direct measure of fitness (V̇O2 max) was conducted to 
characterise the study population. Level of fitness is a potential mediator of response to 
O2Supp. Additionally, hydration status was not measured prior to testing, but participants were 
instructed to attend testing in a hydrated state.  
 
6.6.2 Practical Implications 
- Supplementary oxygen given during a single sprint-based cycling session can assist in 
reducing the extent that performance decreases.  
- Peak power output cannot be increased with supplementary oxygen 
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- Long term effects of the use of oxygen during training are not known and therefore its 
use as a chronic training tool is not yet advised 
 
6.7 Conclusion   
Whilst supplementary oxygen does not increase peak power during repeated sprints, 
participants were able to maintain a higher mean power output (across the 10 sprints). Indices 
of fatigue (MVC, PFT and VA) changed to a similar extent across conditions in response to 
the cycling, but the largest drop was in PFT, suggesting fatigue to be predominately peripheral 
in nature.  
 
6.8 What Next? 
Combining the findings of chapter 4, 5 and 6 it is evident that O2Supp is an ergogenic aid for 
repeat sprint cycling. It is also evident that other mechanisms are at play, other than peripheral 
muscle fatigue. Future research should begin to follow the pathway of oxygen after respiration 
to assess whether performance during O2Supp is limited by delivery or utilisation oxygen to 
the working muscles.  
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7 - Experimental Chapter: 
 The Use of Acute Oxygen Supplementation Upon Muscle Tissue 
Saturation During Repeat Sprint Cycling 
 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
A version of this chapter has been published as a research article. Citation as seen 
below.  
 
Porter M, Reed K, & Jones B. The Use of Acute Oxygen Supplementation Upon Muscle 
Tissue Saturation During Repeat Sprint Cycling. Journal of Human Sport and Exercise, in 
press, (2020)  https://doi.org/10.14198/jhse.2022.171.10 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
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7.1 Abstract 
7.1.1 Objective: 
O2Supp (>0.21 oxygen) as an ergogenic aid is increasingly being investigated and 
utilised by athletic populations. This study examined performance and physiological responses 
(power output, tissue saturation index) to repeat sprint cycling with oxygen supplementation 
(fraction of inspired oxygen [FiO2]1.00).  
 
7.1.2 Design and Methods:  
Fourteen male amateur level cyclists took part. Testing comprised two visits to the 
laboratory. Sessions entailed; 15 min relative intensity warm-up, 10 min of passive recovery, 
followed by 10 x 15 s repeated sprints, during which air inspired had FiO2 1.00 oxygen or 
normal air.  
Outcome measures include, mean power (W) and change in Tissue Saturation Index (ΔTSI%). 
Repeated measures ANOVA were used to examine difference between conditions in mean 
power output. Paired samples t-tests were used to examine differences between conditions in 
ΔTSI (%) and rate of muscle reoxygenation and deoxygenation (%·s-1). The α level was set 
0.05 a priori. 
 
7.1.3 Results:  
Mean power output was 4 ± 2.6% higher in the oxygen condition compared to 
Normoxia (p < 0.01). There was a significant positive correlation between power output and 
reoxygenation rate during O2Supp (r = 0.65, p = 0.04). No correlation was seen between power 
output and reoxygenation rate during Normoxia (r = -0.30, p = 0.40). A significantly increased 
deoxy rate was seen in the O2Supp condition compared to Normoxia (p = 0.05). 
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7.1.4 Conclusion:  
O2Supp (FiO2 1.00) appears to elicit the greatest performance improvements in mean 
power, potentially facilitated by an increasing muscle reoxygenation rate. This evidences the 
utility of oxygen as an ergogenic aid to in cycling performance. This may have implications 
for the chronic application of oxygen as a training tool. 
  
Page 140 of 254 
 
 
7.2 Background 
The previous studies have highlighted the effectiveness of O2Supp as a performance aid 
during repeated sprints, whilst standardising the overlapping methodologies. This study was 
established to further the previous research conducted within this thesis. The first two 
experimental chapters (4 & 5), established when O2Supp is most effective during a repeat sprint 
protocol, and chapter 6 began to narrow down the specific mechanism behind why these 
findings are evident. Chapter 6 found that peripheral fatigue does not limit performance 
capacity during O2Supp, therefore the forthcoming study was designed to assess peripheral 
muscle oxygen profile to try to establish a specific mechanism for such performance changes 
with O2Supp. 
 
7.3 Introduction 
Hyperoxia occurs when cells, tissues and organs are exposed to a level of oxygen higher 
than that of sea level 59. To create hyperoxic conditions one must breathe medical grade oxygen 
or an oxygen enriched gas mixture (O2Supp). The creation of a hyperoxic condition can be 
viewed as an ergogenic aid, which is being explored within various sporting populations.  
 
O2Supp primarily functions on the premise of increasing the supply of muscle oxygen at 
exercise onset 76. O2Supp has been shown to aid repeated sprint performance through an 
increased resynthesis rate of cellular metabolic PCr 99,163. Moreover, O2Supp (FiO2 0.7) has 
been shown to spare PCr degradation (by up to 55 s) over fixed workloads, compared with 
Normoxia 76. It could be expected that O2Supp during repeat sprint training would be effective 
at increasing the resynthesis rate of PCr and muscle oxygenation. Multiple sporting  events rely 
on the ability to replenish and recover intramuscular stores (myoglobin oxygen saturation 
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[MbO2], PCr, ATP) between high intensity efforts to enable continued high intensity 
performance 52,99. 
 
High Intensity Interval Training (HIIT) simulates the energy demands of intermittent-sprint 
sports, with high intensity bouts followed by brief periods of recovery 13. HIIT is categorised 
by peak ability during the first interval followed by decreasing performance in the subsequent 
repetitions 164,183.  Short duration sprints (< 15 s) interspersed with brief recoveries (< 60 s) 
result in near complete depletion of PCr during work periods, and incomplete resynthesis of 
PCr during the rest periods. This resynthesis is an oxidative process that requires free oxygen 
for rapid resynthesis. Performance during acute HIIT is reliant on reducing lactate 
accumulation and maintaining muscle oxygen status to resynthesise PCr rapidly 184.  
 
HIIT based research has utilised NIRS extensively 14,185,186. NIRS provides a non-invasive 
assessment of muscle oxygenation (tissue saturation) and haemodynamic status (peripheral 
blood flow) 187,188. Distinct changes in tissue saturation have been observed by NIRS during 
HITT, characterised by large desaturation and restauration profiles. Similarly, the recovery 
time course of muscle oxygenation  has been suggested to be correlated to PCr, at least 
following sub-maximal exercise, and resultantly NIRS is considered a proxy of PCr resynthesis 
72,189. Attenuating a decline in SaO2 with concurrent O2Supp can increase full body 
oxygenation, by as much as 7% 163. Recent evidence suggests that increasing the recovery rate 
of muscle oxygen can be correlated with improved performance in repeat sprint efforts 17,190. 
These findings highlight the apparent importance of ‘enhanced’ muscle oxygenation profiles 
on subsequent performance. 
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Invasive measures of muscle oxygenation (muscle biopsies) have been previously used in 
O2Supp research,  however, this methodology has very little ecological application 
140. It is 
suggested the NIRS technique should be used within O2Supp research to better characterise the 
peripheral muscle response to this ergogenic aid and more fully inform exercise practitioners 
in ‘real world’ settings. 
 
A primary aim of training modalities such as, HITT and/or repeat sprint cycle training are to 
enhance the delivery and utilisation of oxygen 191. O2Supp has been shown to aid performance 
169 within these exercise disciplines, intuitively NIRS could provide useful novel mechanistic 
insight for the response to O2Supp. 
 
The aim of this study was to assess the peripheral muscle oxygen response to this ergogenic 
aid using the NIRS technique. We hypothesised that both muscle oxygenation and performance 
(power output) would differ during oxygen supplementation compared with normal air.   
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7.4 Methods  
7.4.1 Study Design 
Participants were required to undergo two testing session in the lab over a week period. 
Sessions were completed with at least 48 h between sessions. Laboratory visits were conducted 
at the same time of the day (± 2 h) to minimise circadian effects 192. Participants were asked to 
maintain normal activity and sleep pattern prior to and between testing sessions. Participants 
were requested to arrive at the laboratory adequately hydrated and to abstain from caffeinated 
products in the preceding 4 h of each visit. Additionally, participants were asked to refrain from 
strenuous physical activity 24 h prior to participating.  
 
This study was a single-blind, within-participant design comprising two counterbalanced 
assessments of repeat sprint performance under: O2Supp (FiO2 1.00) or normal air (FiO2 ~ 
0.21). Each of the two sessions participants completed a 15 min cycling warm up, 10 min 
passive recovery, finishing with 10 x 15 s sprints with 45 s of passive recovery on a Wattbike 
cycle ergometer.  All participants had previous experience with repeat sprint lab testing 
protocols. One participant had been included in previous oxygen supplementation research 
within the last 12 months. Performance measures such as: mean and peak power output were 
taken, along with NIRS measures of muscle oxygenation (resaturation and desaturation rates), 
as well as blood lactate concentrations.  
 
Fourteen male amateur level cyclists for the study (1.81 ± 0.04 m, 77.7 ± 11.0 kg, 25.9 ± 7.4 
years, thigh skinfold 10.5 ± 4.1 mm). Participants were healthy and were not taking any 
prescribed medications.  
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Ethical approval for the studies procedure was granted by the University ethics committee in 
accordance with the Declaration of Helsinki. Participants were informed of the procedure and 
asked to give written informed consent and complete a health questionnaire (PAR-Q). 
 
7.4.2 Experimental Protocol 
Participants completed the same procedure on both visits comprising; 15 min warm up 
52% of heart rate reserve 175, 10 min passive recovery, finishing with 10 x 15 s sprints with 45 
s of passive recovery, undertaken using a Wattbike Pro (Wattbike Ltd., Nottingham, UK) with 
the magnetic setting set to zero and air brake set to ten. The protocol was in accordance with 
pilot testing conducted prior to this study i.e. participants had sufficient load in order to reach 
peak power and not exceed max cadence (Figure 7-1).  
 
Wattbike Pro was used to collect performance data (mean power), which was then used to 
calculate fatigue index (FI%) ((Best sprint – worst sprint)/best sprint) *100. No prior 
familiarisation was conducted in the current study as it was established that each participant 
was familiar with repeat sprint cycling on a cycle ergometer.  
 
Hyperoxic and normoxic gas mixtures were administered throughout the repeated sprints. Gas 
mixtures were administered via a rig of 4 x 200 L Hans Rudolph Douglas bags connected to a 
Hans Rudolph mask and head net (Hans Rudolph, Shawnee, KS, USA) were used. O2Supp was 
provided using Douglas bags filled from a medical grade oxygen cylinder (British Oxygen 
Company, Surrey, UK) prior to administration, as previously described. Hyperoxic air at FiO2 
of 1.00 was saturated and warmed to room temperature before administration.  
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Preceding to each trial, a pre-exercise 20 µl capillary blood lactate sample was taken from the 
right ear lobule. Sample was mixed with haemolysing solution within a 0.5 ml haemolysing 
solution cup. Subsequent blood lactate samples were taken two minutes apart after the period 
between the warmup, and during the recovery period of each sprint repetition. All samples were 
analysed within using a Biosen (EKF diagnostics, Cardiff, UK). 
 
Participants were required to wear a portable NIRS device to monitor oxygen saturation of the 
vastus lateralis muscle tissue (PortaMon, Artinis Medical Systems B.V., Elst, Netherlands). 
The NIRS device was fixed to the belly of the right vastus lateralis. Any bodily hair was 
removed within the device placement area and cleaned with an alcohol wipe to remove residue. 
The device was placed 3 cm anterior to the midpoint between the top of the greater trochanter 
and the lateral epicondyle. The device was taped with an adhesive wrapping and secondly 
wrapped with a black-out sports strapping to eliminate the entrance of ambient light. The same 
researcher attached the device on every occasion, ensuring an external pressure of less than 20 
mmHg on the device. Indelible ink was used to draw around the device to guarantee accurate 
NIRS placement during the subsequent visits. Throughout the protocol the NIRS devices were 
connected to a personal computer via the Bluetooth™ system for data acquisition (10 Hz), and 
conversion from analogue to digital data. 
 
The tissue haemoglobin saturation index (TSI), expressed in % and calculated as 
([O2Hb]/([O2Hb + HHb])) × 100 (which demonstrates the O2 supply and O2 consumption) 
193 
was utilised. TSI was calculated using the SRS methodology and was used to assess muscle 
reoxygenation rate. Reoxygenation rate (reoxy rate) (%·s-1) was calculated as the change in 
TSI (%) from the end of the sprint by fitting a linear model to the 45 s part of the TSI (%) 
recovery. The slope of the relationship was retained as an index of reoxygenation rate. 
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Similarly, deoxygenation rate (deoxy rate %·s-1) was calculated as the change in TSI (%) from 
the beginning to end of the sprint by fitting a linear model to the 15 s part of the TSI (%) 
decline. Change (∆) values were obtained during sprint and recovery periods. These were taken 
as; the difference between the baseline value (start sprint) and the one second average of the 
maximum value achieved during the sprint period and; the baseline value (end sprint) and the 
one second average of the maximum value achieved during the recovery period. NIRS data 
was processed using the methodology suggested by Rodriguez 153. A one second moving 
average was applied to the data to attenuate the “noise” in the signal, whilst maintaining the 
integrity of the original data. 
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Figure 7-1. A schematic representation of the experimental methodology during experimental Chapter 4.
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7.4.3 Statistical Analysis  
An a priori power analysis revealed that 10 participants would provide significant 
power to detect differences at an α-level of 0.05 for the primary outcome measure (mean power 
output) (G∗POWER 3.1 Software, Düsseldorf, Germany). Statistical analysis was performed 
using the statistical package, SPSS statistics version 25 for windows (SPSS, Inc, Chicago, IL, 
USA). 
 
A two-way repeated measure ANOVA (condition X time) was used to analyse differences in 
the 10 x 15 s sprints across the different protocols, followed by Turkey’s post hoc tests where 
appropriate. Paired samples t-tests were conducted to examine the differences between the 
conditions for; change in tissue oxygenation (ΔTSI %), deoxy rate (%·s-1) and reoxy rate (%·s-
1). Pearson’s correlations were conducted to test the relationship between tissue oxygenation 
and power output between the conditions. Shapiro- Wilk normal distribution tests were 
conducted on all data. Data was screened for outliers outside of two standard deviations from 
the mean, no data were excluded.  Effect size for individual measures were calculated and 
reported as Cohen’s d and interpreted using bounds as 0.2, 0.5, > 0.8, where they are small, 
medium and large respectively. α-level set at p = 0.05 for all analyses. 
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7.5 Results  
Figure 7-2. shows mean sprint power output (W) per sprint interval. ANOVA found 
a significant interaction effect F (9,13) = 2.66, p = 0.045, d = 0.98) and post hoc analysis 
shows a higher mean sprinting power for sprints 4-6. There was a significant increase (~4 
± 2.6%) in power output (W) in the O2Supp group mean compared to the norm group (d = 
-0.28, 95% CI = 0.87 to 2.52; p < 0.01). Figure 7-2 shows a non-significant; t (13) = 1.735, 
p = 0.11, d = 0.23 reduction in Fatigue index (FI) following 10 cycling sprints under the 
two conditions. A 3% reduction in FI (%) is seen in the O2Supp condition.  
 
Figure 7-2. Mean sprinting power across 10 sprints * significant difference between 
condition (O2Supp and Normoxia) (p < 0.05). 
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Figure 7-3. Fatigue index score under two conditions (n = 14). 
 
Figure 7-4. displays the group average Normoxia vs. O2Supp ΔTSI (%) data trace during 
(10 x 15 s with 45 s recovery) repeat cycling efforts.  During the repeat efforts there was a 
rapid drop in TSI at the onset of each sprint with a nadir achieved approximately 10 s into 
each sprint. During each 45 s recovery period there was a trend of a rapid recovery of group 
TSI (first 20 s - Phase 1), followed by a slowing in the recovery rate (final 25 s – Phase 2).  
The rate and extent of TSI recovery in the O2Supp condition is facilitating a quicker oxygen 
resaturation to baseline; this hyperoxic effect is clear for recovery periods 1-3. This 
response is attenuated as the sprints progress (sprints 4-10). After sprint 6 TSI fails to return 
to baseline as the sprints are completed.
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Figure 7-4. Tissue Saturation Index (TSI %) characteristic representation data for the group, during the repeat sprint cycling protocol. 
Normoxia and O2Supp traces are overlaid. 
Legend. ΔPeak – Change in peak resaturation, P1- Phase One, S1- Sprint One, R1- Recovery.
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Mean blood lactate was higher in the O2 Supp condition (9.81 mmol·L
-1), albeit by a small 
margin (0.43 mmol·L-1), t (9) = 3.36, p < 0.01, d = 0.13. When comparing sprints directly 
between conditions, it was only after sprints 4 and 8 that this difference reached 
significance. 
 
No significant difference was seen in the mean recovery amplitude (i.e. Δ) ΔTSI (%) in the 
O2Supp group vs. Normoxia group (d = -0.33, 95% CI = -1.71 to 0.51; p = 0.25). A mean 
difference in individual sprints ΔTSI (%); 2.4%, 2.2% and 3.0% can be seen in Figure 7-4, 
for Sprints 4-6 O2Supp vs. Normoxia group.  No significant difference was seen within the 
group mean reoxy rate (%·s-1) between the two conditions (d = 0.33, 95% CI = 0.01 to 
0.04; p = 0.26).  A significantly increased deoxy rate (%·s-1) was seen in the O2Supp 
condition compared to Normoxia (d = -0.61, 95% CI = -0.13 to -0.00; p = 0.05). 
 
Figure 7-5. displays a positive correlation between reoxy rate (%·s-1) and mean sprinting 
power during O2Supp (r = 0.65, p = 0.04). No significant correlation was found between 
ΔTSI (%) and mean sprinting during Normoxia (r = -0.30, p = 0.40). 
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Figure 7-5. Relationship between muscle reoxygenation rate (%·s-1) and mean cycling 
power (W) (n =14). ■ O2Supp (---), ● Normoxia (____)  
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7.6 Discussion 
The aim of this study was to assess the peripheral muscle oxygen response to this 
ergogenic aid using the NIRS technique. It was hypothesised that muscle oxygenation and 
performance would differ during oxygen supplementation compared to normal air. This is 
the first paper of its kind to assess changes in the rate of muscle oxygen resaturation, and 
desaturation during O2Supp in repeat sprint cycling, using non-invasive ‘real world’ 
measures. 
 
Primary findings revealed changes in muscle oxygen recovery (%·s-1) rates in the presence 
of extra oxygen (FiO2 1.00). This recovery rate was strongly correlated with preceding 
power output (W) (r = 0.65, p = 0.04) (Figure 7-2 and Figure 7-4). There was no correlation 
between recovery rate and power output during Normoxia (r =-0.30, p = 0.40) (Figure 7-5). 
Lactate levels were higher in the O2Supp condition compared to Normoxia (p < 0.01). 
Additionally, there was an increased deoxy rate in O2Supp compared to Normoxia across 
the 10 sprints (p = 0.05).  
 
The rate of recovery of muscle oxygen is one of most important aspect of fitness to a sprint 
trained athlete 52. The ability to flush out fatigue related metabolic by-products and the 
replenishment of fuel for successive sprints has obvious importance for performance. HIIT 
is highly reliant on the utilisation of PCr during exercise and exclusively upon aerobic 
processes (resynthesis) during periods of recovery 184. O2Supp has been shown to be 
beneficial for sprint performance due to the increased resynthesis rate of cellular metabolic 
PCr 114,163. The significant increase in power output (3.95%), non-significant increase in 
the extent of ΔTSI (%) recovery and reoxygenation rate (%·s-1) seen here are potentially 
indicative of an enhanced PCr resynthesis profile 72. Though PCr resynthesis was not 
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measured directly, muscle (re)oxygenation has been suggested by others to be 
representative of this 72,189,190. Additionally, the changes seen in performance variables (W) 
between O2Supp and normal air, replicated previous research showing increases in mean 
power output (~4 ± 2.6% [30 W]) during O2Supp (Figure 7-4).  
Blood lactate data from this study have been previously published 169. In brief, muscle 
oxygenation data is supported by the significantly reduced lactate response despite a higher 
power output. The ability to attenuate an anaerobic metabolic environment during repeat 
sprint work should allow for enhanced PCr resynthesis. Lactate and muscle oxygenation 
data highlight that despite higher intensity exercise (increased power output), there is a 
higher availability of oxygen. This suggests that in the initial sprints, oxygen availability is 
the primary mechanism for enhanced performance (Figure 7-2).  
 
Studies by Jones et al., 14,77 demonstrated a positive relationship between enhanced muscle 
oxygenation during recovery and increased subsequent performance following a training 
programme. Their study shows that a 3 s faster desaturation time contributes to increase in 
mean cycling performance by as much as 10%. This alteration in desaturation profile is 
suggested to occur as a result of positive peripheral muscle morphological adaptations such 
as increased mitochondrial density and efficiency, resulting in enhanced oxygen extraction 
186,194. The findings of the current study reflects potential adaptations due to similar 
desaturation profile, as seen in Jones et al., 14,77. These findings also mirror those of 
Buchheit et al.,168 who also found that an increased rate of muscle deoxygenation (6%) 
during SIT elicits metabolic adaptations, such as increased citrate synthase activity, 
resulting in increased power output. The current study shows a significant increase in deoxy 
rate and non-significant increase in reoxy rate, similar to the previous studies 14,77,168. Figure 
7-5 highlights that both power and reoxy rate increases with O2Supp although not 
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significantly different from control, they are significantly positively correlated- as power 
increases with O2Supp so does reoxy rate. The increase rate of reoxygenation may likely 
cause the subsequent increase in performance as additional oxygen is available to the 
working muscle. This correlation is not evident during the Normoxia condition where reoxy 
rate has a weak negative correlation with power output. The simplest explanation for this 
is, due to an increased availability of oxygen as a result of the administered O2Supp and 
not as a result of morphological adaptation to training.  
 
Higher re-saturation rates occur from the first sprint, but it is not until sprint 4 onwards that 
performance increases are seen in the O2Supp condition (Figure 7-4). The high availability 
of oxygen allows for rapid resaturation of myoglobin and haemoglobin, meaning 
subsequent sprints can start from a metabolically advantageous point. Inevitably there 
comes a point where, despite extra oxygen, recovery is not rapid enough to maintain 
performance. 
Interestingly, the novel findings of this study open further avenues for exploration. Firstly, 
due to the acute nature (short term effects - minutes) of the current study, the changes in 
muscle oxygen and power output have only been evidenced acutely. Few long-term or 
short-term training studies using O2Supp have examined the effects of ‘chronic 
supplementation’ on muscle oxygen response or peripheral muscle composition (increased 
mitochondrial density, increased baseline utilisation capacity of oxygen). Previous training 
studies 70,71 have demonstrated changes in tissue saturation profile and musculoskeletal 
adaptation i.e. increased mitochondrial biogenesis/ proliferation, increased enzyme activity 
(citrate synthases) following SIT protocols. It would appear intuitive for further studies to 
initially identify the effects of acute O2Supp administration on performance using NIRS 
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(as shown here). An understanding of the effects of O2Supp, whether this is duration and/ 
or dosage dependant, will be key to optimal administration.  
 
Despite equivalent findings between repeat sprints, time trials (TT) and time trials to 
exhaustion (TTE) using O2Supp, there is a lack of comparable studies with short duration 
recoveries following high intensity repeat sprints, even though this training approach is 
commonly used in sprint training programmes 13,52. Using TT or TTE as a training approach 
for intermittent sports is not popular despite the performance benefits for TT and TTE 
116,195. As such the current study should pave the way for further studies exploring 
optimised training for high intensity repeat sprint training.  
 
7.6.1 Limitations 
Due to a technical issue, SaO2 was not ascertained during data collection. Having 
data on the individual response of SaO2 during O2Supp, would have allowed the authors to 
determine whether changes in the muscle oxygenation were related to delivery or 
utilisation. Furthermore, ventilatory parameters would have better informed the results of 
this study. Unfortunately, collecting ventilatory gases whilst administering a manipulated 
gas content, posed logistical constraints that could not be overcome.  
 
7.6.2 Practical Implications 
Many cyclists incorporate some form of HIIT in their training, with the aim of 
improving cycling performance. The results of the current study show that in University 
level cyclists (amateur) when compared with a sea level condition, O2Supp elicits 
immediate acute enhancements to performance measures via an improved muscle 
oxygenation status. This allows athletes to experience an immediate enhancement in their 
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training, allowing them to work harder in a single training session, with the aim of inducing 
greater resultant adaptation. NIRS is a functional tool in which skeletal muscle oxygenation 
data can be seen  in ‘real time’, complimenting external power data , allowing coaches to 
make better informed decisions 191.  
 
7.7 Conclusion 
Supplementary oxygen elicits meaningful performance improvements whilst 
increasing muscle reoxygenation rate during repeat cycling sprints as shown in Figure 7-5. 
This increase in reoxygenation rate may likely cause the subsequent increase in 
performance. This study looks at the mechanistic approach to O2Supp and demonstrates 
the potential utility of O2Supp as an ergogenic aid within cycle and repeat sprint exercise. 
This novel study is the first to demonstrate changes in muscle oxygenation during O2Supp 
using non-invasive ‘real world’ measures.  
 
7.8 What Next? 
This chapter further develops the narrative within this thesis. The first two chapters (4 & 
5) assessed the timing of administration and enabled a standardised protocol for the 
following chapters. The previous chapter (6) explored a potential mechanism to justify the 
performance enhancements being shown. With this chapters results the narrative is now 
that O2Supp is a performance enhancing aid that increases delivery of oxygen to the 
working muscles, which maintains peripheral levels of fatigue during the exercise task. 
Further research should assess whether O2Supp is effective at eliciting chronic performance 
improvements following a period of multi acute sessions with O2Supp.   
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8 - Experimental Chapter: 
The Feasibility of Using Near Infrared Spectroscopy to Assess Muscle 
Oxidative Capacity Following Training with Oxygen Supplementation 
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8.1 Abstract 
8.1.1 Objectives 
The primary aim of this study was to assess the feasibility of using NIRS utilising 
arterial occlusions to measure muscle oxidative changes during a multi week training 
intervention with O2Supp. Secondary aims were to assess recruitment and adherence to 
training and the ability to collect training data from both supervised and unsupervised 
training sessions of participants. 
 
8.1.2 Design and Methods 
13 amateur level cyclists, stature 1.77 ± 0.06 m, mass 77.4 ± 9.6 kg, age 38 ± 8.3 
years, performed 3-week training block consisting of two supervised HIIT sessions a week 
and an additional unsupervised session 2-4 times a week. Participants were randomly 
allocated to either O2Supp (FiO2 1.00, n = 5) or Normoxia (FiO2 0.21, n = 4) during the 
supervised training. An additional control group (n = 4) undertook only unsupervised 
training. Vastus lateralis muscle oxygenation and muscle oxidative capacity together with 
peak cycling power (W) and maximal V̇O2 (ml·kg·min-1) were tested pre and post training 
intervention. 
 
8.1.3 Results  
Analysis shows that it is feasible to recruit, with large retention rates (77%), as well 
as being well received by participants. Adherence to both training sessions (supervised and 
unsupervised) was 100%, with some loss of data during unsupervised training. No 
participants reported any side effects of oxygen supplementation. The NIRS measurement 
used (along with arterial occlusions) were effective at detecting positive changes within 
muscle oxidative capacity. Additionally, O2Supp led to small non-significant changes in 
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pre and post measure of mean power output (18.41 ± 30.43 W), peak power output and 
V̇O2max. 
 
8.1.4 Conclusion  
This study demonstrates that a five-week, O2Supp repeat cycling exercise study 
with measures of NIRS is feasible. A measure of muscle oxidative capacity using NIRS 
has enough sensitivity to detect changes following O2Supp training. The results highlight 
that O2Supp elicits increases in muscle oxidative capacity and increases mean power 
output. Further, the training methodology and data collection techniques were effective as 
evidenced by the adherence rates. However, future studies will need to over-recruit to meet 
power requirements and account for the loss of data experienced during unsupervised 
training session. This study better informs the sports researcher to carry out robust, strongly 
evidenced O2Supp training intervention-based research. 
 
Keywords: Hyperoxia, Fraction of inspired oxygen, Cycling, Feasibility, NIRS.  
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8.2 Background 
The previous four experimental chapters have all progressed a narrative with O2Supp 
that leads into this chapter. Chapter 4 and 5 assessed the most effective component of 
training session for O2Supp, chapter 6 assessed the fatiguing component of O2Supp, and 
chapter 7 assessed a positive trend in muscle oxygen kinetics with O2Supp. Each built a 
narrative to enable this forthcoming chapter to put each of the chapters components 
together to assess whether O2Supp is feasible in a laboratory training study with novel 
measures of muscle oxygen. 
 
8.3 Introduction  
Intervention based training studies are an effective way to establish if a ‘supplement’ 
can enhance performance. However, training studies are notorious for being underpowered, 
lacking control groups, having small effect sizes, and using overly homogeneous 
participants (often male, university age students).  Feasibility studies in principal, look at 
identifying the limitations that are associated with such intervention-based training 
programmes 196,197. This chapter will aim to strengthen the rigor of intervention-based 
training studies in O2Supp. It will do this by employing a three-group intervention with 
control, whilst also using a larger participant pool (other than just university students) and 
addressing issues with power and sample size. Although not all limitations of a training 
study will be addressed (male, small effect size, small sample size) in this feasibility study, 
although it will build on the research ready for future larger studies.  
 
Most intervention-based training studies centre around establishing the performance 
outcomes following an aid, whereas few explore the sensitivity of measures used assess the 
mechanism that the training influences. This is a particular limitation within the O2Supp 
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research, where the majority of research has focused upon performance changes 8,125,139. 
Importantly, mechanistic understanding of performance changes can lead to more highly 
focused training i.e. minimal training need and greater performance enhancement. 
 
The range of methodologies used to investigate the effects of oxygen supplementation on 
sporting performance has increased in recent years 1. These methodologies which vary from 
twitch interpolation to assess muscle fatigue, to muscle biopsies to assess mitochondrial 
respiration, can provide further understanding on different mechanisms 140,169. The 
determination of mitochondrial efficiency could be essential to understanding what occurs 
during O2Supp, and the application of NIRS as a non-invasive measure may allow further 
understanding of this mechanism. 
 
The non-invasive, real-time application of NIRS makes it desirable to coaches and athletes 
alike, who have identified the need for wearable technologies to provide useful biofeedback 
198. NIRS has recently been used to assess both delivery and consumption of oxygen to the 
working muscles. Further unpublished research from this institution has shown the 
effectiveness of NIRS as a measurement tool during O2Supp and its sensitivity to detect 
acute changes. NIRS has also been shown to be effective at examining muscle oxygen 
consumption (mV̇O2) when combined with arterial occlusions to assess oxygen 
consumption rate 74,75. mV̇O2 has been commonly used as a proxy/non-invasive measure 
of muscle oxygenation (mitochondrial respiration), whereas direct measure (muscle 
biopsy) can look at mitochondrial respiration, density, and concentration.  
 
The combination of arterial occlusions and NIRS, are used to detect changes in mV̇O2 but 
are not without their own limitations (issues include movement artefact & detection of 
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blood flow). Unlike muscle bioposy, NIRS assesses mV̇O2 using arterial occlusion imposes 
no chronic pain on a participant, although it can impose temporary discomfort to some 
individuals. The arterial occlusions impose between 250-300 mmHg of pressure to the 
upper leg, 10 times that of sports compression garments 51. Additionally, the process of 
arterial occlusions can add an extended duration to research protocols, as the measurement 
needs to be carried out following a rest period. In general, the benefits outweigh the 
negatives, as mV̇O2 can be assessed without any medical intervention, and is relatively 
painless when compared with muscle biopsies. Additionally, arterial occlusions can 
provide information related to the rate of mitochondrial respiration which biopsies cannot. 
 
Feasibility studies are vital for researchers to understand the recruitment strategies needed 
to minimise the limitations of intervention studies, as well as identifying the adherence, 
and retention rates.  El-Kotob et al., 196 commented on the factors that need to be considered 
to ensure recruitment, adherence, and retention rates were high. These include travel 
duration, supervised vs unsupervised training, amount of sessions, use of activity monitors, 
and loss of interest. All factors were taken into consideration during the conception of this 
feasibility study.  
 
We postulate that O2Supp exercise allows an increase in both the delivery of oxygen to the 
working muscles, and the utilisation, therefore allowing a higher training load, potentially 
leading to significant changes in skeletal mV̇O2. This hypothesis is supported  by Cardinale 
et al., 140 and Przyklenk et al., 199 who found that acute O2Supp, increased O2 delivery, 
enhanced performance and intracellular adaptation (mitochondrial density and efficiency). 
However, their studies varied in exercise repetition duration (30 s-30 min), intensity (sub 
max- maximal), fiO2 (0.3-1.0), and modality (endurance vs HIIT). Each of these 
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methodological differences makes it hard to compare results due to the changes in the data 
being associated with these factors rather than the primary aim (O2Supp). Additionally, this 
study will apply non-invasive measures to measure outcomes in mV̇O2, making it real world 
applicable via wearable biofeedback.  
Additional, research is also needed to understand if a multi session training study with 
O2Supp is feasible for participants (in relation to recruitment, retention, and adherence).  
High intensity interval training studies are notoriously under powered 200, most research 
has just two groups (intervention or control) with relatively small sample sizes (n = 6-10 
per group). This sample size is only sufficient for powering for the primary measure, even 
though most research analyses involve 3+ measures. 
This study was conducted to assess the feasibility of using O2Supp during a multi-session 
training intervention with non-invasive measures of muscle oxygen response.  
In order to explore this, a 5-week randomised controlled intervention was carried out, 
where participants were single blinded to the type of gas inhaled during the training. This 
study set out to determine whether a short sprint cycling training intervention with O2Supp 
could influence muscle oxygen utilisation. Additionally, this study aimed to determine if 
the participants would tolerate and adhere to an 8-session training intervention with 
multiple non-invasive measures, for which they had to travel to the lab.  
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8.4 Methods  
8.4.1 Study Design  
This study used a 3-week single blind randomized controlled training study design 
with parallel groups stratified from participant’s baseline V̇O2max. Participants were 
randomly assigned either an experimental group where they trained with oxygen 
supplementation (n = 5,  FiO2 1.0; O2Supp), or normal sea level conditions (n = 4, FiO2 
0.21; Normoxia. A control group only partook in pre and post-tests ran (n = 4, Control). 
Participant data, 1.77 ± 0.06 m, mass 77.4 ± 9.6 kg, age 38 ± 8.3 years, thigh thickness 9.6 
± 1.2 mm. 
 
Participants were recruited from Colchester Borough cycling clubs, who had previous 
experience with laboratory testing. Exclusion criteria included: Females, over 45 years old, 
diseased population.  Due to the large uptake of male participants (95%), females were 
excluded from partaking in order to reduce the potential effects of menstrual cycle on 
results.  
In weeks 1 and 5 (pre and post 3-week training study) participants undertook baseline and 
post-tests respectively. Training consisted of six supervised HIIT sessions within the 
middle 3-week period. Non supervised training was distributed across the 5-week period 
documented in Table 8-1. Training sessions were held on non-consecutive days with at 
least 48 h recovery – two times per week for three consecutive weeks (6 session). Every 
supervised session was conducted under the direct supervision of an exercise physiologist 
on a one-to-one basis. 
 
Participants were informed of the procedure and provided written informed consent. 
Participants were asked to refrain from strenuous physical activity 24 h prior to 
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participating. The study design is shown in a diagram in Figure 8-1 and Figure 8-2. Ethical 
approval for the study was granted by the University of Essex ethics committee in 
accordance to the Helsinki declaration. 
An a priori power calculation was not performed because the effect sizes and standard 
deviations were unknown for the primary measure (mV̇O2), and collection of such data was 
one of the aims of this study. The (pilot) data collected in this study can be used to inform 
power calculations for subsequent larger studies.  
 
8.4.2 Recruitment, Retention and Adherence  
Of the sixty participants that expressed interest in taking part in this study, only 15 
attended pre-test screening, a recruitment rate of 25%. Of those 15 participants who 
attended pre-test screening, the study retained 87% of them (n = 13) with the other 
participants dropping out prior to the start of testing due to extenuating circumstances. The 
adherence rate was 100% of those that conducted the pre-test. Each of the thirteen 
participants conducted all of the sessions that had been randomly allocated to them (8 
sessions for both experimental conditions and 2 sessions for the control condition). 
Participants who signed up but subsequently dropped out expressed that 8 sessions over 5-
weeks was too many sessions in a short period of time, as well as the keeping each session 
at the same time of day and day of the week. No reward was provided to take part in the 
study, participation was of their own accord throughout.  
 
8.4.3 Experimental Protocol 
Pre and Post-test Measures 
Testing Process 
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As documented in  Figure 8-1 and Figure 8-2 the process of testing started with the pre-test 
measures. The order of these measures were; arterial occlusions following a planter flexion 
task, a cycling warm up, a 30 s cycling Wingate sprint, a recovery period and finally a 
cycling maximal incremental exercise test. This procedure was reproduced during the post-
test measures.  
 
30s Wingate Sprint  
The Wingate test was performed following a 5 min 100 W warm up on a Lode cycle 
ergometer (Excalibur, Lode B.V, Groningen, The Netherlands). The 30 s all-out test started 
following 30 s of pedalling at 100 W resistance. Following a 5 s countdown the braking 
resistance was applied to the magnetic flywheel and remained the same throughout the test. 
Braking resistance was set to 0.8 Nm per kg·BM as determined by Lode instructions for 
well-trained cyclists. Participants remained seated throughout the test, with strong verbal 
encouragement throughout. Participants were instructed to pedal as hard and fast as 
possible throughout the whole 30 s and not to conserve energy for an end spurt 201.   
 
Maximal Incremental exercise test  
Following both a 5 min active recovery (100 W) and a 5 min static recovery. Participants 
completed a maximal incremental exercise test until volitional exhaustion on a cycle 
ergometer. This test has been described in detail elsewhere 202. In short, participants cycled 
wearing a Hans Rudolf mask (Hans Rudolph Inc., Kansas, USA) which covered the mouth 
and nose for pulmonary oxygen consumption assessment (Vyntus, Vyaire Medical, 
Basingstoke, UK). The test was commenced with 1 min of cycling at a power output of 100 
W, which was subsequently increased by 25 W every minute until exhaustion. Criteria for 
exercise cessation was a plateau in V̇O2, respiratory exchange ratio (RER) >1.10 and an 
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RPE greater than 18. V̇O2max was calculated as the average of the highest 30 s V̇O2 
measurement. 
 
Supervised Training 
Subjects completed the same procedure on each of the 6 visits over 3 weeks, comprising; 
5 min relative intensity warm up 52% of heart rate reserve 175,176,203, 5 min passive recovery, 
finishing with 10 x 15 s sprints with 45 s of recovery, undertaken using a Wattbike pro 
(magnetic brake set 1, air brake set to 10) (Wattbike, Nottingham, UK). During the 
supervised training sessions participants had either O2Supp or Normoxia. Protocol in 
accordance with pilot testing conducted prior to this study. Participants have sufficient load 
that they are able to reach peak power and not exceed max cadence. The air brake and 
magnetic brake settings were based on participants characteristics, which were established 
in previous studies 169 and pilot testing.  
Wattbike pro was used to collect performance data (mean power and peak power (W)). No 
prior familiarisation was conducted as prior reporting established that each participant was 
familiar with repeat sprint cycling on a cycle ergometer.  
 
Gas administration 
Hyperoxic and normoxic gas mixtures were administered via a rig of 4 x 200 L 
Hans Rudolph Douglas bags connected to a Hans Rudolph mask and head net (Hans 
Rudolph Inc., KS, USA). The oxygen supplementation (FiO2 1.00) condition used medical 
grade oxygen cylinder (BOC, Surrey, UK). In each condition, participants wore the mask 
and breathed from the Douglas bag during the whole session (sprint and recovery). This 
was determined due to results from - Experimental Chapter: and - Experimental Chapter: 
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that showed a continuous supply of oxygen was most effective and increasing acute 
performance. 
 
Blood lactate and Haemoglobin 
Prior to each training session, a pre-exercise (baseline) 20 µl capillary sample of 
blood was taken from the right ear lobe to measure lactate. Each sample was mixed with 
haemolysing solution within a 0.5 ml haemolysing solution cup. Subsequent BLa samples 
were taken during the recovery period between intervals. All samples were analysed for 
Bla within 24 h of withdrawal using a Biosen (EKF diagnostics, Cardiff, UK). 
 
Additionally, haemoglobin was measured pre and post training intervention using a manual 
lancet to the right ear lobe. A single 50 µl capillary blood sample was collected using a 
microcuvettes and subsequently placed in a HemoCue Hb 201+ (HemoCue, Angelholm, 
Sweden). Haemoglobin was used to assist in the estimation of the extent of oxygen delivery 
to the working muscles 204. 
 
Near-Infrared Spectroscopy (NIRS) 
Full details of this methodology are presented in detail in methodology chapter 2. 
In brief, participants wore a portable NIRS device to monitor muscle oxygen saturation of 
the Vastus Lateralis (PortaMon, Artinis Medical Systems B.V., Elst, The Netherland). The 
NIRS device was fixed to the belly of the right Vastus Lateralis, regardless of limb 
dominance. The device was placed 3 cm anterior to the midpoint between the top of the 
greater trochanter and the lateral epicondyle of the right knee 151.  Indelible ink was used 
to draw around the device to guarantee accurate NIRS placement during subsequent visits. 
Throughout NIRS devices were connected to a personal computer via the Bluetooth™ 
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system for data acquisition (10 Hz). NIRS data was subsequently filtered using the 
methodology detailed by Rodriguez et al., 153. 
 
Near Infrared Spectroscopy (NIRS) Analysis 
A pre exercise baseline measure lasting 60s was taken prior to each test. 
Oxyhaemoglobin (O2Hb), deoxyhaemoglobin (HHb) and total haemoglobin concentration 
(tHb) are reported as change from baseline The tissue haemoglobin saturation index (TSI) 
expressed in % and calculated as ([O2Hb]/([O2Hb + HHb])) × 100, which demonstrates the 
O2 supply and O2 consumption 
193, was calculated using SRS methods (see chapter 2) and 
used to assess muscle reoxygenation rate (%.s−1).  
 
Muscle Oxygen Consumption (mV̇O2)  
Arterial occlusions were conducted (at the start of all visits), following a short 
submaximal lower leg exercise (planter flexion using black TheraBand) using a rapid cuff 
inflator (Hockanson, SC12L/E20, PMS Instruments, UK). The cuff was placed proximal 
to the NIRS device. The cuff was inflated to a pressure of 275 mmHg and inflated/deflated 
in 0.3 s. The cuff was inflated for 30 s three times with 30 s rest between occlusions 74. The 
primary measure, mV̇O2, was estimated by fitting the slope of the difference between O2Hb 
and HHb (Hbdiff) signal during each occlusion 205. Greater negative values represent higher 
muscle oxygen consumption. 
Incomplete arterial occlusion was determined by the absence of pulsatility in O2Hb signal 
and the direction of O2Hb and HHb; under complete arterial occlusion these are expected 
to move in opposite directions 74. If this does not occur the occlusion isn’t correctly 
restricting blood flow and flow is still visible on the NIRS trace.  
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Acceptance and Perception 
Throughout the course of the 8 sessions, multiple questions were asked of the 
participants, with specific focus of adherence, toleration and perception of the 
methodology. Participants were asked at the end of the study how much of an impact the 
study had on their normal lifestyle. Additionally, they were asked how tolerable the 
measures were and whether they would volunteer to partake in a similar study in the future. 
Lastly participants were asked if they had any side effects or discomforts directly from the 
oxygen supplementation. All participants were asked regardless of condition. 
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Table 8-1. Mean duration (HH: MM. SS) of non-supervised training performed 
during the total intervention period. 
Intensity Zone O2Supp (n = 5) Normoxia (n = 4) Control (n = 4) 
Intensity Zone I  
(>65% of HR max) 
03:12.10 00:46.04 02:36.30 
Intensity Zone II  
(66-82% of HR max) 
06:26.43 03:01.41 07:11.26 
Intensity Zone III 
(83-87% of HR max) 
02:28.12 07:24.10 01:47.24 
Intensity Zone IIII  
(88%-100 of HR max) 
01:57.02 03:00.00 01:11.12 
Total Training Duration* 16:10.07 13:57.55 13:29.50 
*Zone data was unavailable for every participant. Unsupervised training could be 
conducted on 3 days (additional to the supervised sessions) during the week with rest days 
after each supervised training session.  
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Figure 8-1. A schematic representation of the experimental methodology during the pre and post-test. 
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Figure 8-2. A schematic representation of the experimental methodology during the training sessions. 
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8.4.4 Statistical Analysis  
Statistical analysis was performed using the statistical package, SPSS statistics 
version 25 for windows (SPSS, Inc, Chicago, IL, USA). 
Two-Way analysis of variance ANOVA was performed to examine the main effects of 
condition and time on; peak power (W), mean power (W), V̇O2max (ml·kg·min-1), 
haemoglobin concentration in blood (g·L-1) and mV̇O2 (µM-HB diff·s-1). 
α level set p = 0.05 for all data analysis. 
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8.5 Results  
This study primarily demonstrates that it is possible to design and implement a 
rigorous exercise study, whilst administering a blinded supplement during training 
sessions. Analysis shows that it is feasible to recruit, with large retention rates from the 
study commencement (77%), as well as being well received by participants. Although there 
was an initial pre-study retention rate of only 22%., adherence to training was 100%. The 
adherence of subjects wearing heart rate monitors during unsupervised training (Table 8-1) 
was 70% with training intensity data consequently not obtained.  
As shown in Table 8-2, mV̇O2 was  successfully obtained with 77% of the population, with 
the NIRS signals highlighting incomplete arterial occlusions (as documented in methods) 
during data analysis in 20 out of the 26 arterial measures. The incomplete arterial 
occlusions (33% of the total sample) was due to incomplete obtainment of NIRS signals 
(as documented in methods). No data was lost due to cessation of a measure due to 
discomfort with the arterial occlusions. 
 
When asked about how much the study inconvenienced them, 80% expressed it substituted 
normal training, with 20% expressing it was a burden with travel and additional training 
stress. Additionally, 90% of participants found all measures to be tolerable with small 
discomfort felt during the occlusions. The other 10% expressed they would not partake 
again if they had to take part in occlusions due to the discomfort it caused. No participants 
reported any side effects with the oxygen supplementation or Normoxia and would take 
part again in oxygen supplementation study in the future. 
 
Pre vs post-training represented in Table 8-2 shows positive changes in mV̇O2 (37%),  
haemoglobin concentration (~2 g·L-1), peak (4.1%) and mean (2.7%) cycling power (W) 
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following O2Supp, whilst not being statistically different from change experienced with 
Normoxia (p > 0.05). There was no significant main effect for time, group or interaction 
for any measures (p > 0.05).  
Figure 8-3 depicts representative data of the NIRS traces (O2Hb, HHb and tHb) during the 
three submaximal exercise occlusion procedures. 
Figure 8-4 shows individual mV̇O2 participant data at the pre and post training visits for 
O2Supp and Normoxia. The trend in the data shows that mV̇O2 increases pre to post 
following oxygen supplemented training. Training in Normoxia results in a small decline 
in mV̇O2. The mV̇O2 findings follow a similar trend as the performance variables (mean 
and peak power), it is evident that cycling power improves alongside mV̇O2. However, the 
control group did experience an increase in mV̇O2 as a result of normal endurance training 
during the intervention period. 
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Figure 8-3. Representative data depicting the process of occlusions. 
 
 
Figure 8-4. Individual participant changes in the slope of muscle oxygen consumption 
(mV̇O2) pre and post the training. Group average shown as solid black line.
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Table 8-2. Data from maximal exercise test and Wingate tests pre and post training for cyclists doing sprint interval training with oxygen 
supplementation or normal conditions and the control. 
 O2 Supplementation (n=5)  Normoxia (n=4)  Control (n=4)   
 Pre Post  Pre Post  Pre Post F Stat p-value 
V̇O2max (ml·kg·min-1) 46.10 ± 6.36 46.65 ± 7.78  45.14 ± 3.96 46.11 ± 5.82  48.42 ± 2.63 49.47 ± 6.21 F (2) = 0.037 p = 0.96 
Wmax (W) 340.00 ± 51.84 345.00 ± 
44.72 
 343.75 ± 42.70 362.5 ± 32.27  331.25 ± 37.50 356.25 ± 
51.54 
F (2) = 2.151 p = 0.17   
Peak power Wingate (W) 928.86 ± 79.06 967.32 ± 
29.50 
 989.25 ± 
137.88 
1028.50 ± 
133.29 
 1010.50 ± 
97.48 
1017.5 ± 7.32 F (2) = 0.256 p = 0.78 
Mean power Wingate (W) 650.14 ± 41.24 668.55 ± 
32.26 
 673.25 ± 33.23 692.00 ± 29.30  663.75 ± 67.91 663.50 ± 
72.96 
F (2) = 0.535 p = 0.60 
Haemoglobin concentration 
(g·L-1) 
155.40 ± 11.87 157.00 ± 
14.00 
 156.75 ± 6.24 159.75 ± 8.14  177.75 ± 16.34 167.75 ± 
13.74 
F (2) =0.900 p = 0.44 
mV̇O2 (µM-HB diff·s-1) † 0.11 ± 0.05 0.16 ± 0.06  0.15 ± 0.05 0.10 ± 0.01  0.10 ± 0.04 0.17 ± 0.01 F (2) =3.310 p = 0.10 
Values are mean ± SD. † n = 4 in O2Supp, n = 4 in Normoxia and n = 2 in control.   
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8.6 Discussion 
This feasibility study demonstrates that the application of NIRS to assess muscle 
oxidative capacity, pre and post a 3-week O2Supp intervention, is sensitive enough to detect 
changes in response to training and or supplementation. These findings were achieved 
following a mixed training intervention including supervised and unsupervised training. 
This study, therefore, provides support for the application of non-invasive biofeedback 
measures of muscle oxidative capacity within ‘real world’ training settings.  
 
The adherence to training was 100% throughout the study, however, the adherence of 
subjects wearing heart rate monitors during unsupervised training (Table 8-1) was only 
70% with training intensity data being lost in the process. It is reported that when people 
sign up to studies, they invest their time and effort, therefore the adherence to the proposed 
training is high. The participants that would have had lower adherence tend to drop out 
prior to the study’s commencement. There is little evidence to suggest that participants will 
adhere to training better during supervised vs unsupervised training, however, there is 
evidence to suggest this is the fact with diseased populations 206–208. It was found that 
adherence and training was elevated during supervised training sessions, even though 
supervised sessions were not always feasible (i.e. time consuming and expensive). These 
research studies also found that supervised training was much more effective during an 
intervention study than unsupervised training, although most report that improvements in 
unsupervised group are still greater than no training.  
It is important to ensure that all participants are fully aware of the demands of the study 
prior to participation. This was why this study experienced lower initial up take of 
participants but managed to have very high retention rate, each participant was fully aware 
of the task in hand. Further incentives other than data and training should be made available 
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to participants during training interventions. An increase in incentives may result in 
subsequent increases in initial participant up take, unlike the current study. 
 
There is a high requirement for unsupervised training within sport, as coaches are not 
always available to attend every session with every athlete. Coaches set training plans to 
include both supervised (typically HIIT) and unsupervised training (typically long duration 
endurance). This study trialled a reflection of this type of training practice, with the 
participants completing the high intensity work in the lab, then completing lower intensity, 
longer duration work ‘at home’.  
In future studies of this nature, we suggest further guidance and information need to be 
provided to participants to ensure that data collection is maintained. An increase in 
wearable technology is evident in the sports market, with the market’s growth at around 
20% per year 209. This leads itself to a change in behaviour and routine of athletes, athletes 
are using more technology in sport to aid training and feedback 210. Future studies may see 
an increase in adherence and retention due to athletes being more accustomed to wearing 
devices on their person.  
 
As shown in Table 8-2, mV̇O2 was only successfully attained with 77% of the population, 
with the NIRS signals highlighting incomplete arterial occlusions (as documented in 
methods) during data analysis in 20 out of the 26 arterial measures.  The incomplete arterial 
occlusions (33% of the total sample) was due to incomplete obtainment of NIRS signals 
(as documented in methods). No data were lost due to cessation of a measure due to 
discomfort with the arterial occlusions. 
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To account for the drop out and the sensitivity of the primary measure (mV̇O2 1.5-
2.5%)152,211,212, future studies will need to overpower their sample size. The sample size 
will need to account for the 23% drop out (of data) and the coefficient of variation (~17%) 
of the primary measure 75,213. A specific sample size analysis is problematic due to the 
novelty of the primary measure (mV̇O2) and the methodology applying that measure (6 
session HIIT intervention with arterial occlusions). The research is yet to establish the 
minimal detectable change (MDC) or the minimal clinically important change in mV̇O2 
using arterial occlusions (NIRS) following a training intervention.  
The absolute reliability was used to calculate the MDC of each measure with the following 
formula: MDC = Standard Error of Measurement X 1.96 X √2. The MDC indicates the 
minimal amount of change that can be interpreted as a real change in the primary measure. 
The MDC for mV̇O2 was calculated as 47.12%, therefore a change greater than 48% would 
infer meaningful results. This feasibility study identified changes between 45% and as high 
as 70% for the primary measure. Therefore increasing the sample size of each group to 
align with the upper limit of the research (n = 8-15) would infer meaningful changes in 
mV̇O2, whilst accounting for a loss of data of up to 25% 214–216. Additionally, using the data 
from this preliminary analysis to run a post hoc power analysis puts the sample size needed 
at n = 8 per group (α = 0.95, 1-β = 0.05, large effect size = 0.5 and medium correlation). 
 
Additionally, the process of arterial occlusion within this study was adapted from Southern 
et al., 75 and Jones et al., 74, who both suggested that repeated short occlusions (3-8 s) with 
short rest periods was possible to attain a measure of mV̇O2, however pilot testing in this 
study suggested this to be not possible. Testing established that repeat short duration 
occlusions using a rapid cuff inflator by Hockanson (as referenced by both Southern and 
Jones) was insufficient in the aforementioned time scale (confirmed by manufacture-
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Hockhanson). As a result, this study used a longer cuff inflation of 30 s to attain suitable 
mV̇O2 response using NIRS, which has also been used by Ryan et al., 217 on collegiate 
athletes, sedentary individuals and people with spinal cord injuries.  
 
The preliminary results of the effect of O2Supp during a 5-week high intensity sprint 
cycling intervention on muscle oxidative capacity, mean power output and peak power 
output, has only been investigated by one other study 140. Interestingly, the current study 
found that O2Supp elicited a trend towards meaningful differences in mV̇O2, whereas 
Cardinale et al., 140  found O2Supp did not change haematological (venous blood sample) 
or mV̇O2 parameters following training. The changes in muscle oxygenation evident in this 
study were also replicated in unpublished work by the authors, this highlights that there are 
changes as a result of O2Supp. These differences between studies is likely to be 
methodological differences (HIIT vs Endurance, venous blood vs capillary) rather than as 
a result of O2Supp. Cardinale et al., also found that even though no significant changes in 
haematological or mV̇O2 parameters were evident, the 6-week training programme did 
elicit increases in mean power output (20 km TT). They believe that the changes in 
performance were related to neuromuscular measures that were not assessed and not 
haematological or cardiorespiratory. This study did not measure neuromuscular changes 
however previous work by the authors has highlighted that this may be a potential 
mechanism for changes as a result of O2Supp (fibre recruitment) 
169. 
 
This study’s findings also showed that 3-week HIIT with O2Supp induced significant 
performance improvements (peak power output) compared to the control condition, with 
non-significant changes compared to Normoxia. Our findings contradict those of Kilding 
et al., 125 who found that 8 sessions of O2Supp HIIT was not sufficient at increasing 
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endurance performance any more than Normoxia condition. They highlight reasons for 
why they experienced limited findings; insufficient taper time, lack of neuromuscular 
measurements and reduced FiO2 0.6.  This differs from the current study due to the higher 
FiO2 1.0, although the duration (less than 1 week) given for a taper is a limitation for this 
study too.  
 
Our findings support the notion that O2Supp during high intensity cycling is a strong 
stimulus to increase the rate of muscle oxygenation, subsequently increasing mV̇O2. It is 
also interesting that the control condition experienced a large increase in mV̇O2 across the 
5-weeks, this data is shown within Table 8-1. Table 8-1 highlights that the control condition 
conducted a larger amount of low intensity endurance training without much high intensity 
training, which has also shown to increase muscle oxygenation 218. This shows that the 
current training programme is feasible at increasing muscle mV̇O2 but maybe not more so 
than low intensity endurance training. However, research has reported that HIIT has a 
higher rate of adherence, with participants enjoying it more than longer periods of 
endurance training 219. HIIT can therefore be applied to training studies where possible, to 
ensure retention and adherence, however the effectiveness of lower intensity training 
should not be forgotten and may be more appropriate for novice, older or less active 
population.  
 
For subsequent larger studies it would be prudent to increase the geographic scope of 
inclusivity to enhance the number of participants enrolling in the study to meet a priori 
sample size calculation. This suggests that a specific small geographic location is not a 
practical method of recruitment. Although, further geographic scope can result in increased 
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athlete drop out due to extensive travel time needed to complete a multi session week 
training intervention.  
 
To our knowledge this is the first study to report positive changes in mV̇O2 using NIRS 
during a multi week O2Supp intervention. This may be due to the training methodology (10 
x 15 s sprints 45 s recovery) eliciting a sufficient training stimulus for adaptation in muscle 
oxidative capacity, especially with the additional stimulus of O2Supp. Although a 6-session 
training intervention has been shown to be sufficiently long to observe changes in muscle 
oxidative capacity using NIRS 
14, a longer duration study (6 week with 12 sessions) may 
have shown further improvements in mV̇O2. Increasing the sample size and power by using 
a larger number of participants in a follow up study should be able to examine the 
relationship between mV̇O2 and power output in greater detail. This additional analysis 
may allow researchers to identify mechanisms behind such changes in both variables.  
 
Additionally, with a short turnaround of 48 h between sessions within this study, increasing 
the period of rest (taper) between the last training session and the post-test would have 
allowed for fatigue levels to drop and therefore, greater adaptation may have been 
measurable. It has been shown that a taper period of 7 days is effective at diminishing the 
effects of fatigue induced by intense training, whilst maximising physiological adaptation 
and resultant performance 220.  Therefore, increasing the time between the last training 
session and the post test could have enabled adaptation to be measured in the absence of 
fatigue. 
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8.6.1 Limitations 
This feasibility study has some limitations which are important to address in future 
larger study designs. Firstly, muscle oxidative capacity was measured by NIRS, a novel 
method to evaluate muscle oxidative capacity in this O2Supp research, and not by muscle 
biopsies, which is regarded as the ‘gold standard’ method, although muscle biopsies can be 
used for multiple additional analysis. However,  the non-invasive and real-time application 
of NIRS makes it desirable to coaches and athletes alike who have identified the need for 
wearable technologies to provide useful information 198. 
 
Secondly, blinding of the exercise physiologist to reduce bias. The single blind nature of 
this study may have led to experimenter bias, influencing the results, however standardised 
instructions and encouragement was given equally throughout ALL testing sessions.  
 
Finally, the lack of female participants incorporated within the study limits the scope of 
application of O2Supp to a narrower audience (male dominated). In a larger study, female 
participants should be sought after. Further recruitment strategies (female only sessions, 
wider geographic inclusion) should be applied to increase the female participation for 
future studies.   NIRS research currently focuses on male dominated studies due to a 
limitation in the depth of the near infrared signal – i.e. the depth of the infrared signal needs 
to be more than double the adipose tissue depth 69. Women generally have more 
subcutaneous fat than men and therefore, the depth of the infrared signal is not sufficient 
in these populations, decreasing the sensitivity of the desaturation profile and 
overestimating the overall oxygenation response.  
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8.7 Practical Application  
When combined with arterial occlusions, NIRS is a functional tool in which skeletal 
muscle oxidative capacity can be detected following training blocks, allowing coaches to 
make better informed decisions on the effectiveness of the training programme. 
Unsupervised training during HIIT is feasible for coaches to apply to training programmes 
to ensure adherence when used with the correct monitoring. O2Supp has reported no 
additional side effects from training, when used in an unpressurised reservoir bag during 
HIIT. 
 
8.8 Conclusion  
This novel study demonstrates that a 5-week, O2Supp repeat cycling exercise study 
with measures of NIRS is feasible. NIRS was shown to provide a measure of muscle 
oxidative capacity that was sufficiently sensitive to detect changes following O2Supp 
training. The training and testing approach appear successful supported by the high 
retention and adherence rates of the participants. The results highlight that O2Supp elicits 
increases in muscle oxidative capacity and increases mean power output. However, future 
studies will need to overcompensate the recruitment pool to consider trial uptake and loss 
of data.  
 
8.9 What Next? 
This chapter advances the research narrative within O2Supp research. This research has 
established an effective time to administer O2Supp (Chapter 4 & 5), it has ruled out 
potential mechanisms (Chapter 6) and it has started to evaluate other mechanisms (Chapter 
7), and now it has shown the effectiveness of O2Supp within a training study. Further 
research is needed to take the discussion points of this chapter and develop them into a 
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rigorous experimental study. This would further strength the narrative that O2Supp is an 
effective ergogenic aid within repeat sprint cycling.   
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9 - Chapter Nine: 
 Combined Analysis 
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9.1 Abstract 
9.1.1 Objectives  
Each experimental chapter evidenced that O2Supp permits a higher mean cycling 
power output during high intensity interval training (HIIT) than Normoxia. As each 
experimental chapter O2Supp used similar methodologies, we conducted a combined 
analysis using the data from each experimental chapter to highlight the effectiveness of 
O2Supp within a HIIT session, with particular focus on performance variables - mean and 
peak power output (W), and timing of performance decline.  
 
9.1.2 Design and Methods 
There was a combined sample size of 81 data sets (O2Supp = 41, Normoxia = 40, n 
= 35), Age 26.6 ± 7.8 years, stature 1.81 ± 0.54 m, mass 78.8 ± 10.4 kg. Data used for 
analysis was taken from experimental chapters when O2Supp and Normoxia were used 
throughout the entire session (sprints and inter sprint recovery) (experimental chapters 1 
through 4). Each session consisted of 10 x 15 s repeated cycling sprints on a cycle 
ergometer, interspersed with 45 s recovery.  
Repeated measures analysis of variance (ANOVA) were conducted to look for differences 
according to condition (O2Supp / Normoxia) for; performance with sprint 1 as a baseline 
for mean and peak power, and BLa (mmol·L-1) for each sprint (10 sprints) (condition X 
time). Further, ANOVAs were conducted to assess the differences in performance decline, 
and between mean power output (W) and peak power output (W).  
 
9.1.3 Results  
O2Supp training elicits positive meaningful improvements in mean sprint cycling 
performance using sprint one as baseline (increased by 16 ± 16 W, p < 0.01). 
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O2Supp helps with the attenuation of lactate accumulation and performance decline. Small 
reductions in peak power was evident (25 ± 17 W, p > 0.05). BLa levels were on average 
2 mmol·L-1 lower during O2Supp compared with Normoxia. Performance decline was also 
4% lower in O2Supp.  
 
9.1.4 Conclusion 
This analysis showed that O2Supp during repeated sprint cycling is beneficial for 
mean sprinting power and the attenuation of both performance decline and lactate 
accumulation. O2Supp has shown positive meaningful benefits for repeated sprint cycling 
and could be applied to acute HIIT training sessions.   
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9.2 Background  
Each of the previous chapters added small components to a larger narrative, ‘O2Supp 
is an effective ergogenic aid for repeat sprint cyclists’. Each of the previous studies have 
shown performance enhancing effects of O2Supp, some way or another. However, due to 
the relatively small sample size of each of the previous chapters some questions will 
remain. This forthcoming chapter will try to eradicate them but looking at all the data 
collected within the studies sprints and assess common themes.  
 
9.3 Introduction  
Oxygen supplementation is considered as a relatively new area of focus within the 
sports science community. There is only a small amount of research conducted with large 
samples sizes, meta analyses comparing modalities or effectiveness or  reviews that assess 
O2Supp research as a whole 
1,195,221. The research conducted during the previous 
experimental chapters categorically falls outside of these too, hence the design of this study. 
The haemodynamic meta-analysis by Smit et al., 221 focused on clinical populations 
(diseased patents) rather than sporting populations, therefore, the findings are not as 
relevant. Diseased populations by definition have sub optimum physiology therefore they 
react to stimuli (O2Supp) differently to healthy individuals. Additionally, the meta-analysis 
assessed multiple methodological changes, whereas the current study will be focused on a 
specific population and methodology with lots of data sets, to enable strong inferences to 
be made.   
The previous five experimental chapters were formulated to address specific research 
question within oxygen supplementation. The common factor between these chapters is 
that they all have a relatively small sample size. Each of the studies are sufficiently powered 
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for the primary outcome of each study (mean power output) but may not have sufficient 
power for analysis of secondary outcomes or for post hoc investigation.  
This combined analysis using data from five previous experimental chapters was devised 
to highlight the effectiveness of oxygen supplemented repeat sprint cycling on performance 
outcomes (power output & performance decline) and BLa in trained cyclists, when the 
sample size is 8 times that of its power calculation (n = 8 to 10 for the primary outcome).  
We have already shown that oxygen supplementation would enhance cycling performance 
to an extent greater than that of Normoxia, and that O2Supp would elicit reductions in BLa 
accumulation more so than Normoxia.  This section therefore aimed to demonstrate the full 
extent of the effects. 
 
9.4 Methodology 
9.4.1 Study Design 
Participant information from the experimental chapters was used for the combined 
analysis. Data sample size of 81 (O2Supp = 41, Normoxia = 40, n = 35, Age 26.6 ± 7.8 
years, stature 1.81 ± 0.54 m, mass 78.8 ± 10.4 kg)  
Only data from the full oxygen supplemented condition and the full normoxic condition 
were considered for analysis during this combined chapter. Experimental conditions HN, 
NH in experimental chapter 1, 2, 3 and 4 were not included in the analysis due to their 
varying duration and methodology (pre exercise or inter-sprint recovery).   
 
9.4.2 Experimental Protocol  
Variables 
The main three variables that were used for analysis were; mean power output (W), 
peak power output (W) and BLa concentration (mmol·L-1).  Peak sprinting power (the 
Page 195 of 254 
 
 
highest W achieved in each cycle) and mean sprint power (the average W produced during 
each 15 s cycle) were taken during the ten times 15 s repeated sprints. BLa concentration 
was taken during the inter-sprint recovery period (45 s). This is described in more detail in 
the literature review of this thesis (chapter 3.2.3). 
Mean power output was used to determine the extent of performance decline throughout 
the 10 repeated sprints. Performance decline is described in more detail in section chapter 
3.2.1.  
Additionally, mean (MPO) and peak power (PPO) output variables were used to assess 
performance changes during each subsequent sprint from baseline [ΔS1_MPO & 
ΔS1_PPO]. Sprints 2 to 10 were used for the analysis, sprint 1 was used as a baseline to 
consider participants performance level. 
 
Data handling 
Data from each of the experimental studies was combined to produce one large data 
set. Data from experimental chapter 1 through 4 screening process is documented in each 
relevant chapter and added together to formulate a larger data set.  
Experimental chapter 5 data was added to the large data set following a period of data 
handling. The data from participants training sessions was collated and sorted using the 
median of the six visits which provided one set per participant to use within the main data 
set. The data was subsequently rake weighted to consider the multiple visits from each of 
the participants (0.23 - NN and 2.63 - HH). Data was subsequently screened for outliers 
that were 2 standard deviations from the mean. Two values were removed from the data 
and imputed using estimation maximisation technique.  
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9.4.3 Statistical Analysis 
All statistical analysis was performed using the statistical package, SPSS statistics 
version 25 for windows (SPSS Inc, Chicago, IL, USA). 
Repeated measures analysis of variance (ANOVA) were conducted to look for differences 
according to condition (O2Supp / Normoxia) for change in performance across 10 sprints 
(ΔS1_MPO, ΔS1_PPO) and BLa (mmol·L-1) for each sprint (10 sprints) (condition X time). 
Additional, ANOVAs were conducted to assess the differences in performance decline 
between mean power output (W) and peak power output (W). Post hoc analysis was 
conducted using paired samples t-tests with Bonferroni correction on sprints at an 
individual level for change in mean power output, change in peak power output and BLa. 
α- level was set p = 0.05 for all data analysis. Effect size for individual measures were 
calculated and reported as Cohen’s d and interpreted using bounds as 0.2, 0.5, > 0.8, where 
they are small, medium and large respectively 170. 
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9.5 Results  
Change in Performance - Mean Power. There was a significant main effect on sprint 
performance across the 10 sprints (Time) when using sprint one as a baseline F (8,200) = 
33.31, p < 0.01, d = 2.31. There was no significant main effect for sprint performance 
according to condition F (1,25) = 0.96, p = 0.34, d = 0.39. An interaction effect was evident 
for mean power output between the conditions across the sprints (Condition X Time) (F 
(8,200) = 7.93, p < 0.01, d = 1.12). Figure 9-1 shows that as the repeated sprints progress, 
mean power output in the oxygen supplemented condition begins to plateau and then slowly 
decline, whereas, the Normoxia condition shows a continued decline until sprint 9. Both 
conditions show an effect of motivation and an end spurt during sprint 10. Post hoc analysis 
shows a higher a change in mean power output from sprint 1 for sprints 4 through 10, p < 
0.05. 
 
Change in Performance - Peak Power. There was a significant main effect of time 
on sprint performance across the 10 sprints when using sprint one as a baseline F (8,200) 
= 18.43, p < 0.01, d = 1.72. There was no significant main effect for sprint performance 
according to condition F (1,25) = 2.50, p = 0.13, d = 0.63. An interaction effect was evident 
for peak power output between the conditions across the sprints (Condition X Time) (F 
(9,200) = 7.12, p < 0.01, d = 1.07). Peak power during the oxygen supplemented condition 
maintains at a consistent level following sprint 1, with a small drop after sprint 7-9. On the 
other hand, the Normoxia condition maintains a greater level of peak power throughout the 
first 7 sprints with small decrements throughout and then maintain through to the finish. 
Peak power is maintained for longer in Normoxia than the oxygen supplemented condition. 
Post hoc analysis shows no significant differences in peak power output from sprint 1 for 
any of the sprints, p > 0.05. 
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Overall Performance Decline. There was no significant difference in overall 
performance decline across the two conditions F (1,31) = 0.92, p = 0.34 (Figure 9-4). The 
decline in performance in the Normoxia condition was 4% greater than the O2Supp 
condition.  
 
Blood Lactate. BLa accumulation was taken during inter-sprint recovery (Figure 9-
3). There was a significant main effect of time on lactate accumulation across the 10 sprints 
F (9,225) = 422.90, p < 0.01, d = 8.21. There was also a significant main effect for lactate 
accumulation according to condition (Condition) F (1,25) = 9.81, p < 0.01, d = 1.25. An 
interaction effect was evident for lactate accumulation between the conditions across the 
sprints (Condition X Time) (F (9,225) = 8.82, p < 0.01, d = 1.19). Figure 9-3 visually 
demonstrates the process of lactate accumulation across the 10 repeated sprints in both 
conditions (HH and NN). BLa in both conditions start off at a similar point but differs 
almost immediately. O2Supp condition continues to increase by around mmol·L
-1 after each 
sprint and peaks at 10 mmol·L-1. The Normoxia condition peaks at around 12.25 mmol·L-
1 and is on average 2 mmol·L-1 higher than O2Supp from sprint 3 onwards. Post hoc analysis 
shows no significant differences in lactate accumulation from sprint 1 for any of the sprints, 
p > 0.05. 
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Figure 9-1. Change in Performance - Mean Power Output (W) across 10 sprints with 
sprint 1 as a baseline (81 trials). * significant difference between condition (O2Supp 
and Normoxia) (p < 0.05). 
Legend = O2 Supplementation – HH, Normoxia – NN, Watts – W.  
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Figure 9-2. Mean lactate accumulation during the recovery periods interspersed 
between ten sprints (81 trials). 
Legend: O2 Supplementation – HH, Normoxia – NN. 
 
  
Figure 9-3. Overall Performance Decline throughout the 10 Sprints (mean power 
output) (81 trials). 
Legend: O2 Supplementation – HH, Normoxia – NN. 
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9.6 Discussion  
The combined analysis of this study was a combination of data from the previous chapters.  
The aim of this chapter was to demonstrate the full extent of performance improvements 
with O2Supp. The discussion points of this chapter inform the major discussion points of 
the thesis in its entirety. Therefore, the discussion is included in the following chapter 
(chapter 10).  
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10 - Summary: 
 Conclusions and Implications of Research 
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10.1 Summary of Experimental Chapters 
Experimental 
Chapter 
Chapter Aims Chapter Findings 
1 - To explore the effects of O2Supp, both during recovery and during 
cycling, on sprint cycle performance. 
To confirm the methodologies used throughout the latter thesis 
chapters. 
- 4% increase in mean power output during O2Supp. 
- O2Supp attenuated performance decline by up to 5%. 
2 - To determine whether O2Supp is more effective during or between 
repeat sprint intervals. 
- Continuous O2Supp appears to be more effective than discontinuous O2Supp for 
performance. 
- Continuous O2Supp condition attenuated decline in performance more than 
Normoxia. 
3 - To develop an understanding of the effects of O2Supp on repeat sprint 
cycling fatigue, using twitch interpolation technique. 
- Mean power output increased by over 4% during O2Supp. 
- No change in fatigue related measures (twitch interpolation)  
4 - To further develop an understanding of the effects of O2Supp on 
repeat sprint cycling using near infrared spectroscopy. 
- Increased muscle deoxygenation and reoxygenation rate with O2Supp (NIRS). 
 
5 - To explore the feasibility of using NIRS, arterial occlusions and 
repeated cycling sprints during a multi session training study with 
periods of supervised and unsupervised training. 
- To identify whether the proposed methodologies (NIRS) are sensitive 
enough to detect changes in muscle oxidative capacity using arterial 
occlusions. 
- NIRS is sensitive enough to detect small but meaningful increases mVO2 in the 
O2Supp group.  
- Training was well received by the participants with high adherence and retention 
rates. 
- All methods (NIRS, occlusions, training) were tolerable by 90% of the participants.  
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10.2 Summary  
The main aims of this thesis were to identify the extent to which O2Supp can be used 
as an ergogenic aid in both acute and chronic repeat sprint cycling training, and to begin to 
examine the underlying mechanisms. The literature review (chapter 2) identified that 
O2Supp research has limited comparable studies (studies with similar dosages and 
methodologies). Chapter 2 enabled the conception of the methodologies and research aims 
used throughout this thesis. Chapter 2 also introduced a broader overview of the literature 
within O2Supp research and addressed how O2Supp can affect repeat sprint cycling and the 
potential mechanisms behind these effects. Research for this chapter allowed for the 
formulation of the research questions that would later be addressed in the 5 experimental 
chapters.  
Research question 1 asked “during which component of a cycling training session is 
O2Supp most effective at increasing performance?”. Experimental chapters 1 and 2 were 
focused specifically on answering this question – when should oxygen supplementation be 
used? These experiments examined the three main periods that comprise a training session, 
the exercise period, the exercise recovery period between repetitions, and the longer period 
of recovery between main sets of work. It was reported that more components of a training 
session that are supplemented with oxygen, the greater the performance – i.e.  
supplementation during the recovery (s) and sprinting together was more effective than 
supplementation during the cycle or the recovery alone.  
It has been suggested that the increase in performance evident following O2Supp is due to 
the subsequent increase in PCr resynthesis following HIIT intervals 52,93. Although PCr 
changes were not measured during this thesis it is thought that it may be one of the main 
contributing factors for increased performance during O2Supp as stored ATP and PCr 
provides the energy needed during high intensity exercise lasting between 10-15 s. 
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Consequently, repeated sprint exercise continuously depletes PCr stores. A 45 s rest after 
10 s of high intensity exercise only replenishes ~75% of total PCr stores 164. Consequently, 
after several successive sprints in a series, PCr stores will become significantly diminished 
resulting in a reduced sprinting ability. Even though, the PCr energy system is anaerobic 
in nature, its resynthesis requires oxygen. The resynthesis of PCr occurs using products 
from both the Krebs cycle and aerobic glycolysis, which have been shown to be enhanced 
following the use of O2Supp 
99. Enhanced PCr resynthesis due to the consumption of 
hyperoxic gas 99,165 will allow performance to be maintained for longer as evident during 
experimental chapter 1’s results. 
 
Administering oxygen supplementation during inter exercise recovery was more effective 
than no supplementation, but not as effective as supplementation throughout the whole 
session. This advances the oxygen supplementation research, and specifically the works by 
Sperlich et al., Hauser et al., and Zinner et al., 1–3,7,121,136 by identifying that O2Supp in 
longer durations and during exercise and recovery is more effective than either alone. Using 
the data from experimental chapters 1 through 5 show that increasing the duration of 
O2Supp within a HIIT programme leads to increases in mean cycling performance and a 
reduction in both BLa accumulation and peripheral fatigue. This work can and should be 
applied to exercise modalities (running, field sports and rowing) and methodologies (HIIT 
with 1:3 work: rest ratio) similar to that of this thesis.  
 
The second question posed was – research question 2 ‘Which physiological mechanisms 
does O2Supp effect to allow for improvements in performance capacity?’. Experimental 
chapters 3, 4 and 5 were devised to further understanding regarding the mechanisms that 
underlie the beneficial effects of O2Supp effects. Experimental chapter 3 looked at the 
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effect of O2Supp on peripheral muscle fatigue. This allowed further understanding of how 
O2Supp attenuates peripheral fatigue whilst maintaining power output. It helped provide 
evidence that the mechanism for increased power must lie within the peripheral muscle 
belly. This was demonstrated during this chapter, using MVC, a global measure of fatigue. 
The force applied during the MVCs dropped by around 20% in the Normoxia condition, 
and by around 28% in the O2Supp condition. This shows that there was greater (albeit non-
significant) muscle fatigue as a result of the higher mean power output in the O2Supp 
condition. Interestingly, the change in PTF and %VA were broadly similar across 
conditions. The drop in voluntary activation (%) was small and less than 1.5% different 
between conditions. The drop in PTF however was large, although again similar between 
conditions (34 and 38%, Table 6-1). These results support the findings of Thomas et al., 
172, who report performance in shorter efforts is predominately curtailed by peripheral 
measures, rather than any central fatigue as proposed by Gandevia 28 and Nybo et al., 35. 
This was demonstrated in experimental chapter 3 when O2Supp led to a 4% increase in 
cycling performance (mean power) without changes in peripheral muscle fatigue.  
 
Using the findings from experimental chapter 3, experimental chapters 4 and 5 were 
devised to investigate mechanisms occurring within the peripheral muscle belly. These 
mechanisms would be identified using NIRS. Two significant findings occurred when 
investigating the effect of supplementary oxygen on muscle oxygen utilisation and 
reoxygenation. It was found during both acute (experimental chapter 4) and chronic 
(experimental chapter 5) exercise, muscle oxygenation and cycling performance increased 
more in the presence of O2Supp. In experimental chapter 4 both increased muscle oxygen 
reoxygenation and increased utilisation were experienced by participants in O2Supp 
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condition. This is the first research study that demonstrates increased muscle reoxygenation 
(NIRS) during O2Supp.  
The rate of recovery of muscle oxygen is one of most important aspect of fitness to a sprint 
trained athlete 52. The ability to flush out fatigue related metabolic by-products and the 
replenishment of fuel for successive sprints has obvious importance for performance. HIIT 
is highly reliant on the utilisation of PCr during exercise and exclusively upon aerobic 
processes (resynthesis) during periods of recovery 184. O2 Supp has been shown to be 
beneficial for sprint performance due to the increased resynthesis rate of cellular metabolic 
PCr 114,163. The significant increase in power output (3.95%), non-significant increase in 
the extent of ΔTSI (%) recovery and reoxygenation rate (%·s-1) seen here are potentially 
indicative of an enhanced PCr resynthesis profile 72. Though PCr resynthesis was not 
measured directly, muscle (re)oxygenation has been suggested by others to be 
representative of this 72,189,190. 
 
In future studies, NIRS could be applied to O2Supp research more frequently to definitively 
determine whether delivery or utilisation of the additional oxygen is the most important 
factor. From our research, we hypothesise that it appears to be increased utilisation, as 
evident through increases in resaturation, and larger desaturation profiles. Appling NIRS 
in conjunction with other mechanisms (such as peripheral fatigue, muscle biopsies and 
ventilation kinetics) will give insightful information into specific mechanisms to further 
develop O2Supp research.  
 
Experimental chapter 5 set out to identify the feasibility of O2Supp being applied to a 3-
week training intervention answering research question 3 - “Is O2Supp effective during 
chronic supplementation?”. The findings of this chapter highlighted that O2Supp is more 
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effective during single acute HIIT sessions, although small increases in mV̇O2 and 
performance were experienced with chronic O2Supp. These findings oppose those of 
Cardinale et al.,140 who found that O2Supp did not change haematological or mV̇O2 
parameters following training. Cardinale et al., also found that even though no significant 
changes in haematological or mV̇O2 parameters were evident, the six-week (8 session) 
training programme did elicit increases in mean power output (assessed via a 20km time 
trial). They state that the changes in performance were related to neuromuscular measures 
that were not assessed rather than haematological or cardiorespiratory alterations. 
Although, neuromuscular measures were not assessed in experimental chapter 5, chapter 2 
showed that peripheral muscle fatigue was not a significant factor in reducing performance 
following O2Supp. Thus, this thesis does currently not support the hypothesis of Cardinale 
et al., who believe neuromuscular factors to be a primary factor in performance change. 
 
It is also evident (experimental chapter 5) that O2Supp can be applied to multi session 
research (and training) with very high retention rates, with no immediate adverse side 
effects. Additionally, experimental chapter 5 evidences that NIRS is a sensitive measure 
for non-invasive detection of mV̇O2 during O2Supp. This chapter is the first of its kind to 
assess the feasibility of applying O2Supp to a short term HIIT intervention with sensitive 
non-invasive measures of biofeedback. This chapter lends itself nicely for a follow up study 
with increased sample size to assess the effectiveness of O2Supp as an ergogenic tool 
during chronic use.  
 
It can be shown throughout this thesis that O2Supp is a useful ergogenic aid for both acute 
and chronic repeat sprint cycling. O2Supp increased mean sprinting power, muscle oxygen 
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utilisation and reoxygenation, whilst attenuating performance decline and BLa 
concentration. 
It is suggested that an increase in muscle oxygen kinetics, PCr resynthesis, resulting in 
lower BLa concentration is why O2Supp elicits such large improvements in performance 
capacity. Therefore, if used during a full exercise session and administered at normal 
atmospheric pressure (1 ATM) oxygen supplementation is likely to become a popular 
training supplement.  
 
10.3 Key Findings 
The key findings of this thesis are: 
- O2Supp offers a new and effective ergogenic aid to cycling HIIT programmes. 
- This thesis is the first to consistently show supplementation with oxygen increases 
mean cycling power output by up to 4% compared to normal atmospheric 
conditions.  
- This thesis includes experimental chapters that show O2Supp increases the rate at 
which oxygen is utilised by the working muscles during exercise and subsequently 
these muscles reoxygenate faster during periods of recovery. This is a novel finding 
in the literature 
- The findings of this thesis highlight that O2Supp attenuated performance fatigue 
experienced during a HIIT session.  
- This thesis contains a novel first study to assess the feasibility of using O2Supp in 
a multi session training programme combined with non-invasive measures of 
muscle oxidative capacity.  
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10.4 Limitations 
This research has several limitations that could be potentially addressed in future 
research. Firstly, the rate of PCr resynthesis O2Supp is a key component of HIIT research, 
and a direct measure of PCr was not possible in the current methodology. A direct measure 
of PCr (via muscle biopsies or phosphorus nuclear magnetic resonance) would have 
supported the discussions during each of the experimental chapters and would have allowed 
slightly less speculation related to its response to supplementary oxygen. Ideally this 
measure would have been included in experimental chapter 2 through 5, however, 
methodological constraints in our lab meant this was not possible. Future research should 
incorporate a direct measure of PCr to detect changes in PCr resynthesis, further elucidating 
the changes due to O2Supp. 
Another limitation of this thesis is the exclusion of SaO2 measures from experimental 
chapters 2 through 5. SaO2 was measured during experimental chapter 1 with a very low 
degree of success. The common equipment used to measure SaO2 is a pulse oximeter 
typically placed on the index finger of a participant. This location is problematic for a 
cycling HIIT session, the participant grabs and squeezes the handlebars, as well as it being 
in a direct path for surface run off of sweat from the upper body. Both of these problems 
lead to the pulse oximeter detecting erroneous data on over 85% of the participants. Pulse 
oximeters were removed from experimental 2-5 due to the lack of consistent viable results, 
allowing participants to be non-restricted in holding the handlebars. Further research 
should incorporate a measure of SaO2 to understand the arterial oxygen fluctuations with 
O2Supp. It is recommended not to use finger based pulse oximeters, instead use forehead 
sensors 222. This method of pulse oximetry was not available during the course of this thesis. 
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Another, limitation of this thesis comes from experimental chapter 5 with the use of NIRS 
to measure muscle oxidative capacity, a novel method to evaluate muscle oxidative 
capacity in this O2Supp research, and not by muscle biopsies, which is regarded as the ‘gold 
standard’ method. However, the non-invasive and real-time application of NIRS makes it 
desirable to coaches and athletes alike who have identified the need for wearable 
technologies to provide useful information 198. 
 
Additionally, the single blind nature of the study is not the ‘gold standard’ for 
supplementation research. The single blind nature of this study may have led to 
experimenter bias, influencing the results, however standardised instructions and 
encouragement was given equally throughout ALL testing sessions. To increase the rigor 
of this study a double or triple blinding of the gas administration should be considered.  
Another limitation of this thesis is that all experimental chapter (1-5) were conducted using 
male participants only, thus reducing the ability to generalise. During the conception of 
experimental chapter 1 participants were recruited independent of sex, although no females 
partook in the research. All future experimental chapters subsequently recruited male 
participants only. Including females into experimental chapters would have led to further 
limitations as some researchers suggest exercise  response differences during menstrual 
cycle 223,224, due to hormonal fluctuations. Future research should identify the effectiveness 
of O2Supp on females’ exercise performance during different stages of their menstrual 
cycle however this was beyond of the scope of this thesis. 
 
10.5 Future Research 
The research in O2Supp as an ergogenic aid is still in its infancy. The research 
conducted within this thesis has both provided answers and more questions. Following on 
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from this thesis and addressing some of its limitations the following research questions 
could be addressed: 
- What is the primary mechanism that causes such significant increases in power 
output when O2Supp is used in HIIT programmes?  
- How can medical grade oxygen be administered in a safe and effective manner in a 
range of sporting environments? 
- How does the dose and duration of oxygen supplementation influence performance 
and recovery? 
 
Many hypotheses related to O2Supp are formulated using findings from the research 
conducted in high altitude studies, or medical pressurised oxygen settings. It is unlikely 
that the response of the body to hyperoxia is the exact opposite as its response to hypoxia, 
but the knowledge that altitude studies provide is a good starting point. For example, low 
oxygen tension stimulates the production of EPO in order to maximise available oxygen. 
The long-term effects of hyperoxia in relation to EPO and other blood components are, as 
yet, unknown. Similarly, whilst findings taken from studies on patients with respiratory 
disease who utilise hyperbaric hyperoxia are useful, it is likely that the nature of their 
disease reduces the transferability of any findings to athletes. 
Another important factor to consider is how to administer medical grade oxygen safely and 
effective to a wider sporting population. Research into the mechanisms underlying the 
success of O2Supp is increasing, therefore, the focus may begin to move toward how we 
make it widely accessible. Understanding the potential limiting factors in administration of 
oxygen will enable companies to produce suitable products. Companies such as Boost 
Oxygen© and Oxygen Plus© are already producing handheld aids, but their cannisters only 
hold enough for 1-2 min’ worth of oxygen. This thesis explicitly shows that O2Supp needs 
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to cover an entire cycling HIIT session lasting up to 15 min for it to be of any measurable 
benefit.  
 
10.6 Conclusion 
The work throughout this thesis addresses the effectiveness of O2Supp during a 
cycling HIIT programme and has highlighted most effective time to administer additional 
oxygen; it has also identified potential mechanisms involved (Figure 10.1). A key aspect 
of this thesis has been to identify the usability of O2Supp within a cycling HIIT training 
programme. 
The findings of this thesis suggest that O2Supp is most effective for performance during 
both the work and recovery durations within a HIIT training programme, with potential 
mechanisms being increased utilisation of oxygen at a muscle level. Another key aspect of 
this thesis is that O2Supp can be feasibly applied to a short-term training intervention with 
non-invasive measures of mV̇O2 being sensitive enough to detect changes, as evidenced by 
experimental chapters 3 through 5. The findings of this thesis emphasise the importance of 
O2Supp as an ergogenic aid, whilst highlighting that further work needs to be done before 
advocating its use to the wider sporting world.   
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Figure 10-1. Questions answered within this thesis.   
Literature Review 
Experimental Chapter 3 
Experimental Chapter 4 
Experimental Chapter 2 
Experimental Chapter 5 
What is oxygen supplementation? 
When is it most effective? 
What mechanisms does it use/ effect? 
Is oxygen supplementation effective 
during a short-term training 
intervention? 
Oxygen supplementation 
Experimental Chapter 1 
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12 – Appendices 
Additional information used throughout this thesis 
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12.1 Outline of Literature Review 
The literature review (chapter 2) provides a comprehensive overview of each aspect 
of this thesis. The literature review will focus on O2Supp– commonly referred to as 
hyperoxia, and its role within a high intensity interval training session, as well as the 
mechanisms it effects (such as muscle oxygenation and muscular fatigue). The literature 
review is followed by the detailed aim and hypotheses of the thesis.  
A methods section is included as chapter 3. This section details many of the methods, 
equipment and statistical considerations used repeatedly throughout the thesis. 
 
12.2 Outline of Experimental Chapter 1 – When is Oxygen supplementation 
Most Effective for Sprint Cycling Performance?  
Concurrent supplementation with oxygen (O2Supp) enhances performance but this 
type of delivery is not feasible in performance situations due to the equipment size 
(compressed gas cylinders) and expertise needed to administer it safely. Laboratory 
administration is needed to administer the gas in a controlled environment. This study 
aimed to determine when hyperoxic gas elicits the greatest effect on cycling performance. 
Specifically, we aimed to determine whether O2Supp given after a fatiguing task but prior 
to repeated sprints had a similar effect to when O2Supp was given during the repeated 
sprints alone. 
Eight trained male cyclists underwent four visits to the laboratory. Each session comprised 
a pre-fatiguing task (15 km cycling time-trial), 15 min recovery (FiO2 1.00 (H) or Normal 
(N) air), followed by 10 x 15 s repeated sprints (during which time H or N was given). 
Thus, the 4 conditions were NN, HN, HH & NH. Repeated measures ANOVAs (α set to p 
< 0.05) were used to examine difference between conditions in power output (peak and 
mean Watts). 
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Peak and mean power output were significantly increased during full hyperoxic (HH) 
compared with normoxic (NN) condition [4% and 3% respectively] (p < 0.05). 
O2Supp (FiO2 1.00) during recovery and exercise appears to elicit the greatest 
improvements in peak and mean power. This shows that use of supplementary oxygen is 
beneficial during maximal activity, and in recovery periods between exercise blocks. 
 
12.3 Outline of Experimental Chapter 2 – The Effect of Manipulating the 
Timing of Oxygen Supplementation on Repeat Sprint Cycling 
Performance 
The aim of this study was to determine the optimal time to administer oxygen during 
a repeat sprint protocol on cycling performance. 
Ten male amateur University students participated. Testing comprised four visits to the 
laboratory in a counterbalanced design. Each session entailed; 5 min cycling warm up 
(~200 W), 5 min passive recovery, followed by 10 x 15 s repeated sprints interspersed with 
45 s passive recovery, during which the air inspired was manipulated using a FiO2 of 1.00 
or 0.21 (normal air). The inspired air during the sprints and/or the recovery periods, 
determined the four conditions: NH, HN, HH, NN. For example, in HH, participants had 
supplementary oxygen during the 10 sprints and the 45 s recovery periods, whilst in HN, 
participants had supplementary oxygen during the sprints, but normal air during the 
recovery periods. It was hypothesised that the HH condition would evoke the largest 
performance improvements.  
Outcome measures included, mean power (W), performance decline (%) and BLa 
(mmol·L-1). Repeated measures ANOVA were used to examine differences between 
conditions in outcome measures.  
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There was no significant effect of O2Supp on mean power (W), BLa (mmol·L
-1) or 
performance decline (%) (p > 0.05). However, a common trend in HH condition was 
evident, with lowest levels of lactate accumulation and the shallowest decline in 
performance across the 10 sprints. 
However, it appeared that non constant O2Supp during repeat sprint cycling has a negative 
effect on performance when administered in short (15-45 s) interchangeable bouts during 
a training session. Therefore, oxygen supplemented training during short durations of a 
training session (HN, NH) is not as effective for maximising performance compared to 
training with oxygen throughout. 
 
 
12.4 Outline of Experimental Chapter 3 – The Effects of Oxygen 
Supplementation on Repeated Sprint Cycling Performance and Muscle 
Fatigue 
Oxygen supplementation (FiO2 > 0.21) can evoke performance improvements in 
aerobic and anaerobic exercise. The aims of study 3 were to determine the effects of 
breathing hyperoxic gas (FiO2 1.00) on repeated cycle performance, and to assess the nature 
and extent of fatigue after intermittent sprinting. 
Testing (n = 14 males) comprised two visits to the laboratory. Each session involved 10 x 
15 s repeated cycle sprints breathing FiO2 1.00 (O2Supp) or FiO2 0.21 (Normoxia). Muscle 
fatigue was measured pre and post sprints using maximal voluntary contraction (MVC), 
voluntary activation (VA) and potentiated doublet twitch (PTF). Blood lactate (BLa) was 
taken between sprints. 
Paired samples t-tests were used to examine differences between conditions in power 
output (peak and mean Watts) and BLa. Two-way ANOVA was used to examine fatigue 
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variables pre and post sprints according to condition. Effect sizes were also calculated and 
reported as Cohen’s d. 
Mean power output was 4% greater in O2Supp (p < 0.01), with no difference in peak power 
(p > 0.05). There was a significant increase in BLa in O2Supp compared with Normoxia (p 
< 0.01) in sprints 4 and 8, with large but non-significant differences in sprints 5-7 and 9-
10. Despite the greater mean power achieved, there was no significant difference in 
measures of muscle fatigue (MVC, VA and PTF) (p > 0.05) in response to the cycling, 
although a large drop in PTF occurred in both conditions implying an decrease in the 
potentiation of the muscle (fatigue). 
O2Supp can elicit improvements in mean cycling power, with no significant change in post 
exercise muscle fatigue. O2Supp as a training aid may provide performance enhancing 
effects during repeated sprint cycling by reducing concurrent muscle fatigue, primarily via 
peripheral factors.  
 
12.5 Outline of Experimental Chapter 4 – The Use of Acute Oxygen 
Supplementation Upon Muscle Tissue Saturation During Repeat Sprint 
Cycling 
This study examined performance (power output) and physiological responses 
(Tissue Saturation Index- a measure of muscle oxygenation status) to repeat sprint cycling 
with O2Supp (FiO2 1.00).  
Fourteen amateur male cyclists participated. Testing comprised two visits to the laboratory. 
Sessions entailed; 15 min relative intensity warm-up, 10 min of passive recovery, followed 
by 10 x 15 s repeated sprints, during which air inspired had FiO2 1.00 oxygen or normal 
air.  
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Outcome measures included mean power (W) and change in TSI (ΔTSI%). Repeated 
measures ANOVA were used to examine difference between conditions in mean power 
output for each sprint. Paired samples t-tests were used to examine differences between 
conditions in ΔTSI (%) and rate of muscle reoxygenation and deoxygenation (%·s-1). 
Pearson’s correlation tests were used to identify the relationship between power output and 
muscle reoxygenation rate between conditions.  
Mean power output was 4% higher in the oxygen condition compared to Normoxia (p < 
0.01). There was a significant positive correlation between power output and reoxygenation 
rate during O2Supp (r = 0.65, p = 0.04). No correlation was seen between power output and 
reoxygenation rate during Normoxia (r = -0.30, p = 0.40).  
O2Supp (FiO2 1.00) appears to elicit the greatest performance improvements in mean 
power, whilst increasing muscle reoxygenation. This novel research is the first to show 
positive increases in muscle oxygenation with O2Supp and to suggest the mechanisms 
behind benefit of supplementary oxygen on sprint performance. 
 
12.6 Outline of Experimental Chapter 5 – The Feasibility of Using Near 
Infrared Spectroscopy to Assess Muscle Oxidative Capacity following 3 
Weeks Training with Oxygen Supplementation 
The primary aim of this study was to assess the feasibility of using near infrared 
spectroscopy (NIRS) utilising arterial occlusions to measure muscle oxidative changes 
during a multi week training intervention with oxygen supplementation (O2Supp). 
Secondary aims were to assess recruitment and adherence to training and the ability to 
collect training data from both supervised and unsupervised training sessions of 
participants. 
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13 amateur level cyclists performed 3-week training block consisting of two supervised 
HIIT sessions a week and additional unsupervised sessions 2-4 times a week. Participants 
were randomly allocated to either O2Supp (FiO2 1.00, n = 5) or Normoxia (FiO2 0.21, n = 
4) during the supervised training. An addition control group (n = 4) undertook only 
unsupervised training. Muscle oxygenation and muscle oxidative capacity together with 
peak cycling power (W) and V̇O2max (ml·kg·min-1) were tested pre and post training 
intervention. 
Analysis shows that it was feasible to recruit to this type of study, with large retention rates 
(77%), and that the intervention well received by participants. Adherence to both training 
sessions (supervised and unsupervised) was 100%, with some losses in data during 
unsupervised training. No participants reported side effects with the oxygen 
supplementation. The measurements used (NIRS with arterial occlusions) were effective 
at detecting positive changes within muscle oxidative capacity. Additionally, O2Supp led 
to small non-significant changes in pre and post measure of mean power output (18.41 ± 
30.43 W), peak power output (38.46 ± 77.22 W) and V̇O2max (0.45 ± 2.52 ml·kg·min-1). 
This study demonstrates that a short cycling exercise intervention using NIRS to assess 
change is feasible. This is supported by the high retention and adherence rates. The results 
show that O2Supp training elicits increases in muscle oxidative capacity and small 
increases in mean power output. Our measure of muscle oxidative capacity using NIRS 
and arterial occlusions was sensitive enough to detect positive changes to short term 
training. However, future studies will need to overcompensate the recruitment pool to 
consider trial uptake and loss of data.  
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12.7 Chapter Combining Experimental Data 
Each experimental chapter has evidenced that O2Supp permits a more sustained 
cycling power output during high intensity interval training (HIIT). As each experimental 
chapter O2Supp used during similar methodologies, we hypothesised that a combined 
analysis using the data from each experimental chapter could provide greater statistical 
power to  explore the effectiveness of O2Supp within a HIIT programme, with particular 
focus on performance variables - mean and peak power output (W), and performance 
decline.  
There was a combined data set of 81 (O2Supp = 41, Normoxia = 40). Data used for analysis 
was taken from experimental chapters when O2Supp and Normoxia were used throughout 
the entire session (sprints and inter sprint recovery) meaning experimental chapters 1 
through 4. Each session in these chapters consisted of 10 x 15 s repeated cycling sprints on 
a cycle ergometer, interspersed with 45 s recovery.  
Repeated measures analysis of variance (ANOVA) were conducted to look for differences 
according to condition (O2Supp / Normoxia) for change (from sprint 1 to 10) in mean and 
peak power and BLa (mmol·L-1) for each sprint (10 sprints) (condition X time). t-tests were 
conducted to assess the differences in performance decline between mean power output 
(W) and peak power output (W).  
O2Supp training elicits positive meaningful improvements in mean sprint cycling 
performance using sprint one as baseline (increase by 16 ± 19 W). Small reductions in raw 
peak power was experienced (25 ± 23 W) with O2Supp. Performance decline was also 4% 
lower in O2Supp.  
 
O2Supp helps attenuate lactate accumulation and performance decline. BLa levels were on 
average 2 mmol·L-1 lower during O2Supp compared with Normoxia.  
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This analysis showed that O2Supp during HIIT is beneficial for mean sprinting power and 
the attenuation of both performance decline and lactate accumulation. O2Supp has shown 
positive and meaningful benefits for cycling HIIT and could be applied to acute HIIT 
training programmes.  
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12.8 Systematic Literature Search 
This literature summary followed the PRISMA guidelines 225 that were deemed 
acceptable for this review. PRISMA has four main sections, it was deemed that the methods 
section (structured search terms, and inclusion and exclusion criteria) and results section 
(study selection) were only relevant to this literature summary.  Identifying funding, risk 
ratios, data handling, synthesis of results and the analysis of key groups, were not suited 
for this review.   
Studies were identified for literature summary using a variety of electronic and paper 
databases: Web of Science (performed on 24th November 2016), Pubmed (performed on 
24th November 2016), and Google Scholar (performed on 24th November 2016) with the 
search criteria; ‘Post exercise hyperoxia’, ‘hyperoxia exercise recovery’, ‘recovery’, 
‘fatigue’, and ‘central and peripheral fatigue’. In the region of 600 studies were identified 
for review. Only journal articles and abstracts published between 1990 till September 2016 
were considered for this literature analysis. Relevant journals published between December 
2016 and 2019 were added for detailed ongoing review of the literature.  
Procedures for selecting and evaluating the effectiveness of the articles were adapted using 
the Quality of Reporting of Meta-analyses (QUOROM) statement where applicable 226. 
Both titles and abstracts were screened for suitability, and any duplicates were removed. 
Those papers that cleared scrutiny based on their title and/or their abstract, were 
subsequently read in full to confirm their suitability.   
600 articles were identified following the literature search, with only 68 studies meeting 
our inclusion criteria. This is due to them not meeting all our inclusion criteria. As well as 
this a number of 240 papers were excluded due them being off topic when reviewed in 
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detail. Figure 12-1. shows the process of eliminating articles and finalising the journals to 
be reviewed.   
 
Figure 12-1. Illustrates the process of eliminating articles based on selection criteria. 
 
Papers must meet both inclusion criteria’s, these were; (1) participants had to be healthy in 
complete absence of any type of disease, (2) be within an age range of 16 and 50 years old. 
This ensures participants can partake off their own volition and are physically capable to 
participate in the study.  
Studies were excluded if they included any of the subsequent terms; “children”, “disease”, 
“elderly adults”, “animals”. Articles were also excluded if they were not originally written 
in English. During the original literature searches papers were excluded if they were written 
prior to 1970, although multiple papers were used if they were cited by more than 10 of the 
How many studies after 
relevant literature search? (n = 
600) 
Removed due to not meeting 
inclusion criteria. (n = 240) 
Studies included within 
review. (n = 68) 
How many removed due to 
title/ abstract? (n = 266) 
Removed due to duplicates. 
(n = 26) 
Papers excluded after abstract 
analysis with reasons (n = 240). 
136: Diseased/ clinical 
Population  
38: Age 
23: Animal study 
18: Non-English transcript 
25: Other 
Page 254 of 254 
 
 
papers that were included in the final article list. Papers were also included if they were 
used for definitions or ground-breaking findings but fell outside the inclusion date range.  
